Unnamed: 0,patient_filename,t,text,type,n,cmem_t_is_parsed,cmem_t_reasoning,cmem_t_rules_str,cmem_t_ans_str,cmem_t_memory_str,cmem_t_memory_len,cmem_t_memory_str_len,cmem_t_edit_distance,cmem_t_is_updated
743,TCGA-AN-A046.1304FB17-A20A-4EBC-9CC8-1554808AC1F6,1,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Right Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Radical mastectomy Grade: 2. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,BRCA,0,True,"The T stage is determined by the size of the tumor. According to the report, the patient underwent a radical mastectomy, which involves removing the entire breast. The tumor was described as infiltrative ductal carcinoma and was graded as a 2. The T stage was reported as T2. The T stage is determined by the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being a tumor of any size with direct extension to the chest wall or skin. Since the report specifies T2, the size of the tumor is more than 2 cm but not more than 5 cm.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.",5.0,257.0,,
1216,TCGA-E2-A15F.19360B66-C514-4EE1-ACD7-08873828133E,0,"SPECIMENS: A. UPPER OUTER QUADRANT LEFT BREAST. B. LEFT BREAST CANCER. C. SLN #1. D. SLN #2. E. SLN #3. SPECIMEN(S): A. UPPER OUTER QUADRANT LEFT BREAST. B. LEFT BREAST CANCER. C. SLN #1. D. SLN #2. E. SLN #3. INTRAOPERATIVE CONSULTATION DIAGNOSIS: A- upper outer quadrant left breast: Lesion 2 mm from posterior margin. B- left breast cancer: Tumor at anterior margin. TPC, TPD, TPE-sentinel lymph node #1, #2, #3: No tumor seen. Diagnoses called by Dr. to Dr. at. (C, D, E) and. I. (A,B). GROSS DESCRIPTION: A. UPPER OUTER QUADRANT LEFT BREAST. Received fresh labeled with the patient's identification and ""upper outer quadrant left breast"" is an oriented (single-. anterior, double-lateral) 18 g, 2.5 x 2.5 x 2 cm needle localized lumpectomy with radiograph. Ink code: Anterior-. yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-orange. Specimen is serially sectioned from. lateral to medial in to 8 slices revealing a 0.5 x 0.4 x 0.3 cm firm fibrous area with hemorrhage that is closest to the. posterior margin at 0.2 cm. Representatively submitted: A1: lateral margin, perpendicular sections. A2: slice 3, posterior superior. A3: slice 4, anterior/superior. A4: slice 4, posterior superior (mass). A5: slice 4, anterior/inferior. A6: slice 6, posterior inferior. A7: slice 5, superior (mass). A8: slice 5, inferior. A9: slice 6, inferior. A10: slice 7, superior. A11: slice 7, inferior. A12: medial margin, perpendicular sections. B. LEFT BREAST CANCER. Received fresh labeled with the patient's identification and ""left breast cancer"" is an oriented (single-anterior, double-. lateral) needle localized lumpectomy with radiograph. Ink code: Anterior-yellow, posterior-black, medial-green,. lateral-right, superior-blue, inferior-orange. Specimen is serially sectioned from medial to lateral into 7 slices. revealing a 1.8 x 1.5 x 1.5 cm firm tan stellate mass that is closest to the anterior margin at less than 0.1 cm. Tissue. is procured. Representatively submitted: B1-B2: medial margin, perpendicular sections. B3: slice 2, anterior/inferior. B4: slice 3, mid section. B5: slice 3, anterior/inferior. B6: slice 4, anterior/superior (mass). B7: slice 4, posterior superior. B8: slice 4, anterior/inferior. B9: slice 4, posterior inferior. B10: slice 5, anterior/superior (mass). B11: slice 5, posterior superior. B12: slice 5, anterior-inferior (mass). B13: slice 5, posterior inferior. B14: slice 6, anterior/inferior. B15: lateral margin, perpendicular sections. C. SLN #1. Received fresh labeled with the patient's identification and ""SLN #1"" is a 2 x 1.5 x 1 cm piece of adipose tissue. containing a 1.5-cm lymph node. It is sectioned and a touch prep is performed; lymph node is submitted entirely in. cassette C1. D. SLN #2. Received fresh labeled with the patient's identification and ""SLN #2"" is a 1.5 x 1 x 0.3 cm piece of adipose tissue. containing a 0.5-cm lymph node. A touch prep is performed in the lymph node is submitted entirely in cassette D1. E. SLN #3. Received fresh labeled with the patient's identification and ""SLN #3"" is a 2 x 2 x 1 cm piece of adipose tissue. containing a 2-cm lymph node. Specimen is sectioned, touch prep is performed, submitted entirely in cassette E1. DIAGNOSIS: A. BREAST, LEFT OUTER QUADRANT: - BREAST TISSUE. - RADIAL SCAR. - PREVIOUS BIOPSY SITE. - NO MALIGNANCY IS SEEN. B. BREAST, LEFT, EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE II, MEASURING 0.5-CM. - DUCTAL CARCINOMA-IN-SITL NUCLEAR GRADE 2/3, SOLID TYPE. - LYMPHOVASCULAR INVASION IS SEEN. - TUMOR IS VERY CLOSE TO THE ANTERIOR MARGIN (<1 MM). PREVIOUS BIOPSY SITE CHANGES. SEE SYNOPTIC REPORT. C. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NEGATIVE FOR METASTATIC CARCINOMA (0/1). D. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NEGATIVE FOR METASTATIC CARCINOMA (0/1). E. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NEGATIVE FOR METASTATIC CARCINOMA (0/1). SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: B: LEFT BREAST CANCER. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.8cm. Additional dimensions: 1.5cm x 1.5cm. Tumor Site: Upper outer quadrant. Margins: Negative. Distance from closest margin: Less than 0.1cm. anterior. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. /ascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/3. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 5%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: Low. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative. Performed on Case: outside core biopsy. Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: 1) upper outer quadrant radial scar by core biopsy. 2) 12 o'clock invasive cancer. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 7. CLINICAL EXPERIENCE: Patients with a recurrence score of: 7 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 6%. ER Score: 11.4 Positive. PR Score: 9.7 Positive. Her2 Score: 8.9 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. The maximum tumor size from the gross description and all slides of the tumor is 1.8cm,. The smaller measurement 0.5cm in the diagnosis refers to a partial tumor measurement. from a representative slide of the tumor. The maximum tumor size 1.8cm is the total final measurement used for the cancer staging. in this case. The stage remains unchanged pT1c pNO. Case discussed with Dr. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.",BRCA,0,True,"The maximum tumor size from the gross description and all slides of the tumor is 1.8 cm. According to the rules provided, T1 tumors are 2 cm or less in size. Therefore, the tumor in this report is a T1 tumor.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.",6.0,308.0,91.0,True
898,TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE,1,"Final Diagnosis. A. Breast, left, simple mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III). [tubules 3/3, nuclei 1/3, mitoses 1/3; Nottingham score 5/9] is identified forming a mass (4.8 x. 2.7 x 1.9 cm) located in the lower outer quadrant of the breast. Biopsy site changes are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. Lobular. carcinoma in situ is also present. All surgical resection margins, including the deep margin, are. negative for tumor (minimum tumor free margin, 0.3 cm, deep margin and 0.5 cm, superficial. margin). With available surgical material, the AJCC staging is pT2NXMX (see comment). B. Breast, right, simple mastectomy: Benign nonproliferative breast parenchyma. C. Lymph nodes, left axillary, lymphadenectomy: Multiple (14) lymph nodes are negative for. tumor. D. Lymph nodes, left lowest axillary, lymphadenectomy: Fibroadipose tissue, negative for. tumor. No lymphoid tissue identified.",BRCA,1,True,"The tumor size is 4.8 x 2.7 x 1.9 cm, which is larger than 2 cm but not larger than 5 cm. This falls under the 'T2 tumors' category according to the rules provided.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.",8.0,414.0,85.0,True
586,TCGA-A7-A26J.5CC0C09F-70F6-458A-B8E6-18BDC074BE74,1,"Date Coll: SPECIMEN. A. Left axillary sentinel node. B. Left breast silk on superior breast. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left breast cancer. CLINICAL HISTORY: year-old white female with cancer. POST-OP DIAGNOSIS: Same. GROSS DESCRIPTION. A. Received fresh labeled ""left axillary node"" is a 3.8. x. 2.4 x 0.6 cm. portion of soft, lobulated golden-yellow. adipose tissue. Two (2) slightly rubbery tan-pink tissues in. keeping with lymph node measuring 0.8 and 1.8 cm. in greatest. dimension are recovered. The specimen is entirely submitted in. three blocks as labeled: BLOCK SUMMARY: #A1,A2 - One (1) bisected lymph node per cassette;. -1 adipose tissue. B. Received fresh labeled ""left breast"" is a 21.5 cm. (superior to inferior) x 20.5 cm (medial to lateral) x 3.8. cm (anterior to posterior) diffusely cauterized soft, lobulated. tan-gold-white portion of fibroadipose tissue in keeping with breast. designated as left per requisition slip and container and oriented. by a single suture as stated previously. A 7.2 cm (medial to. lateral) x 4.7 cm (superior to inferior) tan-white skin ellipse is. present along the anterior aspect. The intact deep margin is inked. black and the specimen is sectioned. There is a central, stellate,. 3.0 cm (medial to lateral) x 2.2 cm (superior to inferior) x 2.0. cm. (anterior to posterior) rubbery tan-white lesion at the junction of. the four quadrants with several cylindrical tan-white structures in. keeping with site of prior needle core biopsy. A portion of the. lesion and a portion of normal are submitted for tissue procurement. as. requested. The lesion is present within 0.8 cm of the skin. surface in the vicinity of the nipple and is within 0.5 cm of the. inked deep margin. The parenchyma throughout the remainder of the. specimen consists predominantly of glistening lobulated golden. yellow adipose tissue with a moderate amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality. is identified. Three rubbery white-pink tissues in keeping with. lymph nodes measuring up to 0.8 cm in greatest dimension are. recovered from the lateral aspect of the specimen. Representative. sections are submitted in 12 blocks as labeled. BLOCK SUMMARY: 1-2 - Tumor to inked deep margin; 3-4 - tumor to. skin (4 includes nipple); 5-6 - tumor to adjacent parenchyma; 7 -. random upper outer quadrant; 8 - upper inner quadrant; 9 - lower. inner quadrant; 10 - lower outer quadrant; 11 - two whole lymph. nodes; 12 - one bisected lymph node. MICROSCOPIC DESCRIPTION. Invasive carcinoma: Histologic type: Ductal (with lobular features). Histologic grade : III. Overall grade: 8/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 2. Greatest dimension (pT) : 3.0 cm. Specimen margins: Negative. Vessel invasion: Present. Calcification: Negative. Nipple (Paget's) : Carcinoma involves the deep nipple tissue, and. is present in the deep dermis within the skin adjacent to the. nipple (areolar area) . Invasion of skin or chest wall: As above. Ductal carcinoma in situ: Histologic pattern: Cribriform. Nuclear grade: 3. Central necrosis: Present. 8 DCIS of total tumor (if mixed) : < 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes,. fibroadenomata. Comments: Prior biopsy site identified within the main tumor mass. There is an additional satellite nodule of invasive tumor, 2 mm in. greatest dimension, in the lower outer quadrant, away from the main. tumor mass, and associated with ductal carcinoma in-situ. This. focus of invasive tumor is 2 mm from the deep margin. Lymph nodes: Two negative sentinel lymph nodes, and two negative. additional lymph nodes (0/4). Prognostic markers: See previous report,. 4x2. DIAGNOSIS. A. Sentinel lymph node, left axilla, biopsy: Two negative lymph nodes (0/2). B. Breast, deft mastectomy: Invasive ductal carcinoma, grade III, 3.0 cm in greatest. dimension. Negative margins of excision. Lymphovascular invasion identified. Two negative lymph nodes (0/2). ectronic Signature). End Of Report ---.",BRCA,0,True,"The report indicates that the greatest dimension of the tumor is 3.0 cm, which falls within the size range for a T2 tumor (more than 2 cm but not more than 5 cm in size). The T stage is determined by the size of the tumor, and the maximum tumor size is used for cancer staging. Therefore, the T stage for this patient's cancer is T2.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.",9.0,510.0,90.0,True
1514,TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800,2,"Research Gross Description. Research Dx. Left breast (1945 g), mastectomy: Invasive lobular carcinoma. 7 regional lymph nodes, negative for malignancy (0/7). Tumor site: Upper outer quadrant ( 2-3:00). Tumor size: Between 7 and 9 cm. Histopathologic type: Invasive lobular carcinoma. Histopathologic grade (Nottingham): 2. Mitotic count: Low proliferative rate. Pathologic tumor stage: pT3. Margin status: Distance of carcinoma from margins: Superior: 0.8 cm. Inferior: At least 1 cm. Medial: Greater than 2 cm. Lateral: Greater than 2 cm. Anterior: 1 cm. Posterior: Greater than 1 cm. Associated in situ carcinoma: Type: Lobular carcinoma in situ (rare focus). Extensive (>25% of total tumor): No. Separate (extra-tumoral) foci away from main lesion: Not identified. Peritumoral angiolymphatic invasion: Not identified. Dermal angiolymphatic invasion: Not identified. Estrogen receptor: Positive (70 % of tumor cell nuclei staining moderately to strongly). Progesterone receptor: Positive (70 % of tumor cell nuclei staining moderately to strongly). HER-2/neu (ERBB2): Negative (score 0). Duration of fixation in 10% NBF: 12 hours 24 minutes. Appropriate internal and external controls: Yes. Standard assay conditions met? Yes. Pathologic lymph node stage: pNO (including sentinel): No regional lymph node metastasis. Number of nodes positive for metastasis/total number nodes sampled: 0/11. Maximum diameter of largest lymph node metastasis: Not applicable. Extranodal extension by tumor: Not applicable. Distant metastasis: M-not applicable. Additional pathologic findings: Fibrocystic change and usual ductal hyperplasia; seborrheic. keratosis. TNM descriptors (if applicable): AJCC Staging (7th Edition): pT3 pNO M-not applicable. Research QC. T1 Tumor: 50% tumor nuclei. 0% necrosis. 50% normal. Normal: 100% fibroadipose. 1. T2. 50% tumor nuclei. 0% necrosis. 50% normal fibrous tissue and fat. minimal normal breast. T3. 70% tumor nuclei. 0% necrosis. 30% normal. T4. 50% tumor nuclei. 0% necrosis. 50% normal fat, could prob be trimmed. Research Specimen. Specimen Process Time. Blood draw time. Plasma frozen time: Serum frozen time. Buffy coat frozen time: Cold ischemia start time: Formalin fixation start time: Total cold ischemia time: Formalin fixation stopped time. Total formalin fixation time: Specimen Weight. Cryovials x 8. Normal X 4 - 1.) 335 mg 2.) 321 mg 3.) 408 mg 4.) 447 mg. Tumor x 4 - 1.) 351 mg 2.) 357 mg 3.) 252 mg 4.) 322 mg. Specimen Size. Plasma x 3. Serum x 2. Buffy coat X 1. Cryovials X 8. Normal x 4. Tumor X 4. FFPE x 8. Normal x 4. Tumor x 4. Study. Patient Consent. 2.",BRCA,0,True,"The report states that the tumor size is between 7 and 9 cm, which falls within the criteria for a T3 tumor (more than 5 cm in size) according to the provided rules.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage.",T3,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage.",10.0,567.0,95.0,True
640,TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 3.5 cm) with focally. marked intraductal patterns of spread. Concluding tumor classification: NOS, G III, pT2N1aLOV0RX. IGA-A8-A0S4-01A-PR.",BRCA,1,True,"The report states that the tumor diameter is 3.5 cm. According to the rules provided, T2 tumors are more than 2 cm but not more than 5 cm in size. Therefore, the T stage for this report is T2.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",11.0,783.0,84.0,True
773,TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6,1,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 2b M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,BRCA,2,True,"The report specifies a T Stage of 2, which according to the rules indicates that the tumor is more than 2 cm but not more than 5 cm in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",11.0,783.0,100.0,True
791,TCGA-AO-A0J5.5EFC16F4-7FC7-479E-93F7-AEDC2D350A22,3,"Clinical Diagnosis & History: year old female with stage IV breast carcinoma, debulking surgery. Specimens Submitted: 1: SP: Right breast and axillary contents level 1. DIAGNOSIS: 1. BREAST, RIGHT; MODIFIED RADICAL MASTECTOMY: - INVASIVE CARCINOMA, HISTOLOGIC GRADE II/III (MODERATE TUBULE. FORMATION) TO HISTOLOGIC GRADE III/III (SLIGHT OR NO TUBULE FORMATION). NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND SHAPE), MEASURING AT. LEAST 10 CM IN LARGEST DIMENSION GROSSLY. INVASIVE CARCINOMA SHOWS. MICROPAPILLARY FEATURES. FOCAL EXTRACELLULAR MUCIN IS ALSO NOTED. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID CRIBRIFORM. MICROPAPILLARY AND FLAT TYPES, WITH HIGH NUCLEAR GRADE, AND EXTENSIVE. NECROSIS. - LOBULAR INVOLVEMENT BY DCIS IS PRESENT. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR MASS,. AND IS PRESENT ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN ALL FOUR QUADRANTS. - THE DCIS IS LOCATED IN ALL FOUR QUADRANTS. - THE NIPPLE IS INVOLVED BY INVASIVE CARCINOMA. - CALCIFICATIONS ARE PRESENT IN BOTH THE IN SITU AND INVASIVE CARCINOMA. - VASCULAR INVASION IS PRESENT. - THE SKIN IS INVOLVED BY INVASIVE CARCINOMA BY DIRECT EXTENSION INTO THE. DERMIS. - THE ATTACHED SKELETAL MUSCLE IS EXTENSIVELY INVOLVED BY INVASIVE CARCINOMA. BY DIRECT EXTENSION. - INVASIVE CARCINOMA IS CLOSE (LESS THAN 0.1 CM) FROM THE NEAREST DEEP. MARGIN. THE NON-NEOPLASTIC BREAST TISSUE IS UNREMARKABLE. FOCAL CHANGES OF PRIOR PROCEDURE ARE NOTED IN THE AXILLARY TAIL. - METASTATIC CARCINOMA IS PRESENT IN TWO OUT OF TWO LEVEL I LYMPH NODES. (2/2) ADDITIONAL SECTIONS OF THE AXILLARY TISSUE HAVE BEEN SUBMITTED AND. THE FINDINGS WILL BE REPORTED IN AN ADDENDUM. - NUMEROUS FOCI OF METASTATIC CARCINOMA ARE NOTED IN THE AXILLARY SOFT. TISSUE, WITH THE LARGEST MEASURING AT LEAST 1.4 CM. Immunohistochemical stains were performed on formalin-fixed tissue with. the following results for invasive carcinoma (block 1-8): ESTROGEN RECEPTOR. 90% nuclear staining with strong. intensity. PROGESTERONR RECERTOR. Negative (no nuclear staining). HER2. Equivocal (focal 2+). FISH will be performed. (5% of invasive tumor cells exhibit complete membranous staining;. Uniformity of staining: absent;. Homogeneous, dark circumferential pattern: absent). The carcinoma is positive for E-cadherin, supporting lobular. differentiation. Comment: Controls are satisfactory. Ventana' a PATHWAY anti-HER-2/neu is. an FDA-approved rabbit monoclonal primary antibody (clone 4B5) directed. against the internal domain of the c-erbB-2 oncoprotein (HER2) for. immunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation The HER2 test. results are reported in accordance with the ASCO/CAP guideline. recommendations for HER2 testing in breast cancer (J Clin Oncol 2007;. 25(1):118-145). The ER and PR rabbit monoclonal antibodies are also FDA. approved. Some of the imnunohistochemistry and ISH tests were developed and their. performance characteristics were determined by the Department of Pathology. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of 1988 (CLIA , 88). as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: M.D. M.D. 1) The specimen is received fresh labeled, ""right breast and axillary. contents level 1"",. It consists of a breast with attached. axillary contents. The breast measures 20 x 15 x 5 cm with overlying skin. ellipse measuring 18 x 7 x 0.2 cm. Situated centrally on the skin surface is. a. fixed, and retracted nipple measuring 1.5 x 1.0 x 1.0 cm. The surrounding. skin is markedly thickened (up to 0.6 cm) . A suture demarcates the axillary. contents which measures 7 x 5 x 2 cm. The posterior surface of the breast is. inked black and the anterior blue. Part of the posterior surface of the. breast is covered by dark red skeletal muscle, measuring 11 x 4 x 0.5 cm. The specimen is serially sectioned to reveal an irregular tumor bed (10 x. 8.3 x 5.1 cm) with poorly defined white, firm and tan areas. The tumor bed. occupies almost the entire breast volume, extending throughout all four. quadrants. The tumor bed is located 0.2 cm from the posterior margin, 0.3 cm. from the anterior margin, and 0.5 cm from the skeletal muscle. The remaining. breast tissue shows yellow fatty areas with foci of fibrosis. The axillary. tissue is dissected to reveal 13 possible lymph nodes, ranging in size from. 0.4 cm to 1.2 cm. Representative sections are submitted. All dissected lymph. nodes are entirely submitted. The specimen is photographed. Tissue is. submitted to TPS. Summary of sections: N - nipple, nipple base and tumor. s - thickened skin. PM - posterior margin. AM - anterior margin. DSM - deep skeletal muscle. T - tumor central region and closest margins, continuous cross sections,. taken from medial to lateral. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. L1 - axilla, level one lymph nodes. AX axillary tail, entirely submitted. Summary of Sections: Part 1: SP: Right breast and axillary contents level 1. Block. Sect. Site. PCs. 1. AM. 1. 11. ax. 11. 1. DSM. 1. 9. L1. 9. 2. LIQ. 2. 2. LOQ. 2. 3. N. 3. 1. PM. 1. 1. s. 1. 10. T. 10. 2. UIQ. 2. 2. UOQ. 2. Procedures/Addenda: Addendum. Date Complete: By: 1. Addendum Diagnosis. PART #1. RIGHT BREAST AND AXILLARY CONTENTS: THE REMAINING AXILLARY TISSUE IS ENTIRELY SUBMITTED. NO ADDITIONAL LYMPH. NODES ARE IDENTIFIED. ,MD.",BRCA,1,True,"The report states that the tumor involves the nipple and skin by direct extension, which qualifies as T4 tumors of any size with direct extension to the chest wall or skin. The maximum tumor size is at least 10 cm, but the T stage is primarily determined by the direct extension to the chest wall or skin.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T4,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",11.0,973.0,89.0,True
867,TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4,0,"Final Diagnosis. Breast, left, wide local excision: Infiltrating ductal carcinoma, Nottingham grade II (of III). [tubules 3/3, nuclei 2/3, mitoses 2/3; Nottingham score 7/9], forming a mass (1.9 x 1.8 x 1.2 cm). [AJCC pT1c]. Ductal carcinoma in situ, intermediate nuclear grade, comprises approximately 5-. 25% of tumor volume (including the ductal carcinoma in situ, the tumor is 2.1 cm, in greatest. dimension). Angiolymphatic invasion is absent. The non-neoplastic breast parenchyma shows. proliferative fibrocystic changes. All surgical resection margins, including the separately. submitted re-excision of the medial margin, are negative for tumor (minimum tumor free margin,. 0.5 cm, deep and inferior margin). Lymph nodes, left axillary sentinel, excision: Multiple (8) left axillary sentinel lymph nodes are. negative for metastatic carcinoma [AJCC pN0 (i-) ( )]. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel lymph. node tissue and confirms the H&E impression.",BRCA,0,True,"The report states that the infiltrating ductal carcinoma forms a mass with the greatest dimension of 1.9 cm. According to the rules provided, T1 tumors are 2 cm or less in size. Therefore, the T stage for this patient is T1.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",11.0,973.0,100.0,True
937,TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F,1,"Qurgical Pathology. CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. ""Left breast biopsy (AF1)"" fresh. A 7 x 4.9 x 1.7 cm yellow-white. fibrofatty breast biopsy notable for a 2.5 x 3.5 x 2 cm firm, white lesion. After consultation with Dr. , it was deemed that no surgical margins. or orientation are required on this specimen. The tissue surface is inked in. black, however. Tissue from the lesion is sent to the Tissue Bank for Estrogen. and Progesterone receptor study. The frozen section remnant (AF1) was taken. from the lesion area is submitted in Block A1. A representative sampling from. the lesion area is submitted in Blocks A2-A5. Due to the fact that neither. margins or orientation is an issue in the specimen, only a sampling of the. lesion is taking-- the entire breast biopsy is not submitted. B. ""Left breast"", fresh. A mastectomy specimen consisting of a 19 x 10 cm. ellipse of skin, a 24 x 15 x 5 cm breast and a 11 x 6 x 3.5 cm axillary tail. The deep surfaces of the breast are inked in black. The skin ellipse contains. the nipple and surrounding areola and is notable for a 4.5 cm freshly sutured. horizontal incision medial to the nipple. The breast specimen is notable for a 7 x 6 x 1.5 cm hollow biopsy cavity lined. by mildly firm, granular red-pink tissue 0.1 cm thick. At its closest point,. the biopsy cavity is 1.5 cm from the posterior surface, 1.7 cm from the. inferior surface, 9 cm from the superior surface, and 1.2 cm from the. overlying anterior skin surface. The remainder of breast is diffusely composed. of yellow-white fibrofatty tissue. No focal lesions are noted. BLOCK SUMMARY: B1- representative section of nipple. B2- representative section of biopsy cavity and closest approach to posterior. surface. B3- representative section of biopsy cavity and closest approach to inferior. surface. B4- biopsy cavity and closest approach to anterior skin surface. B5-B6- additional sections of biopsy cavity. B7-B8- representative sections of upper medial portion of breast. B9-B10- representative sections of lower medial portion of breast. B11-B12- representative sections of upper lateral breast. B13-B14- representative sections of lower portion of breast. B15- four lymph node candidates from most medial portion of axillary tail. B16- four lymph node candidates from mid portion of axillary tail. B17- three lymph node candidates from most lateral portion of axillary tail. B18- three lymph node candidates from most lateral portion of axillary tail. B19- three lymph node candidates from most lateral portion of axillary tail. Dr. INTRA OPERATIVE CONSULTATION: A. ""Left breast biopsy"" AF1- positive for invasive carcinoma. DIAGNOSIS: A. ""LEFT BREAST BIOPSY"": INFILTRATING DUCTAL CARCINOMA, HISTOLOGIC GRADE 3, NUCLEAR GRADE 2. N.S.A.B.P. Diagnosis Diss cite. hary. Tumat. (Tircle) primiry SUALIFIED Date 916th. MAXIMUM TUMOR SIZE 3.5 CM. IN SITU DUCTAL COMPONENT REPRESENTS APPROXIMATELY 15 TO 20% OF TUMOR MASS. B. ""LEFT BREAST"" (MASTECTOMY) : BREAST TISSUE WITH BIOPSY CAVITY. NO EVIDENCE OF MALIGNANCY. 1 OF 15 LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (SEE NOTE). BENIGN PROLIFERATIVE CHANGES OF THE BREAST INCLUDING EXTENSIVE FIBROSIS,. DUCT ECTASIA, APOCRINE METAPLASIA, AND HYPERPLASIA OF THE USUAL TYPE. NOTE: One large lymph node (B18) appears negative for malignancy but is being. reprocessed for further examination. An addendum will be issued to this. report documenting the findings in this. ADDENDUM 1: Review of a reprocessed blocks (B18) shows three lymph nodes with no evidence. of malignancy. The one large lymph node mentioned in the original report. specifically contains no evidence of ma Lignaticy.",BRCA,1,True,"The maximum tumor size in this report is 3.5 cm, which falls under the 'T2' category of tumors that are more than 2 cm but not more than 5 cm in size. This is stated in the report as 'MAXIMUM TUMOR SIZE 3.5 CM' under the diagnosis for the left breast biopsy.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",11.0,973.0,100.0,True
971,TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C,1,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT AXILLA #1 SENTINEL, BIOPSY -. A. ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1). B. METASTATIC TUMOR MEASURES 0.5 CM. PART 2: LYMPH NODE, RIGHT AXILLA #2 SENTINEL, BIOPSY -. A. ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1). a METASTATIC FOCUS MEASURES 1.1 CM. C. EXTRACAPSULAR EXTENSION IS IDENTIFIED. PART 3: BREAST, RIGHJ, TOTAL MASTECTOMY -. A. MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA WITH APOCRINE FEATURES, NOTTINGHAM SCORE. 8/9 (TUBULES - 2, NUCLEAR GRADE - 3, MITOSES - -3). B. THE LARGER INVASIVE TUMOR MEASURES 2.4 CM, AND IS LOCATED AT 9:00 O'CLOCK POSITION. C. THE SMALLER INVASIVE TUMOR MEASURES 1.1 CM, AND LOCATED AT 12 O'CLOCK POSITION. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, APOCRINE AND SOLID TYPES WITH COMEDO. NECROSIS. E. DUCTAL CARCINOMA IN SITU CONSTITUTES 20% OF THE TOTAL TUMOR MASS AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT (UPPER OUTER QUADRANT). F. LYMPHOVASCULAR INVASION IS IDENTIFIED. G. ALL SURGICAL MARGINS OF RESECTION ARE FREE OF TUMOR. H. NIPPLE IS FREE OF TUMOR. I. SKIN IS NEGATIVE FOR TUMOR. J. MICROCALCIFICATIONS ARE PRESENT IN ASSOCIATION WITH DCIS AND INVASIVE CARCINOMA. K. NON-NEOPLASTIC BREAST PARENCHYMA WITH FIBROCYSTIC CHANGES. L. ER POSITIVE, PR POSITIVE, HER-2/NEU POSITIVE 3. PART 4: LYMPH NODES, RIGHT AXILLARY, DISSECTION -. A. ONE (1) OF SEVENTEEN LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/17). B. FOCUS OF METASTATIC CARCINOMA MEASURES 1.3 CM. C. EXTRACAPSULAR EXTENSION IS IDENTIFIED. CASE STNUPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. SIZE OF TUMOR: Lower inner quadrant. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2.4 cm. TUMOR AGGREGATE SIZE: TUMOR TYPE (invasive component): Sum of the sizes of multiple invasive tumors: 3.5 cm. NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 2. Mitotic activity score: 3. Total Nottingham score: 8. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 3. DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Solid, Apocrine, DCIS admixed and outside of invasive carcinoma component, Ductal. SURGICAL MARGINS INVOLVED BY INVASIVE carcinoma COMPONENT: in situ, multifocal, Percent of tumor occupied by in situ component: 20 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 3. LYMPH NODES EXAMINED: 19. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 1.3 mm. METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE): SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC:",BRCA,1,True,"The largest invasive tumor measures 2.4 cm, which falls under the 'T2' category of tumors that are more than 2 cm but not more than 5 cm in size. The presence of a smaller invasive tumor does not affect the T stage as it is determined by the size of the largest tumor.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
The maximum tumor size is used for cancer staging, but it does not supersede T4 classification if there is direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",12.0,1092.0,94.0,True
730,TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE,1,"Sex: Female. I.O.B.: IRN #: (ef Phys. SPECIMENINFORMATION. Acct i Reg #: DIAGNOSIS. DIAGNOSIS: Right breast modified radical mastectorny: Two areas of invasive lobular carcinoma. Sizes: 2.8 and 1.8 cm. Architectural score: 3 of 3. Nuclear score: 2 of 3. Mitotic score: 1 of 3. Total score: 6 of 9. Grade 2. Extensive lobular carcinoma in situ present. No evidence of angiolymphatic invasion. No evidence of skin and nipple involvement. Prognostic was previously performed and will not be repeated unless requested. Deep margin of excision is inveived by carcinoma. Attached axillary lymph node: One lymph node, metastatic carcinoma present. Size: 0.4 cm. No evidence of extracapsular extension. TMN: T2pN1. OLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Right modified radical mastectomy with sentinel node mapping with frozen section. Invasive lobular carcinoma. ER positive, PR. positive, Her-2 negative. Postoperative Diagnosis: Symptams/Radiologic Findings: SPECIMENS: Right breast. SPECIMENDOTA. GROSS DESCRIPTION: The specimen is received in formalin labeled with the patient's name. tht breast. The specimen consists of a portion of fibroadipose. breast tissue and overlying skin measuring 20.0x 15.0 x 6.0 cm and weighs 448 grams. The skin surface measures 15.0 x 10.5 cm and is light tan. wrinkled. There is slight puckering of the skin surface noted that measures 2,0 cm that is 8.5 cm from the nipple. The nipple is eccentrically placed and. appears grossly unremarkable. There is no orientation given to the specimen. The deep margin is inked. Sectioning reveals gray-tan mass measuring. 1.8 x 1.5 x 1.5 cm that is 0.1 cm from the deep margin. it is located at the periphery of the breast. A second mass measuring 2,8 x 2.5 x 2.5 cm that is. 0.1 cm from the deep margin, 0,2 cm from the skin surface, corresponds to the puckered area noted previously mentioned on the skin surface The. surrounding tissue reveals yellow-tan fatty fibroadipose tissue predominantiy with areas of gray fibrous tissue. No other lesions are identifiea, On the. periphery of the breast, there is a grav-tan nodule possible lymph node measuring 2,0 x 1.0x 1,0 cm. Received with the specimen ara thrse cassettes. one green, one yellow. one clue labeled. epresentative sections are submitted in cassettes labeled : follows: pipple,. block 1; sections from the first lesion in blocks 2 througn 5, sections from the second lesion in biocks 6 through 9; posorule lymph node sectioned in total. in blocks 10 through 12; random sections from all four quadrants in blocks 13 through 16,.",BRCA,1,True,"The report mentions two invasive lobular carcinoma areas with sizes 2.8 cm and 1.8 cm. The larger tumor size is used for staging, which is 2.8 cm, classifying it as T2 according to the rules: 'T stage is determined by the size of the tumor.', 'T1 tumors are 2 cm or less in size.', 'T2 tumors are more than 2 cm but not more than 5 cm in size.'","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,93.0,True
630,TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE,1,"Diagnosis: 1. Poorly differentiated invasive solid carcinoma, clearly consistent with. a. ductal breast carcinoma (maximum reconstructed tumor diameter: 3.0 cm; forming. a ventral margin, caudal distance 0.5 cm, lateral 1 cm, cranial 1.2 cm, medial and. dorsal 1.5 cm). The tumor-free, ink-stained resection margin of the ventral follow-up resection. material (preparation 4) gives rise to the following tumor classification: NOS, G III,. pT2 pN0(0/13)LOVORO.",BRCA,0,True,"The maximum reconstructed tumor diameter is 3.0 cm, which falls within the size range for a T2 tumor (> 2 cm but not more than 5 cm). The report also mentions that there is no lymph node involvement (pN0) and no distant metastasis (M0), but these factors do not affect the T stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1492,TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66,1,"SPECIMEN: Sex: F. Date Collected: Date Received: Clinical History/Diagnosis: Right Breast CA. Source of Specimen(s): 1: Sentinel nodes right axilla. 2: Right breast lumpectomy. 3: Final posterior margin (pectoral margin). 4: Final anterior and medial margin. Gross Description: Received in four parts. Source of Tissue: 1. Labeled #1, ""sentinel node right axilla"". Touch Preparation/Frozen Section Evaluation: TOUCH PREP NO TUMOR SEEN,. FROZEN SECTION NO TUMOR SEEN PER. Gross Description: Received fresh for touch preparation/frozen section. evaluation labeled ""sentinel node right axilla"" are two tan focally blue dye stained firm. lymph nodes, 2.0 cm in greatest dimension. They are sectioned, touch preparations are. made and frozen sections are performed on each lymph node. The frozen section. residues are submitted in two blocks. The remaining lymph node tissue is. entirely submitted in four blocks. Designation of Sections: 1FSA- frozen section lymph node A, 1FSB- frozen. section lymph node B, 1A-1B- 1TPA, 1C-1D- 1TPB. Summary of Sections: multiple. Source of Tissue: 2. Labeled #2, ""right breast lumpectomy"". Gross Description: Received fresh labeled ""right breast lumpectomy"" is a 9.0 x 7.5 x 4.5. cm yellow-tan fragment of breast tissue. It is covered in part by a 5.0 x 2.5 cm light-tan. skin ellipse. There is a short stitch denoting the superior margin and a long. stitch denoting the lateral margin. The margins are inked in black, the. specimen is serially sectioned to reveal predominantly yellow-tan adipose. tissue. There is an ill-defined, 3.0 x 2.5 x 1.6 cm firm mass having tan. gritty cut surfaces with infiltrating borders. This grossly appears to. come closest to the inked anterior, posterior and medial margins. Representative sections are submitted in ten blocks. Designation of Sections: 2A- superior, 2B- inferior, 2C-2D- medial, 2E-. lateral, 2F-2H- anterior, 2I-2J- posterior. Summary of Sections: multiple. Source of Tissue: 3. Labeled #3, ""final posterior margin (pectoral. margin)"". Gross Description: Received fresh labeled ""final posterior margin (pectoral margin)"" is a. 2.2 x 1.0 x 0.4 cm red-purple fragment of soft tissue and muscle. There is a stitch present. marking the final margin and this area is inked in black. The specimen is. sectioned and entirely submitted in one block. Designation of Sections: Block 3. Summary of Sections: undesignated-multiple. Source of Tissue: 4. Labeled #4, ""final anterior and medial margin"". Gross Description: Received fresh labeled ""final anterior and medial margin"" is a 6.0 x. 0.6 cm tan elliptical fragment of skin excised to a depth of 0.4 cm. The margins are. inked in black, it is serially sectioned and entirely submitted in two blocks. Designation of Sections: 4A-4B. Summary of Sections: multiple. Final Diagnosis: 1. Right axilla, sentinel lymph nodes, excision: - Two lymph nodes with no tumor seen (0/2), see note. Note: Immunohistochemical stains for Cytokeratin will be reported as an. addendum. 2. Right breast, lumpectomy:- Invasive lobular carcinoma, grade II with. microscopic focus of pleomorphic changes (3.0 cm); lymphovascular invasion. is not seen. - Invasive carcinoma extends to the inked and cauterized lateral and inked. anterior breast parenchymal margin; approximately 2.0 mm from the inked. posterior margin. - Focal atypical ductal hyperplasia approximately 1.0 mm from inked. superior margin. 3. Final posterior margin: - Fibroadipose tissue and skeletal muscle, no tumor seen. 4. Final anterior and medial margin: - Skin and subcutaneous tissue, no tumor seen. (pT2 NO Mx). Pathology Fellow: Pathologist(s): Procedures/Addenda. Addendum Date Ordered: Date Complete: Addendum Diagnosis. Immunohistochemistry stains for the sentinel lymph nodes (specimen #1) do. not reveal metastatic carcinoma, comfirming the histologic diagnosis. These tests were developed and their performance characteristics. determined by the immunohistochemistry laboratory at the. These tests have not been cleared or approved by the U.S. Food. and Drug Administration. The FDA has determined that such clearance or. approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1998 (CLIA) as qualified to perform high complexity clinical. testing. INVASIVE BREAST CANCER TEMPLATE: Excisions and Mastectomies. Specimen Type. Excision. Lymph Node Sampling. Sentinel lymph node(s) only. Specimen Size (for excisions less than total mastectomy). Greatest dimension:9.0 cm. Laterality. Right. Tumor Site(s). Not specified. Invasive Component. Solitary. Greatest dimension: 3.0 cm. Histologic Type(s). Invasive lobular. Invasive Lobular Carcinoma Type. Classical Solid Trabecular and Pleomorphic. Invasion. Invasion confined to breast parenchyma. Angiolymphatic Invasion. Absent. Intraductal Carcinoma. Extensive intraductal component (EIC) [>25% of tumor mass and. extending beyond edges of invasive carcinoma]. Absent. Lobular carcinoma in situ. Absent. Margins. Margin(s) involved by invasive carcinoma: lateral. Regional Lymph Nodes. 2 regional lymph nodes examined. No regional lymph node metastasis histologically, no examination for. isolated tumor cells (NO). Ancillary Immunopathology Studies (performed on. ER. Positive. PR. Negative. Her2-Neu. 1+. pTNM: T2 NO Mx.",BRCA,0,True,"The report indicates that the invasive lobular carcinoma in the right breast has a greatest dimension of 3.0 cm. According to the rules provided, T3 tumors are more than 5 cm in size, T1 tumors are 2 cm or less in size, and T2 tumors are more than 2 cm but not more than 5 cm in size. Therefore, the tumor size indicates a T2 stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
486,TCGA-A2-A0CV.FBDDD9EE-0A5C-4CAB-9EB3-48B6431A9A84,1,"Specimen #: F. Race: ASIAN - PACIFIC ISLANDERTaken: Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 LEFT. B: NON SENTINEL LYMPH NODE LEFT. C: LEFT BREAST AND AXILLARY CONTENT. FINAL DIAGNOSIS: A-C. TUMOR BREAST, TYPE: LEFT, MASTECTOMY WITH AXILLARY AND SENTINEL LYMPH NODES. INVASIVE (70-80% intraductal DUCTAL CARCINOMA WITH AN EXTENSIVE INTRADUCTAL COMPONENT. NOTTINGHAM SCORE: 6. NOTTINGHAM GRADE: GRADE tumor II (MODERATELY largely intermixed DIFFERENTIATED) with invasive). TUMOR TUMOR (Tubules= NECROSIS: SIZE (GREATEST 2, Nuclei= NOT IDENTIFIED. DIMENSION) 3, Mitoses= : 4.1 1; CM mitotic (MEASURED count GROSSLY) <1 per 10 HPF). MICROCALCIFICATIONS. MARGINS LYMPHATIC INVASION: PRESENT. VENOUS PRESENT / IN INVASIVE AND IN SITU TUMOR AND IN BENIGN DUCTS. NEGATIVE. NEAREST NEAREST MARGIN, MARGIN, IN-SITU INVASIVE TUMOR: TUMOR: 2.5 MM (DEEP, SLIDE C6). INTRADUCTAL NUCLEAR GRADE: COMPONENT: 3 DUCTAL CARCINOMA 3 MM (DEEP, IN SITU, SLIDE CRIBRIFORM C6) TYPE. LYMPH ONE - NODES: (1) SENTINEL METASTASIS LYMPH IN NODE TWO (SPECIMEN OF EIGHTEEN A) : (2/18) POSITIVE EXAMINED LYMPH NODES. EXTRANODAL EXTENSION: PRESENT, 4 MM. ONE (1) LYMPH NODE (SPECIMEN C, LOW, C12) : POSITIVE. NIPPLE IDENTIFIED. - EXTENSION: PRESENT, 1 MM. SKIN IDENTIFIED. MULTICENTRICITY: NOT. EXTRANODAL INVOLVEMENT: INVOLVEMENT: NOT NOT PRESENT. ESTROGEN, PREVIOUSLY PROGESTERONE RECEPTOR STATUS AND HER 2 NEU WERE REPORTED. IN SURGICAL. ADDITIONAL PATHOLOGIC COLUMNAR pT2N1aMX CHANGES: CASE. STAGE: PATHOLOGIC. SCLEROSING ADENOSIS. CELL CHANGE WITH ATYPIA. FIBROCYSTIC CHANGES, USUAL DUCTAL HYPERPLASIA, FIBROADENOMA. MMENT. Specimen #: FINAL DIAGNOSIS (continued) : The earlier report,. of a core biopsy indicates hormone receptors. are POSITIVE (100% strong staining for both estrogen and progesterone. receptors) and Her2 by immunihistochemistry is NEGATIVE (1+). CLINICAL DIAGNOSIS AND HISTORY: year old with left breast 4 X 4 cm mass in left upper outer quadrant. detected with 1cm lymph node. PRE-OPERATIVE DIAGNOSIS: left breast cancer. POST-OPERATIVE DIAGNOSIS: same. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE: LYMPH NODE. REPORTED TO: DR. REPORTED BY: DR. # BLOCKS: 2. # SCRAPE PREPS 2. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received fresh for intraoperative consultation labeled with patient's. designated ""SENTINEL NODE #1 COUNT 104"" consists of a 1.0 x. 0. 8 x 0.5 cm very firm lymph node with homogeneous yellow tan cut surface. Touch preps are prepared. Half of node submitted for CBCP protocol and. remaining half submitted for paraffin section. B. Received fresh labeled with the patient's name. designated. NON-SENTINEL LYMPH NODE LEFT"" is tan pink soft tissue measuring 0.7 x 0.5. x. 0.2 cm. The presumed lymph node is bisected and submitted entirely. Received fresh labeled with patient's name. designated ""BREAST. Specimen #: GROSS DESCRIPTION (continued) : AND AXILLARY CONTENTS"" consists of 380 gram left mastectomy oriented with. single stitch medial, two stitches superior, stitch on highest axillary. portion. Specimen measures 23 cm medial to lateral 15 cm superior to. inferior, 3 cm anterior to posterior. Attached skin ellipse displays a. centrally located everted nipple measuring 1 cm. No discharge is. identified. No scars are identified. There is a well-defined pink white firm gritty mass in the left outer. quadrant measuring 4.1 x 3.5 x 1.5 cm. Tissue surrounding the mass is. remarkably nodular and firm with possible superior extension of primary. lesion to approximately 5 cm (C4) Focal hemorrhage consistent with. previous biopsy is also noted. Remaining quadrants are also composed of. remarkably nodular focally indurated dense fibrous tissue. No additional. masses identified. Fatty tissue comprises 20% of specimen and is. unremarkable. The attached axillary tail measures 9 x 3.5 x 1.5 cm. Sectioning reveals. sixteen lymph nodes ranging from 0.5 x 0.7 cm in greatest dimension. Sectioning of lowest lymph node shows a firm pink white cut surface with. possible involvement by lesion. INK KEY. blue superficial. black: deep. SUMMARY OF SECTIONS: C1: skin. C2: lower outer quadrant mass. C3: margin of C2. C4: possible extension of tumor. C5 : margin of C4. C6: mass with deep margin. C7: additional mass. C8: lower outer quadrant. C9: upper outer quadrant. C10: upper inner quadrant. C11: lower inner quadrant. C12: one low lymph node. C13: two low bisected lymph nodes, one inked blue. C14: three low lymph nodes. C15: one high lymph node. C16: two high lymph nodes bisected, one blue. C17: one high lymph node intact. Matched sections of C1 C7-C12 and C15 are submitted in OCT for CBCP. rotocol. Specimen #: GROSS DESCRIPTION (continued) : C18 : nipple. C19: mass with deep margin. C20 : : mass with deep and superficial margin. C21: six additional lymph nodes. 21CF.",BRCA,1,True,"The report states that the largest mass in the left breast measures 4.1 x 3.5 x 1.5 cm, which is greater than 2 cm but not more than 5 cm in size. This corresponds to a T2 stage according to the rules provided.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1481,TCGA-OL-A66J.D5DE4BB3-81AC-44CB-9336-060F324C7A2F,0,"FINAL PATHOLOGIC DIAGNOSIS. A. Lymph node, sentinel #1, right axillary, excision: - One lymph node, negative for metastatic carcinoma (0/1). - Biopsy site changes identified. B. Lymph node, sentinel #2, right axillary, excision: - One lymph node, negative for metastatic carcinoma (0/1). C. Lymph node, sentinel #3, right axillary, excision: - One lymph node, negative for metastatic carcinoma (0/1). D. Lymph node, sentinel #4, right axillary, excision: - One lymph node, negative for metastatic carcinoma (0/1). E. Breast, right, partial mastectomy: - Invasive lobular carcinoma, see breast pathologic. parameters. - Margins of excision free of tumor, distance to the closest margin >2 mm. to superior and anterior. - Lobular intraepithelial neoplasia (LCIS), classic type. - Atypical ductal hyperplasia. - Previous biopsy site identified with extensive fat necrosis. - Flat epithelial atypia, focally associated with microcalcifications. - Sclerosing adenosis, focally associated with microcalcifications. - Microcalcifications in benign ductal and stroma. - Fibrocystic changes with cystic apocrine metaplasia. F. Breast, additional superior medial margin, excision: - Focal atypical ductal hyperplasia. - Lobular intraepithelial neoplasia (ALH/LCIS). - Focal flat epithelial atypia. to Sclerosing adenosis focally associated with microcalcifications. - Microcalcifications in benign ductules and stroma. - Fibrocystic changes with cystic apocrine metaplasia. - Duct ectasia. Breast Pathologic Parameters. Specimen E: Breast, right, partial mastectomy. 1. Invasive carcinoma: A. Size: Gross measurement: 1.6 x 1.5 X 1.4 cm. B. Composite histologic (modified SBR) grade II. - Architecture: 3. - Nuclear grade: 2. - Mitotic count: 1. C. Associated lobular intraepithelial neoplasia (LCIS): - Within main mass (forming <5% of tumor volume). - Extending away from main mass. 3. Excisional biopsy margins: Free of tumor. - Invasive carcinoma > 2 mm from anterior and superior margins. - Additional margins greater than 3 mm away. 4. Blood vessel and lymphatic invasion: Not definitively identified. 5. Axillary lymph nodes: Negative for tumor (0/4). 6. Special studies (see. - Strong expression of ER in 90% of invasive tumor nuclei. - Strong expression of PR in 50% of invasive tumor nuclei. - Her2/neu antigen (FISH) Not amplified. Ratio 1.5. 7. pTNM: pT1c, NO(sn), MX. Clinical History: The patient is an. year old female with a history of biopsy proven grade Il. ILC of the right breast who undergoes right breast needle localization. lumpectomy and right axillary sentinel node dissection. Most recent breast. imaging on. showed in the right breast at the 10 o' clock position an. irregularly shaped heterogenous enhancing mass with irregular margins and. metallic clip artifact at mid depth measuring 1.4 X 1.2 X 1.2 cm representing. the biopsy proven malignant lesion. Posterior to that main mass was a focal. non-mass like enhancement measuring 1.6 x 1.1 cm suspicious for extension of the. disease with a total extent of 2.8 cm. Comment. Part E: The tumor reveals a mixed ductal and lobular morphologic appearance,. however, immunohistochemical stains for E-cadherin were performed on. representative areas and supports the presence of a lobular carcinoma. Case presented at multidisciplinary breast conference on. Specimens Received: A: Right axillary sentinel node#1. B: Right axillary sentinel node #2. C: Right axillary sentinel node #3. D: Right axillary sentinel node #4. E: Right breast partial mastectomy. F: Additional superior medial margin. Gross Description: The specimen is received in six containers each labeled with the patient' S name. and medical record number. A. Container A is further designated as 1. Right axillary sentinel node #1.'. Received fresh and placed in formalin is a 1.5 x 1.2 x 1.0 cm firm, rubbery. lymph node that is dissected and entirely submitted in cassette A1. B. Container B is further designated as 2. Right axillary sentinel node #2. Received fresh and placed in formalin is a 0.7 X 0.6 X 0.4 cm tan, rubbery lymph. node candidate that is entirely submitted in cassette B1. C. Container C is further designated as '3. Right axillary sentinel node #3.'. Received fresh and placed in formalin is a 0.9 X 0,7 X 0.4 cm tan, rubbery lymph. node candidate. It is entirely submitted in cassette C1. D. Container D is further designated as 14. Right axillary sentinel node #4. Received fresh and placed in formalin is a 0.6 x 0.5 x 0.2 cm tan, rubbery lymph. node candidate that is entirely submitted in cassette D1. E. Container E is further designated as '5. Right breast partial mastectomy'. with the paper work additionally designating 1 stitch = lateral. Received fresh. and placed in formalin is a 99.5 gram, 8.5 cm (superior to inferior) X 10.0 cm. (medial to lateral) X 3.5 cm (anterior to posterior) breast lumpectomy specimen. on a radiographic grid with a corresponding x-ray film. There is a metallic. clip located in the center of a spiculated irregularly shaped mass which. corresponds to C3-C4, D3-D4 and D5. The metallic clip is located in D4. There. is a questionable extension of the mass into grids E3-E4. A wire extends through. the center of this mass entering at B5 and terminating at F1. The specimen is. received with two sutures, long designating lateral and short designating. superior. The margins are inked as follows: superior blue, inferior green,. anterior black, posterior red, lateral violet and medial yellow. The. specimen is serially sectioned from lateral to medial into 14 slices to reveal a. 1.6 X 1.5 X 1.4 cm firm, white poorly circumscribed mass extending from slice 6. to slice 9. There is a metallic clip found on the center of this mass in slice. 8. The mass approaches the anterior margin within 0.3 cm (slice 9) and the. posterior margin within 0.6 cm (slice 7). Additionally, the lesion is 3.5 cm. from the inferior margin and 0.7 cm from the superior margin. The mass is. greater than 2 cm from both the medial and lateral margins. The wire terminates. in slice 11. The remainder of the breast tissue consists of grossly. unremarkable yellow, lobulated adipose tissue. Representative sections are. submitted as follows: E1: mass with clip (slice 8) showing approach to posterior and superior margins. E2-E3: anterior margin from slice 8. E4-E5: mass in slice 7 showing closest approach to posterior margin. E6-E7: mass in slice 6 demonstrating biopsy site changes. E8: inferior margin from slice 6. E9-E10: mass in slice 10 showing nearest approach to anterior margin. E11: posterior margin slice 7. E12-E13: posterior inferior margin slice 8. E14: posterior margin slice 9. E15: anterior margin slice 9. E16: anterior margin slice 8. E17: anterior superior margin slice 6. E18-E20: sections immediately lateral to mass (slice 5). E21-E22: sections immediately medial to mass (slice 10). E23: grossly unremarkable breast parenchyma slice 3. E24: grossly unremarkable breast parenchyma slice 12. E25: lateral margin serially sectioned (slice 1). E26: medial margin serially sectioned (slice 14). F.Container F is further designated as '3. Additionalsuperior medial margin,. short stitch marks new true margin.' Received fresh is a 38.0 gram portion of. yellow, lobulated fibroadipose tissue that measures 8.5 X 6.0 X 1.5 cm. The. short stitch designates the new true margin. This aspect is inked blue. The. specimen does not have any further orientation. The specimen is serially. sectioned to reveal that is primarily composed of yellow, lobulated adipose. tissue with a region of enhanced firm, white fibrosis measuring 2.4 X 1.5 X 1.5. cm that appears to abut the new true margin. The specimen is entirely submitted. sequentially in cassettes F1-F23 with the fibrotic region in F9-F14. Pathologist Sign Out:",BRCA,0,True,"The report states that the size of the tumor is 1.6 x 1.5 x 1.4 cm, which falls under the T1c category (T1 tumors are 2 cm or less in size, and T1c tumors are 1 to 2 cm in size).","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T1c,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
456,TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63,1,"Final Pathologic Diagnosis: A. Right axillary sentinel lymph node #1, count = 3500, dissection: Metastatic. adenocarcinoma in one of two lymph nodes (1/2). B. Right axillary sentinel lymph node #2, count = 500, dissection: No tumor in two. lymph nodes (0/2). C. Right breast, partial mastectomy: 1. Invasive micropapillary carcinoma, 2.1 cm, associated with microcalcifications; see. comment. 2. Atypical lobular hyperplasia. 3. Fibroadenoma. 4. Microcalcifications in benign ducts. D. Sentinel lymph node #3, count = 350, dissection: No tumor in two lymph nodes. (0/2). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive micropapillary carcinoma. - Invasive tumor size: 2.1 cm maximum diameter. The tumor is present in slices 4, 5, 9, and 10; however. the tumor has been banked from slices 6, 7, and 8. Therefore, the tumor extends through seven. consecutive slices, each with a width of approximately 0.3 cm, for a total maximum diameter of 2.1 cm. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: < 10 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in <10%, 3 points. Working Draft. Total points and SBR grade - 7 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Resection margins for invasive tumor: - Deep margin: Negative (1 cm). - Medial margin: Negative (0.9 cm). - Lateral margin: Negative (0.6 cm). - Anterior/superio: margin: Negative (0.5 cm). - Anterior/inferior margin: Negative (greater than 1 cm). - Ductal carcnoma in situ (DCIS) type: None identified. Microcalcifications: Present involving both benign ducts and invasive carcinoma. - Lobular carcinoma in situ (LCIS): None identified. - Lymph node status: - Number of positive lymph nodes: 1. - Total number sampled: 6. - Diameter of largest metastasis: 2.1 mm. - Extranodal extension: Absent. - AJCC/UICC stage: pT2N1aMX. - Nontumorous breast tissue: Atypical lobular hyperplasia, fibroadenoma, and sclerosing adenosis. - Additional comments: We reviewed the original frozen section slides and concur with the frozen section. diagnosis rendered. The metastatic tumor in Part A was only present in the additionally submitted. sections of the lymph node (slide A2). Level sections on A2-A4 confirms the diagnosis. Select slides from. part C were shown at the. the faculty in attendance concurred. with the above diagnosis of micropapillary type of invasive carcinoma. Dr. has reviewed A2. and concurs with the diagnosis. An immunohistochemical test for estrogen and progesterone receptors was performed on block C9. The test for estrogen receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. The test for progesterone receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block C9 using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Slide A2 was shown at the departmental Consensus Conference, and the faculty in attendance concurred. with the above diagnosis. Intraoperative Consult Diagnosis. FS1 (A) Right axillary SLN #1, biopsy: Negative for carcinoma. (Dr. Clinical History. The patient is a. year-old woman with right breast carcinoma. Working Draft. Gross Description. The specimen is received in four parts, each labeled with the patient's name and medical record number. Part A is received fresh and labeled. It consists of one pink-yellow,. soft, fatty tissue that measures 3.1 x 2.5 x 0.8 cm. The specimen is strained and two candidate lymph. nodes are found, the smallest is inked blue and submitted with a representative section of the largest. submitted for frozen diagnosis #1, thereafter submitted in cassette A1. The remnant of the largest lymph. node is transected and entirely submitted in cassettes A2-A3, and the remnant of the yellow fatty tissue is. submitted in cassette A4. Part B, additionally labeled. consists of a single fragment of yellow,. fibrofatty tissue measuring 2 x 1.8 x 0.4 cm. The specimen is entirely submitted in cassette B1. Part C, additionally labeled. consists of a right breast specimen oriented. with a short superior and a long stitch lateral. The specimen measures 3.2 cm from anterior to posterior,. 5 cm from medial to lateral and 6.5 cm from superior to inferior. The resection margins are inked as. follows for microscopic evaluation: anterior superior in blue, anterior inferior in green and posterior in. black. The specimen is serially sectioned from medial to lateral into twelve slices. There is gray-white,. fibrous tissue in the superior half of the specimen in slices 3-11, measuring 2.4 x 2 x 1.5 cm. White. fibrous tissue extends from this area to the anterior inferior aspect in slices 5-8. The gray-white fibrous. tissue appears extend to the inked margin in the posterior superior aspect of slices 3 and 4, and appears. to be 0.5 cm from the anterior superior inked margins in slices 5 and 9. Representative sections are. submitted as follows: Cassette C1: Representative medial margin, slice 1, bread-loafed. Cassette C2: Representative section of slice 3. Cassettes C3-C5: Slice 4. Cassette C6: Representative section of slice 5. Cassette C7: Representative section of slice 6. Cassette C8: Representative section of slice 8. Cassette C9: Representative section of slice 9. Cassettes C10-C11: Representative sections of slice 10. Cassette C12: Representative section of slice 11. Cassette C13: Representative lateral margin, slice 12, bread-loafed. Part D, additionally labeled. consists of a single, yellow, fibrofatty tissue fragment. measuring 2.5 x 1.5 x 0.4 cm. The specimen is entirely submitted in cassette D1. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as. investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (""CLIA""). as qualified to perform high-complexity clinical testing. Fee Codes: Other Specimens. pecimen Class: Accessioned: Specimen(s) Received: Right axillary contents. Final Diagnosis. Axilla, right, ""contents,"" excision: 1. Scar tissue, fat necrosis and suture with giant cell reaction. No malignancy is. identified. Working Draft. 2. No metastatic tumor identified in five lymph nodes. (0/5). Specimen Class: Accessioned: Specimen(s) Received: Final Diagnosis. Review of. from : Breast, right, 10 o'clock, core biopsies: Infiltrating ductal carcinoma, SBR Grade 2; see. comment. FND OF REPORT.",BRCA,1,True,"The report indicates that the size of the tumor is 2.1 cm, which falls within the range for a T2 tumor (more than 2 cm but not more than 5 cm). The presence of lymph node metastasis or other factors does not affect the T stage in this case.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1202,TCGA-E2-A14W.9ECD3DA1-25A4-4325-9B3B-6D7C12283C37,1,"SPECIMENS: A. SLN #1. B. SLN #2. C. LEFT BREAST. D. SLN #3. E. UPPER OUTER QUANDRANT LEFT BREAST. F. SLN #4. G. INFERIOR MEDIAL LEFT BREAST MARGIN. SPECIMEN(S): A. SLN #1. B. SLN #2. C. LEFT BREAST. D. SLN #3. E. UPPER OUTER QUANDRANT LEFT BREAST. F. SLN #4. G. INFERIOR MEDIAL LEFT BREAST MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA/TPB - SLN #1/SLN #2: Negative for tumor cells. TPD/TPF - SLN #3/SLI #4: Negative for tumor. Called by Dr to Dr. at. I (A, B). (D) and. (F). C - left breast: (gross exam only) 2.5 x 2 x 1.5 cm tumor located 1.2 cm from the closest/deep margin; tumor extends. to the nipple and areola, called by Dr. to Dr. at. GROSS DESCRIPTION: A. SLN #1. Received fresh is a tiny piece of lymphoid tissue within fibroadipose tissue, 0.4 x 0.2 x 0.2 cm. A touch prep is. performed; submitted entirely in cassette A1. B. SLN #2. Received fresh is a piece of lymphoid tissue within fibroadipose tissue, 0.4 x 0.2 x 0.2 cm. A touch prep is performed;. submitted entirely in cassette B1. C. LEFT BREAST, STITCH AT AXILLARY TAIL. Received fresh labeled with the patient's identification and ""left breast, stitch in axillary tail"" is an oriented 392g, 20. x. 14.5 x 2 cm mastectomy with 11.5 x 5.2 skin ellipse and 1.6cm inverted and ulcerated nipple. Ink code: Anterior/superior-blue, anterior/inferior-orange, posterior-black. The specimen is serially sectioned into 18 slices. from medial to lateral with the nipple in slice 5 revealing a 2.5 x 2 x 1.5 cm white-tan firm well-circumscribed mass. beneath the nipple, present in slices 5 to 7 that is 1.2 cm from the deep margin. A gross diagnosis was conveyed to. OR and tissue is procured. Representatively submitted: C1-C2: slice 5, mass and extension to nipple. C3: slice 5, mass and deep margin. C4: slice 6, superior posterior mass. C5: slice 6, anterior inferior mass. C6: slice 6, inferior posterior mass. C7: slice 7, mass and normal appearing parenchyma. C8: slice 8, normal appearing parenchyma adjacent to mass. C9: slice 3, upper inner quadrant. C10: slice 9, upper outer quadrant. C11: slice 10, lower outer quadrant. C12: slice 4, lower inner quadrant. C13: skin. C14-C17: nipple. C18: 1 axillary lymph node. D. SLN #3. Received fresh is a lymph node, 0.3 x 0.3 x 0.2 cm. A touch prep is performed and the lymph node is submitted. entirely for cassette D1. E. UPPER OUTER QUADRANT LEFT BREAST; STITCH AT NEW UPPER OUTER MARGIN. Received fresh labeled with the patient's identification and ""upper outer quadrant left breast; stitch at new upper. outer margin"" is an oriented 37g, 9 x 6.3 x 0.8 cm fibrofatty tissue. Final margin is inked black. Serial sectioning. reveals no discrete lesions. Representatively submitted in cassettes E1-E6. F. SLN #4. Received fresh is a lymph node, 0.3 x 0.3 x 0.2 cm. A touch prep is performed; submitted entirely in cassette F1. G. INFERIOR MEDIAL BREAST-LEFT; STITCH AT DEEP MARGIN. Received fresh labeled with the patient's identification and ""inferior medial breast-left; stitch at deep margin"" is an. oriented 3g, 4.1 x 2.5 x 0.6 cm fibrofatty tissue. Final margin is inked black. Serial sectioning reveals no discrete. lesions. Entirely submitted in cassettes G1-G4. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. BREAST, LEFT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3), WITH ULCERATION OF THE NIPPLE. - TUMOR MEASURES 2.5 CM IN GREATEST DIMENSION. - MARGINS, NO TUMOR SEEN. - ONE LYMPH NODE WITH NON-NECROTIZING GRANULOMAS, NO TUMOR. SEEN (0/1) (SEE NOTE). NOTE: Special stains have been ordered on the lymph node and those results will be reported in an addendum. A. CD31 stain has been ordered for evaluation of lymphvascular invasion and those results will be reported in an. addendum. D. SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). E. BREAST, LEFT, UPPER OUTER QUADRANT, EXCISION: - FIBROADIPOSE TISSUE, NO TUMOR SEEN. F. SENTINEL LYMPH NODE #4, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). G. BREAST, LEFT, INFERIOR MEDIAL MARGIN, EXCISION: - FIBROADIPOSE TISSUE, NO TUMOR SEEN. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.5cm. Tumor Site: Central. Margins: Negative. Distance from closest margin: Greater than 1cm. deep. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/5. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Positive by FISH. Pathological staging (pTN): pT2N0. CLINICAL HISTORK. year-old. recent dx of left breast cancer in. core biopsy. -IDC ER/PR positive, Her2. (illegible) Now for left mastectomy and sentinel lymph node biopsy-2 cm retroareolar mass. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. ADDENDUM: NOTE: A CD31 stain was performed on C4 and is negative showing no evidence of lymphvascular invasion. Special. stains (GMS, AFB, PAS) were performed on the lymph node (C18) and are negative showing no evidence of fungal. or acid fast organisms. The non-necrotizing granulomas would be consistent with the patient's history. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.",BRCA,0,True,"The tumor size is reported as 2.5 cm in greatest dimension, which falls under the 'T2' category of tumors that are more than 2 cm but not more than 5 cm in size. The report mentions that the tumor extends to the nipple and areola, but this does not affect the T stage as size is the primary factor unless there is direct extension to the chest wall or skin, which is not the case here.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
746,TCGA-AN-A04C.045B2852-E1FF-4376-8F39-60FC940224D0,1,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: Radical mastectomy Grade: 2. T Stage: 2 N Stage: 1 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,BRCA,1,True,"The report specifies a T Stage of 2, which indicates that the tumor is more than 2 cm but not more than 5 cm in size. This is consistent with the definition of a T2 tumor in the provided rules.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1135,TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525,1,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resectio. - right breast with axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of neoplastic cell nuclei. HER2 protein stained with HercepTestTM by DAKO. Positive reaction in invasive carcinoma cells. ( Score = 3+ ). Macroscopic description: Right breast sized 23 x 18 x 4 cm removed along with axillary tissues sized 12 x 8 x 3.5 cm and a skin flap of 21 x 11 cm. Weight. 700 g. Tumour sized 4.5 x 3.5 x 3 cm found on the boundary of outer quadrants, located 4.2 cm from the ouer boundary, 0.5 cm from. the base and 1.7 cm from the skin. Microscopic description: Carcinoma invasivum (partim signet ring cell carcinoma) - NHG2 (3+3+1/7 mitoses/10 HPF - visual area 0.55mm). Glandular tissue showing parenchymal atrophy. Axillary lymph nodes: Metastases et micrometastases carcinomatosae in lymphonodis (No XIV/XVI). Infiltratio capsulae lymphonodorum et. telae perinodalis. Emboliae carcinomatosae vasorum. Histopathological diagnosis: Carcinoma invasivum mammae dextrae. Metastases et micrometastases carcinomatosae in lymphonodis axillae (No XIV/XVI). (NHG2; pT2; pN3a). Final. diagnosis to be given after supplementary tests. Examination: Histopathological examination. page 2 / 2. Gender: F. Examination performed or. Examination result/Final Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. NHG2, pT2, pN3a. Invasive ductal carcinoma of the pT2, pN3a. Immunophenotype: CK7-, CK 5/6-, GCDFP-15-, E-cadherin+, PAS+. Compliance validated L,.",BRCA,3,True,The tumor size is 4.5 x 3.5 x 3 cm which is more than 2 cm but not more than 5 cm. This falls under the 'T2' category according to the rules.,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1322,TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B,2,Laterality:Right. Path Report BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 5.2 x 5.2x5.2 cm. Grossly evident lesion: Yes. Histologic type: Lobular carcinoma. Histologic grade: Tumor extent: Not specified. Lymph nodes: 22/22 positive for metastasis (Axillares 22/22). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,BRCA,3,True,"The T stage is determined by the size of the tumor. In this report, the tumor size is 5.2 x 5.2x5.2 cm, which is more than 5 cm, classifying it as a T3 tumor. The presence of lymph node metastasis (22/22 positive lymph nodes) and extracapsular invasion of the lymph nodes do not affect the T stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T3,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1213,TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36,1,"SPECIMENS: A. RIGHT TUBE AND OVARY. B. UTERUS WITH LEFT TUBE, OVARY AND CERVIX. C. SENTINEL LYMPH NODE #1 LEFT AXILLA. D. SENTINEL LYMPH NODE #2 LEFT AXILLA. E. SLN #3. F. SLN #4. G. WLE LEFT BREAST NEEDLE LOCALIZATION. SPECIMEN(S): A. RIGHT TUBE AND OVARY. B. UTERUS WITH LEFT TUBE, OVARY AND CERVIX. C. SENTINEL LYMPH NODE #1 LEFT AXILLA. D. SENTINEL LYMPH NODE #2 LEFT AXILLA. E. SLN #3. F. SLN #4. G. WLE LEFT BREAST NEEDLE LOCALIZATION. GROSS DESCRIPTION: A. RIGHT TUBE AND OVARY. Received fresh is a 90 gm ovary and fallopian tube. There is a 7 x 5 x 4.5 cm thin walled multiloculated, translucent. paratubal cyst filled with clear fluid. There are no papillary excrescences seen. Representative sections submitted for. frozen section and resubmitted for permanent examination in cassette FSA1. The ovary measures 3.5 x 3 x 2 cm. The ovary is bisected to reveal pale yellow cut surface. One corpus luteum cyst is present measuring 1.5x0.8x0.7. cm. The fallopian tube measures 7.5 cm in length, 0.5 cm in diameter. Serial section through the fallopian tube to. reveal unremarkable cut surface. Representative sections submitted for microscopic examination as follows: A1: cyst. A2: section from the ovary. A3: 3 sections from the fallopian tube. A4: 2 sections from the paratubal cyst. B. UTERUS WITH LEFT TUBE, OVARY AND CERVIX. Received in formalin is a 1,421 gm uterus with left fallopian tube and ovary. The uterus measures 19 cm from. superior to inferior, 10 cm from right to left, 14 cm from anterior to posterior. The cervix measures 5.5 cm in length, 4. cm in diameter. Serosal surface is pale, smooth and glistening. Multiple leiomyomas are identified protruding from. the anterior surface ranging in size from 2.5 cm in diameter to 9 x 5.5 x 4 cm. The anterior uterus is inked in blue,. posterior is inked in black. The uterus is bivalved to reveal multiple leiomyomas in the myometrium and right under. endometrium ranging in size from 0.7 cm in diameter to 8 cm in diameter. The endometrial cavity is distorted by the. leiomyomas. The leiomyoma is serial sectioned to reveal white whorled cut surface with focal necrosis. The uterine. cervix is sectioned to reveal a cystic lesion containing yellow sticky material at posterior cervix measuring 2.5 cm in. diameter. The left ovary measures 3 x 2 x 1.5 cm. The left fallopian tube measures 8 cm in length and 0.6 cm in. diameter. A paratubal cyst measuring 2 cm in diameter is identified with thin wall and contains clear fluid. The ovary. and fallopian tube are serial sectioned to reveal unremarkable cut surface. Summary of sections submitted for. microscopic examination as follows: B1: anterior cervix. B2: posterior cervix with cyst. B3-B4: 2 sections from the anterior uterus endometrium. B5-B6: 2 sections from the posterior uterus endometrium. B7-B10: each has 2 sections from the largest leiomyoma. B11-B12: each has 2 sections from the 2nd largest leiomyoma. B13: section from left ovary including cyst. B14: 3 sections from the fallopian tube. B15-B16: each has 2 sections from the largest leiomyoma. C. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh are two tan pink lymph nodes 1.5 x 1.2 x 0.7cm and 2 x 1.5 x 1cm. The specimens are sectioned and. a touch prep is taken. C1: 1 lymph node. C2: 1 lymph node. D. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh is a tan pink lymph node 0.5 x 0.4 x 0.4cm. The specimen is sectioned and a touch prep is taken. Toto D1. E. SLN #3. Received fresh is a tan pink lymph node 1 x 0.5 x 0.4cm. The specimen is sectioned and a touch prep is taken. Toto. E1. F. SLN #4. Received fresh is a tan pink lymph node 0.5 x 0.4 x 0.4cm. The specimen is sectioned. Toto F1. G. WLE LEFT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and ""left breast needle localization"" is an oriented 58g, 6.5 x. 6.5 x 4.8cm needle localized lumpectomy with radiograph. Ink code: anterior-orange, posterior-black, superior-blue,. inferior-yellow, medial-green, lateral-red. Specimen is serially sectioned from medial to lateral into 7 slices revealing. a. 2x2 x 2cm tan white firm well circumscribed mass, 0.6cm from the closest posterior margin in slices 3-5. A portion. of the specimen is submitted for tissue procurement. Representatively submitted: G1: medial margin slice 1. G2-G3: next to mass slice 2. G4-G5: superior margin slice 3. G6: deep margin slice 3. G7-G8: inferior margin slice 3. G9: anterior margin slice 3. G10-G11: mass slice 3. G12-G17: slice 4. G18: mass slice 5. G19: deep margin slice 5. G20: next to mass slice 6. G21-G24: lateral margin slice 7. DIAGNOSIS: A. OVARY AND FALLOPIAN TUBE, RIGHT, SALPINGO-OOPHORECTOMY: BENIGN OVARY. - FALLOPIAN TUBE WITH PARATUBAL CYST. B. UTERUS, OVARY AND FALLOPIAN TUBE, LEFT, HYSTERECTOMY AND SALPINGO-OOPHORECTOMY: - WEAKLY PROLIFERATIVE ENDOMETRIUM. - ADENOMYOSIS. - LEIOMYOMAS, LARGEST MEASURING 9 CM. - BENIGN CERVIX, OVARY AND FALLOPIAN TUBE. C. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - TWO LYMPH NODES, NO TUMOR SEEN (0/2). D. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). E. SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). F. SENTINEL LYMPH NODE #4, LEFT AXILLA, BIOPSY: - FIBROADIPOSE TISSUE, NO LYMPH NODE OR TUMOR SEEN. G. BREAST, LEFT, NEEDLE LOCALIZATION WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 3, WITH NECROSIS,. LYMPHOID INFILTRATE, AND FOCAL SQUAMOUS FEATURES. - TUMOR MEASURES 2.2 CM. MARGINS, FREE OF TUMOR. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE 3,. MINOR COMPONENT. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.2cm. Tumor Site: 4:00. Margins: Negative. Distance from closest margin: Greater than 0.5cm. all margins. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Present. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/4. DCIS present. DCIS Quantity Estimate 5%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: High. ER/PR/HER2 Results. ER: Negative. PR: Negative. HER2: Negative by FISH. Pathological staging (pTN): pT 2NN0. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: G18. ER: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. PR: Negative Allred Score: 2 = Proportion Score 1. +. Intensity Score 1. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the proportion score. (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of cells staining, 4 = 31-60% of. cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak intensity of staining, 2 = intermediate. intensity of staining, 3 = strong intensity of staining), with a scoring range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of less than. or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistrv was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR 136, 1:100). provided by Dako. ) following the manufacturer s instructions. This assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published results in the medical literature,. information provided by the reagent manufacturer and by internal review of staining performance. CLINICAL HISTORY: year-old. lemale. G3. P3 asive ductal cancer of the left breast and uterine fibroid. PRE-OPERATIVE DIAGNOSIS: Left breast DCIS, Adnexal cyst and uterine fibroid. INTRAOPERATIVE CONSULTATION: FSA: Right tube and ovary: Benign cyst-defer further classification to permanent. Diagnosis by Dr., called to Dr. at. TPC1-2/TPD/TPE: SLN #1, 2, 3, lert axilla - No tumor seen. F. GROSS EXAMINATION: SLN #4 left axilla: No tumor seen. Diagnosis called to Dr. at. I (C-F) by Dr. Microscopic/Diagnostic Dictation: Pathologis. Final Review: Pathologist 1. Final: Pathologist,.",BRCA,0,True,"The report mentions that the invasive ductal carcinoma in the left breast measures 2.2 cm, which falls under the T2 category of tumors that are more than 2 cm but not more than 5 cm in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
929,TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF,3,"Patien. surgical F. CLINICAL HISTORY: Right breast Ca, rule out deep margin positive. GROSS EXAMINATION: A. ""#1 right modified radical mastectomy"", in formalin. Received in the. container is a portion of breast with an attached skin ellipse containing the. nipple and an axillary dissection. The specimen measures 18.5 x 14 x 3.9 cm. The attached skin ellipse measures 14.7 x 6.3 cm. The nipple appears grossly. unremarkable. There is a small 0.5 cm hole 1.7 cm inferior to the nipple. The. deep surface of the specimen is inked in blue and the specimen is serially. sectioned revealing a 3.5 x 2 x 1.5 cm firm white mass in the medial portion. of the specimen. The mass is fairly well-circumscribed but very firm to. palpation. Grossly it appears to approach within 0.2 cm of the deep surgical. margin. There is no definite biopsy cavity; however, there is a small area of. hemorrhage just adjacent to the tumor mass. Tissue from the tumor mass has. been sent for estrogen and progesterone receptors. Block Summary: A1- section through nipple. A2- section through hole in skin ellipse. A3-A5- sections of tumor with adjacent deep margin. A6-A9- representative sections of tumor. A10- representative sections of upper lateral quadrant. A11- representative section of lower lateral quadrant. A12- representative section of upper medial quadrant. A13- five lymph node candidates from level three. A14-A15- one large lymph node bisected, level three. A16- one large lymph node bisected and one small lymph node candidate, level. three. A17- one lymph node candidate bisected, level three. A18- one lymph node candidate bisected, level three. A19- four lymph node candidates from level II. A20- one lymph node candidate bisected from level II. A21- two lymph node candidates from level II. A22- five lymph node candidates from level I. A23- two lymph node candidates from level I. A24- two lymph node candidates from level I. A25- two lymph node candidates from level I. MICROSCOPIC EXAMINATION: Most of the tumor consists of tubules and cribriform glands composed of. atypical cells with a moderate amount of eosinophilic cytoplasm and oval. nuclei with distinct relatively small nucleoli. There is a sparse. inflammatory response. A minor non-comedo intraductal component is present,. within or near the tumor mass. Away from the tumor, no intraductal carcinoma. or epithelial hyperplasia is seen. DIAGNOSIS: A. ""RIGHT"" BREAST, MODIFIED RADICAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMA (2.5 CM), NSABP HISTOLOGIC GRADE II/III,. NUCLEAR GRADE MODERATELY DIFFERENTIATED. A NON-COMEDO INTRADUCTAL CARCINOMA COMPONENT IS IDENTIFIED, COMPRISING. LESS THAN 10% OF THE CARCINOMA. NO TUMOR IS SEEN IN THE DEEP SURGICAL MARGIN. 1 of 2. NO VASCULAR INVASION IS IDENTIFIED. TWO OF SEVENTEEN (2/17) LYMPH NODES ARE POSITIVE FOR METASTATIC. ADENOCARCINOMA. BREAST TISSUE WITH APOCRINE METAPLASIA AND MICROCALCIFICATIONS IN. NON-NEOPLASTIC LOBULES. 2 of 2.",BRCA,1,True,"The tumor size is 2.5 cm, which falls within the size range for a T2 tumor (more than 2 cm but not more than 5 cm in size). The fact that the tumor approaches the deep surgical margin does not affect the T stage, as the T stage is determined solely by the size of the tumor, unless there is direct extension to the chest wall or skin, which is not mentioned in this report.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1326,TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74,1,"Gross Description: There is a breast with tumor of irregular shape up to 3 cm in its largest dimension. At. the distance of 1.5 cm from the 1st tumor node there is the 2nd node up to 1 cm in size. In the axillary. fatty tissue there are lymph nodes with lipomatosis (suspicion of metastases). Microscopic Description: Infiltrating lobular carcinoma of the breast, G-3, with multicentric type of. growth. There are single signet-ring cells. Ten examined lymph nodes demonstrated metastases. IHC-stainings: ER - positive reaction 98% 3+; PR - positive reaction 50% 3+; Her-2/neu - negative reaction. 1+; Ki-67 - 6%. Diagnosis Details: Tumor Features: Indeterminate, Tumor Extent: T2 tumor size more than 2cm not. more than 5 cm, Venous Invasion: Not specified, Margins: Absent, Treatment Effect: Comments: Original records read pT1N2M0. But tumor size is up to 3 cm in largest dimension, which. corresponds to T2. Formatted Path Reports: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 0 X 0 x 3 cm. Grossly evident lesion: Yes. Histologic type: Lobular carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Lymph nodes: 8/10 positive for metastasis (Axillary 8/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Tumor Features: Indeterminate, Tumor Extent: T2 tumor size more than. 2cm not more than 5 cm, Venous Invasion: Not specified, Margins: Absent, Treatment Effect: IHC-. stainings: ER - positive reaction 98% 3+; PR - positive reaction 50% 3+; Her-2/neu - negative reaction 1+;. Ki-67 - 6%.Original records read pT1N2M0. But tumor size is up to 3 cm in largest dimension, which. corresponds to T2. IHC-stainings: ER - positive reaction 98% 3+; PR - positive reaction 50% 3+; Her-2/neu. - negative reaction 1+; Ki-67 - 6%. Comments: Breast-right.",BRCA,2,True,"The report states that the largest dimension of the tumor is up to 3 cm, which falls within the criteria for a T2 tumor (more than 2 cm but not more than 5 cm in size). The presence of lymph node metastases and the absence of distant metastases do not affect the T stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1270,TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734,0,"BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 1.8 x 1 x 1 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal and lobular carcinoma. Histologic grade: Tumor extent: Not specified. Lymph nodes: 7/7 positive for metastasis (Regional 7/7). Right,Jupper. Extracapsular invasion of the lymph nodes: Not specified. inner. Margins: Not specified. quadrant. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",BRCA,2,True,"The report states that the tumor size is 1.8 x 1 x 1 cm, which falls under the category of T1 tumors (T1 tumors are 2 cm or less in size). Therefore, the T stage for this patient is T1.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1074,TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13,3,"N. PATIENT HISTORY: The patient is a year-old female. Date of last menstrual period: Not given. PRE OP DIAGNOSIS: Left breast cancer. POST OP DIAGNOSIS: Same. PROCEDURE: Left modified radical mastectomy. FINAL DIAGNOSIS: PART 1: LEFT BREAST, MODIFIED RADICAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA OF BREAST, NOTTINGHAM SCORE 8/9 (TUBULES 3, NUCLEI 3, MITOSES 2). B. NEOPLASM MEASURES 5.5 CM IN MAXIMUM DIMENSION. C. NEOPLASM EXTENDS INTO DERMIS. D. MARGINS OF RESECTION FREE OF NEOPLASM. E. EXTENSIVE DERMAL LYMPHOVASCULAR EXTENSION IDENTIFIED (T4d). F. NO PAGET'S DISEASE OF NIPPLE IDENTIFIED. G. METASTATIC CARCINOMA IN INTRAMAMMARY LYMPH NODE, 1 OF 1, 0.7 CM IN DIAMETER WITH. EXTRACAPSULAR EXTENSION. PART 2: LEFT AXILLARY CONTENTS, AXILLARY DISSECTION. METASTATIC CARCINOMA IN LYMPH NODES, 3 OF 3. PART 3: LEFT AXILLARY CONTENTS, AXILLARY DISSECTION. METASTATIC CARCINOMA IN LYMPH NODES, 2 OF 2. COMMENT: Estrogen_ Progesterons and Her-2/Neu analyses were performed on the two previous specimens (outside block from: and di. wand interpreted on both specimens as ER negative, PR negative and Her-. 2/Neu negative. If repeat analyses are desired on current specimen, please contact the laboratory.",BRCA,2,True,"The T stage is primarily determined by the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned. In this report, the tumor measures 5.5 cm in maximum dimension and extends into the dermis (T4d), indicating a T4 stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T4,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
734,TCGA-AC-A7VB.53881871-C36B-4622-BFC6-4DA3635D7B26,0,"Provider Group : Date of Service: Date Received: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. - F. RIGHT BREAST AND AXILLARY LYMPH NODES, MASTECTOMY, SENTINEL. LYMPH NODE BIOPSIES, AND AXILLARY LYMPH NODE DISSECTION: - Multifocal invasive ductal carcinoma, Nottingham grades 2-3. See comment. - Largest tumor nodule: 1.5 cm in diameter (6 o'clock aspect). - Two smaller nodules: 0.6 and 0.8 cm (7-8 o'clock aspect). - Ductal carcinoma in situ (DCIS), high nuclear grade, solid type. - DCIS comprises less than 10% of biopsy tissue volume, and is associated. with all three invasive tumor nodules. - Mastectomy margins are free of tumor. - Carcinoma is 3 cm from the inferior margin and is at least 6 cm from. all other margins. Metastatic carcinoma in three of fifteen lymph nodes (3/15). - Largest metastatic focus: 0.9 cm in diameter. - Extranodal extension present. - Positive lymph nodes are sentinel lymph nodes #2, #3, and #4. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive ductal carcinoma, Nottingham grade 2-3. Type and grade (in situ): DCIS, high-nuclear grade. Primary tumor: pT1c(m). Regional lymph nodes: pN1c. Distant metastasis: Not applicable. Stage: IIA. Lymphovascular invasion: Indeterminate. Margin status: Negative. COMMENT: The three foci of invasive carcinoma have similar histologic features,. although the tumor grade is somewhat variable in the largest tumor nodule, where. there is a variable rate of mitosis, and nuclear pleomorphism ranging from. intermediate to high-grade. The smaller tumor nodules contain high-grade malignant. Printed: This report continues. Acct No. -. Pathology - Page 1/6. Page 1 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. epithelial cells arranged in solid sheets with frequent mitoses, compatible with. Nottingham grade 3. There is enough morphologic similarity between three nodules. to suggest that they have a common origin. Intradepartmental consultation: concurs with this impression. Invasive Breast Cancer Tumor Staging Information. AJCC Cancer Staging Handbook, 7th Ed. and CAP Protocol (revised June 2012). Previous pathology specimens: his report continues (FINAL). Printed: MR No. -. lage 2 Doc# 1. Pathology - Page 2/6. SPECIMEN IDENTIFICATION. Procedure/specimen type: Modified radical mastectomy. Laterality: Right. Lymph node sampling: Sentinel lymph node biopsies followed by lymph. node dissection. INVASIVE CARCINOMA TUMOR CHARACTERISTICS. Histologic type: Invasive ductal carcinoma (multifocal). Tumor sites: 6:00-8:00. Tumor size: Largest tumor nodule 1.5 cm. Tumor focality: Multifocal. Histologic grade (Nottingham Score): 2-3 of 3. Tubule formation: 3 of 3. Nuclear pleomorphism: 2-3 of 3. Mitotic rate: 2-3 of 3 (variable mitotic rate). Lymphovascular invasion: Indeterminate. Macroscopic and microscopic extent of tumor: No skin or chest wall invasion identified. DUCTAL CARCINOMA IN SITU (DCIS): Present in association with three invasive tumor. nodules. MARGINS. Invasive carcinoma: Negative. Ductal carcinoma in situ: Negative. LYMPH NODES. Total lymph nodes examined. 15. Number of lymph nodes involved. 3. Size of largest metastatic deposit: 0.9 cm. Extranodal extension: Present. PATHOLOGIC STAGING: Primary Tumor (pT): pTic(m). Regional lymph nodes (pN): pN1a. Distant metastasis (pM): Not applicable. AJCC Stage: IIA. ANCILLARY STUDIES: on 2. previous biopsies (additional HER2 studies. pending, to be reported in an addendum). Estrogen receptor: 85-96% positive cells, strong intensity. Progesterone receptor: 0% positive cells. HER2: Additional studies pending, to be reported in an. addendum. Printed: This report continues. Acct No. Pathology - Page 3/6. Page 3 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. Ki-67: Variable, previously reported 7-69%. Source of Specimen: A. Sentinel lymph node;#1--. right axillary. B. Sentinel lymph node;#2--. right axillary. C. Sentinel lymph node;#3-. right axillary. D. Sentinel lymph node;#4. right axillary. E. Breast surgical;right. F. Axillary nodes right. Clinical History/Operative Dx: Right breast cancer. Intraoperative Diagnosis: A. Sentinel node #1. - diagnosis: Negative for carcinoma. B. Sentinel node #2. - diagnosis: Rare atypical cells, suspicious for carcinoma. (Defer to. permanents). D. Sentinel node #4. and. - diagnosis: Positive for carcinoma. The intraoperative interpretation(s) was/were performed and rendered at. Gross Description: A. Part A is designated as sentinel node #1. right axilla, touch prep. Initially received in the fresh. state four frozen section/touch prep evaluation is a 1.0 x 0.8 x 0.6 cm piece of red-tan soft tissue. Examination reveals a 0.7 x 0.6 x 0.5 cm lymph node. The cut surfaces are fatty and rubbery, pink and. tan. Two touch imprint slides are prepared for microscopic evaluation. The lymph node is entirely. Printed: This report continues. Acct No. Pathology - Page 4/6. age 4 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. submitted for routine histology in A1 with a sentinel node protocol performed. B. Part B is sentinel node #2. Initially received in the fresh state for touch prep/frozen section. evaluation is a 1.5 X 1.2 x 1. 0 cm yellow-tan portion of tissue. Examination reveals a 0.8 x 0.6 x 0.6 cm. lymph node. Sectioning demonstrates a rubbery, pink and tan cut surfaces. Two touch imprint slides are. submitted for microscopic evaluation. The Ivmph node is entirely submitted for routine histology in B1. with a sentinel node protocol performed. C. Part C designated as sentinel node #3. right axillary. Received in formalin is a 1.5 x 1.5 x 0.7. cm fragment of fat. Examination reveals two possible apparent lymph nodes, 0.8 x 0.6 x 0.4 cm each. The. lymph node is serially sectioned and entirely submitted for microscopic evaluation in C1 with a sentinel. lymph node protocol performed. D. Part D is designated as sentinel node #4. right axillary. Initially received in the fresh state for. frozen section/touch imprint evaluation is a 1.5 X 1.2x 1.0 cm yellow-green portion of fatty soft tissue. Examination reveals a 1.0 x 0.8 x 0.8 cm dense, pink-gray lymph node. Two touch imprint slides and a. representative section is submitted for frozen section evaluation. The residual frozen tissue is submitted in. D1 for permanent sections and the touch imprint aspect of the lymph node is submitted in D2 for. permanent sections with a sentinel lymph node protocol performed. E. Received fresh labeled ""right breast."" Sutures present for orientation purposes. A portion of tumor is. submitted for. Laterality: Right. Specimen: Mastectomy. Size of mastectomy: (M-L x S-I x A-P): 23.5 x 19x 5 cm. Axillary tail: Not present. Skin: 24 x 18 cm, pigmented skin. Nipple/areola: Yes, center of skin. Specimen weight: 971 grams. Ink code: Blue - superior-anterior, orange - inferior-anterior, black - deep. Stabs: Total # 11, M-I= 1, L-S= 11. Nipple in slab #6. Time of resection: Time placed into formalin: Time out of formalin: Lesion 1: Biopsy site present. Size: 1.5 x 1.4 x 0.8 cm, stellate, gray-white, firm mass. Location: 6:00. Involves slabs # 3-4. Distance to nearest margin(s): 3 cm from inferior margin, 6 cm from deep margin. Lesion #2: Biopsy site present. Size: 0.8 x 0.5 x 0.5 cm. Location: 7:00. Involves slabs #2-3. Distance to nearest margin(s): 6 cm from inferior. Printed: This report continues (FINAL). MR No. -. Acct No. -. Pathology - Page 5/6. - Page 5 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. Lesion #3: No biopsy site present. Size: 0.6 x 0.6 x 0.5 cm. Location: 7:00. Involves slabs #4. Distance to nearest margin(s): 5 cm from inferior. Non-lesional breast: Fibrofatty breast tissue. Cassette summary: E1) smallest 7:00 tumor, previously biopsied (portion of the small tumor submitted for. E2-E4) largest 6:00 lesion,. E5) central breast tissue,. E6-E7) lateral breast tissue,. E8) nipple/subareolar breast tissue,. E9) representative breast tissue,. E10-E11) fibrous tissue medial to largest tumor,. E12) representative medial breast tissue,. E13) mass #3, 7:00,. E14-E15) central posterior breast tissue. F. Part F is which axillary nodes, right. Received in formalin is an 83 gram partially tattered portion of. yellow-tan fatty soft tissue, 13.0 x 9.0 x 2.6 cm. Examination reveals eleven lymph nodes ranging from 0.2. cm to 1.9 X 1.4 x 1.2 cm in greatest dimension. The lymph nodes are entirely submitted for microscopic. evaluation. Cassette summary: F1) four lymph nodes,. Ne. F2) four lymph nodes,. F3) one lymph node, bisected,. F4) one lymph node, bisected,. F5-F6) largest lymph node, serially sectioned. Microscopic Description: A. - C. Immunohistochemical stain: CK OSCAR, showing focal metastatic carcinoma in specimens B and. C. D. Immunohistochemical stain: CK OSCAR, highlighting metastatic carcinoma. HER2 - results pending, to. be reported in an addendum. E. Immunohistochemical stain: HER2, to be reported in an addendum. F. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Printed: END OF REPORT (FINAL). MR No. -. Acct No. 'atient Name -. Pathology - Page 6/6. uge 6 Doc# 1.",BRCA,1,True,"The largest tumor nodule is 1.5 cm in diameter, which falls under the 'T1' category. The 'c' substage indicates multifocal tumors with the largest contiguous tumor nodule being 1.5 cm or less in size. The 'm' substage indicates multiple tumor foci, none of which is 5 cm or more in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
622,TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA,1,"Diagnosis: Poorly differentiated invasive ductal carcinoma (tumor diameter: 3.0 cm). Concluding tumor classification: NOS, G III, pT2LOVORO.",BRCA,0,True,"The T stage is determined by the size of the tumor. In this report, the tumor diameter is 3.0 cm, which falls in the T2 category (more than 2 cm but not more than 5 cm in size). The information about the tumor being poorly differentiated (grade III) and having lymphovascular invasion (LOV) does not affect the T stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
789,TCGA-AO-A0J3.29C262B5-D49D-4125-9661-19033A8EC6A8,1,"Clinical Diagnosis & History: Right breast cancer with axillary positive FNA. Specimens Submitted: 1: SP: Right breast and axillary contents level 1 and 2. 2: SP:Additional level one lymph node , right axilla. DIAGNOSIS: 1. BREAST, RIGHT; MODIFIED RADICAL MASTECTOMY: - MULTIPLE FOCI INVASIVE DUCTAL CARCINOMA WITH NEUROENDOCRINE. DIFFERENTIATION, HISTOLOGIC GRADE III/III (SLIGHT OR NO TUBULE FORMATION). NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND SHAPE) RANGING IN SIZE. FROM 0.1 CM TO 4.2 CM. - THERE IS A DOMINANT TUMOR MASS WHICH MEASURES 4.2 CM IN GREATEST DIMENSION. WITH MULTIPLE SATELLITE NODULES SPANNING AN AREA OF 9.0 CM. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED, SOLID, FLAT/CLINGING,. MICROPAPILLARY, AND CRIBRIFORM TYPES WITH INTERMEDIATE TO HIGH NUCLEAR GRADE. AND MILD NECROSIS. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR MASS,. AND IS PRESENT ADMIXED WITH THE INVASIVE COMPONENT. - THE INVASIVE CARCINOIMA IS LOCATED IN ALL FOUR QUADRANTS AND THE. CENTRAL AREA. - THE DCIS IS LOCATED IN ALL FOUR QUADRANTS AND THE CENTRAL AREA. - SMALL FOCUS OF LOBULAR CARCINOMA IN SITU (LCIS) IS IDENTIFIED. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA. IS IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN THE INVASIVE AND IN SITU CARCINOMA. NO VASCULAR INVASION IS NOTED. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - BIOPSY SITE, FIBROCYSTIC, AND COLUMNAR CHANGES AND MICROSCOPIC. INTRADUCTAL PAPILLOMAS ARE ALSO IDENTIFIED. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL I: 0/23; LEVEL II: 0/11; INTRAMAMMARY (ELEVEN o' CLOCK) : 1/1. - THE METASTATIC FOCUS MEASURES 1.9 CM. - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. LYMPH NODE, LEVEL ONE, RIGHT AXILLA, ADDITIONAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: M.D. 1) The specimen is received fresh and labeled, ""right breast and axillary. contents levels 1 and 2"" and consists of a breast measuring 33.0 x 27.5 x. 6.0 cm with overlying skin ellipse measuring 33.0 x 17.0 cm. Situated. centrally on the skin surface is a flattened nipple measuring 0.9 x 0.9 cm. and areola measuring 4.2 cm. The skin shows bruising at the 8 o'clock. positions. No definitive scars are appreciated. A suture demarcates the. axillary contents which measures 11.0 x 6.5 cm. Two tags are present,. designating levels 1 and 2. The posterior surface of the breast is inked. black and the anterior/superior red and interior/inferior green. The. specimen is serially sectioned to reveal a firm tumor nodule measuring 4.2. x 3.5 x 3.2 cm located centrally at the subareolar aspect, located 1.0 cm. from the deep margin with surrounding firm satellite extension involving a. 9.0 x 5.5 x 5.0 cm area involving all four quadrants. A full face section of. the largest tumor nodule is taken, sectioned and submitted accordingly. Additional representative sections showing the satellite nodules are. submitted. The remaining breast tissue shows, lobular adipose tissue with. scant white fibrous breast tissue. The axillary tissue is dissected to. reveal an enlarged tan lymph node located in the upper outer quadrant at 11. o'clock position, measuring 2.5 cm in greatest dimension with a grossly. positive cut surface. A representative section of the lymph node is. submitted. All identified lymph nodes are submitted. Representative sections. are submitted. All dissected lymph nodes are entirely submitted. Summary of sections: N - nipple. NB - nipple base. S - representative skin. D - tumor to deep margin. TN- largest tumor nodule to surrounding papillary nodules. PN- surrounding papillary tumor nodules. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN11 grossly positive 11 o'clock lymph node. LN1- lymph nodes (level 1). BLN1- bisected lymph nodes (level 1). TLN1- - trisected lymph nodes (level 1). SLNIserially sectioned single lymph node (level 1). LN2 - lymph nodes (level 2). BLN2 bisected lymph node (level 2). 2) The specimen is received in formalin, labeled ""Additional level 1 lymph. node, right axilla"" and consists of a single pink tan fatty lymph node. measuring 1.2 x 1 x 0.3 cm. The lymph node is entirely submitted. Summary of sections: LN- lymph node. Summary of Sections: Part 1: SP: Right breast and axillary contents level 1 and 2. Block. Sect. Site. PCs. 4. BLN1. 4. 1. BLN2. 1. 1. D. 1. 2. LIQ. 2. 3. LN1. 3. 1. LN11. 1. 2. LN2. 2. 2. LOQ. 2. 3. N. 3. 1. NB. 1. 1. S. 1. 4. SLN1. 4. 3. TLN1. 3. 2. TN. 2. 3. 3. 2. UIQ. 2. 2. UOQ. 2. Part 2: SP:Additional level one lymph node , right axilla. Block. Sect. Site. PCs. 1. LN. 1. Procedures/Addenda: Addendum. Date Complete: D. Addendum Diagnosis. RIGHT BREAST AND AXILLARY CONTENTS, LEVEL 1 AND 2: - IMMUNOHISTOCHEMICAL STAINS SHOW THE TUMOR CELLS TO BE NEGATIVE FOR. HER2 (G/1+). M.D.",BRCA,1,True,"The report indicates that the dominant tumor mass measures 4.2 cm in greatest dimension, which falls under the 'T3' category of 'Tumors more than 5 cm in size'. The presence of multiple satellite nodules and ductal carcinoma in situ (DCIS) do not affect the T stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T3,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
781,TCGA-AO-A03N.44527CD3-6EC3-4861-8394-CEA005A17A9E,1,"Clinical Diagnosis & History: vio femals with left breast ductal CA. Specimens Submitted: 1: SP: Sentinel node #1, level 1, left axilla (fs). 2: SP: Sentinel node #2, level 1, left axilla (fs). 6. 3: SP: Sentinel node #3, level 1, left axilla (fs). 4: SP: Sentinel node #4, level 1, left axilla (fs). 5: SP: Left breast. 6: SP: Sentinel node #5, level 1, left axilla. 7: SP: Left axillary contents, levels 1 and 2 (. 8: SP: Left subscapular nodes. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1, LEVEL I, LEFT AXILLA; EXCISION: - METASTATIC CARCINOMA INVOLVING ONE OUT OF ONE LYMPH NODE (1/1). - THE METASTATIC FOCUS MEASURES 2 MM. - NO EXTRANODAL EXTENSION IS SEEN. 2). LYMPH NODE, SENTINEL #2, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODK (0/1). 3). LYMPH NODE, SENTINEL #3, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 4). LYMPH NODE, SENTINEL #4, LEVEL I, LEFT AXILLA; EXCISION: - METASTATIC CARCINOMA INVOLVING ONE OUT OF ONE LYMPH NODE IN THE FORM. OF A SINGLE CLUSTER IDENTIFIED IN A H/E STAINED SECTION (1/1). 5). BREAST, LEFT; MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION) NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE) ' MEASURING 2.5 CM IN LARGEST DIMENSION GROSSLY (AT LEAST 2.3 CM. MICROSCOPICALLY). - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID AND CRIBRIFORM. TYPES WITH INTERMEDIATE NUCLEAR GRADE AND MINIMAL NECROSIS. - THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH THE INVASIVE COMPONENT. - FOCAL LOBULAR CARCINOMA IN SITU (LCIS) IS ALSO IDENTIFIED, CLASSICAL TYPE. (TYPE A). - THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER OUTER QUADRANT AND UPPER. INNER QUADRANT. - THE DCIS I3 LOCATED IN THE UPPER OUTER QUADRANT AND UPPER INNER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA IS. IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN THE IN SITU CARCINOMA AND IN BENIGN. BREAST PARENCHYMA. - VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES AND. INTRADUCTAL PAPILLOMA WITH ATYPIA. RESULTS OF SPECIAL STUDIES (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. 6). LYMPH NODES, SENTINEL #5, LEVEL I, LEFT AXILLA; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 7). LYMPH NODES, LEFT AXILLA, LEVEL I AND II; EXCISION: - LEVEL I: ELEVEN BENIGN LYMPH NODES (0/11). LEVEL II: ONE BENIGN LYMPH NODE (0/1). 8). LYMPH NODE, LEFT SUBCAPSULAR; EXCISION: - ONE BENIGN LYMPH NODE (0/1). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-C. NEG-HER2. NEG CONT. IMM RECUT. Gross Description: M.D. M.D. 1) The specimen is received fresh for frozen section consultation, labeled. ""sentinel node number 1, level 1 left axilla"" and consists of one lymph node. measuring 2.5 x 1.2 x 1.0 cm. Entirely submitted for frozen section. (bisected) . Summary of sections: FSA-FSB. frozen section control. M.D. 2) The specimen is received fresh for frozen section consultation, labeled. ""sentinel node number 2, level 1 left axilla"" and consists of one lymph node. measuring 1.2 x 0.5 x 0.5 cm. Entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. M.D. 3) The specimen is received fresh for frozen section consultation, labeled. sentinel node number 3, level 1 left axilla"" and consists of one lymph node. measuring 1.2 x 0.5 x 0.5 cm. Entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. M.D. 4) The specimen is received fresh for frozen section consultation, labeled. ""Sentinel node number four, level one, left axilla"" and consists of one. lymph node measuring 0.9 x 0.4 x 0.4 cm. The lymph node is bisected and. entirely submitted for frozen section diagnosis. Summary sections: FSC -- frozen section control. , M.D. 5) The specimen is received fresh, labeled ""Left breast and consists of a. breast measuring 21.5 x 14.0 x 3.4 cm with an overlying skin ellipse. measuring 10.8 x 5.0 cm. Situated centrally on the skin surface is an. everted nipple measuring 1.3 x 1.3 x 0.6 cm and areola measuring 2.2 x 2.2. cm. A suture demarcates the axillary aspect. The posterior surface of the. breast is inked black, the anterior aspect is blue and the axillary aspect. green and the specimen is serially sectioned to reveal an indurated. tan-white tumor measuring 2.5 x 2.4 x 2.3 cm, and located predominantly in. the upper outer quadrant, between 12 o' clock and one o' clock, focally. extending into the upper inner quadrant, 0.2 cm from the anterior aspect and. 0.7 cm from the deep margin. Sectioning of the axillary aspect reveals no. grossly identifiable lymph nodes. Tissue is submitted for TPS. Representative sections are submitted. Summary of sections: N - nipple. NB - nipple base. T - tumor. TAM, TDM-tumor to anterior aspect and deep margin respectively. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. P.A. 6) The specimen is received in formalin, labeled ""Sentinel node, number. five, level one, left axilla"" and consists of two single. pink-tan firm lymph nodes measuring 0.9 x 0.6 x 0.3 and 1.4 x 0.8 x 0.6 cm. The lymph nodes are bisected and entirely submitted. Summary of sections: BLN bisected lymph nodes. P.A. 7). The specimen is received in formalin, labeled ""Left axillary contents. one and two tags attached"". It consists of a 7 x 4 x 3 cm fragment of. fibroadipose tissue. Two tags are present, designating levels 1 and 2. Multiple lymph nodes are identified, ranging in size from 0.9 cm to 2.7 cm. All identified lymph nodes are submitted. Summary of sections: L1LN - level one lymph nodes. L1BLN-level one bisected lymph nodes. L2BLN-level two bisected lymph nodes. P.A. 8) The specimen is received in formalin, labeled ""Left sub-scapular - node"". and consists of a single pink-tan, fatty lymph node measuring 0.3 x 0.2 x. 0.2 cm. The lymph node is entirely submitted. Summary of sections: LN- lymph node. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, left axilla (fs). Block. Sect. Site. PCs. fsa. 1. 1. fsb. 1. Part 2: SP: Sentinel node #2, level 1, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Sentinel node #3, level 1, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 4: SP: Sentinel node #4, level 1, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 5: SP: Left breast. Block. Sect. Site. PCs. 2. liq. 2. 2. loq. 2. 1. n. 1. 1. nb. 1. 4. 4. 1. tam. 1. 1. tdm. 1. 2. uiq. 2. 2. uog. 2. Part 6: SP: Sentinel node #5, level 1, left axilla. Block. Sect. Site. PCs. 2. BLN. 4. Part 7: SP: Left axillary contents, levels 1 and 2. Block. Sect. Site. PCs. 4. L1BLN. 8. 2. LILN. 4. 1. L2BLN. 2. Part 8: SP: Left subscapular nodes. Block. Sect. Site. PCs. 1. LN. 1. Procedures/Addenda: Addendum. Date Complete: MD. Addendum Diagnosis. ADDENDUM REPORT. SITE: LEFT BREAST (PART #5). ER: 70% NUCLEAR STAINING WITH MODERATE TO STRONG INTENSITY. PR: 3% NUCLEAR STAINING WITH WEAK INTENSITY. HER2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 0). MD. Intraoperative Consultation: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1A,B). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS: BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS: BENIGN LYMPH NODE. PERMANENT DIAGNOSIS : SAME. MD.",BRCA,1,True,"The tumor size is reported as 2.5 cm in largest dimension, which falls under the 'T2' category of tumors that are more than 2 cm but not more than 5 cm in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",11.0,941.0,100.0,True
1240,TCGA-E2-A1II.4F2A288E-8162-4579-BCD2-0FF31B0EEB3C,0,"SPECIMENS: A. RIGHT BREAST LESION. B. ADDITIONAL POSTERIOR MARGIN. C. LEFT BREAST CANCER. D. ADDITIONAL POSTERIOR -LATERAL MARGIN. E. SENTINEL L.N. LEFT AXILLA #1. F. SENTINEL L.N. LEFT AXILLA #2. G. SENTINEL L.N. LEFT AXILLA #3. H. SENTINEL L.N. LEFT AXILLA #4. I. SENTINEL L.N. LEFT AXILLA #5. J. ADDITIONAL INFERIOR MARGIN. K. ADDITIONAL POSTERIOR MARGIN. SPECIMEN(S): A. RIGHT BREAST LESION. B. ADDITIONAL POSTERIOR MARGIN. C. LEFT BREAST CANCER. D. ADDITIONAL POSTERIOR -LATERAL MARGIN. E. SENTINEL L.N. LEFT AXILLA #1. F. SENTINEL L.N. LEFT AXILLA #2. G. SENTINEL L.N. LEFT AXILLA #3. H. SENTINEL L.N. LEFT AXILLA #4. I. SENTINEL L.N. LEFT AXILLA #5. J. ADDITIONAL INFERIOR MARGIN. K. ADDITIONAL POSTERIOR MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: A. Right breast: An ill-defined firm area about 0.3cm from posterior margin, additional margin B received. (gross only). C. Left breast: 1.7 x 1.5 x 1.3 cm nodule located 0.1-cm from posterior and inferior junction. Sentinel lymph nodes, left axilla, #1-5: Lymph nodes, negative for tumor on touch preparation. Diagnoses called to Dr. at. 1. (A),. (C). (E-I) by Dr. GROSS DESCRIPTION: A. RIGHT BREAST LESION. Received fresh labeled with matching patient identifiers is an oriented (single-anterior, double-lateral,. triple-superior) 20g, 5.2 x 4.9 x 1.6 cm lumpectomy with 1.4 x 0.3 cm skin ellipse accompanied by. mammograms. The specimen is inked as follows: Anterior-blue, posterior-black, superior-red, inferior-. orange, medial-green, lateral-yellow. The specimen is serially sectioned from medial to lateral into 5. slices revealing a 1 x 0.5 x 0.5 cm ill-defined firm hemorrhagic area approaching the closest posterior. margin at 0.3cm. The entire specimen is submitted for microscopic evaluation: A1: Medial margin. A2-A3: Section 2 entirely submitted. A4-A6: Section 3, A6 demonstrates ill-defined firm area. A7-A9: Section 4 entirely submitted. A10-A13: Lateral margin. B. ADDITIONAL POSTERIOR MARGIN. Received in formalin in a container labeled with matching patient identifiers is a 2.6 x 2.4 x 1.1cm breast. tissue with orientation, the suture designating the final posterior margin. This area is inked black. The. specimen is serially sectioned and submitted entirely in cassettes B1-B4. C. LEFT BREAST. Received fresh labeled with matching patient identifiers is an oriented (single-anterior, double-lateral,. triple-superior, quadruple-posterior) 94g, 9.6 (anterior to posterior) x 7.5 x 4.4 cm lumpectomy. The. specimen is inked as follows: Anterior-blue, posterior-black, superior-red inferior-orange, medial-green,. lateral-yellow. The specimen is serially sectioned from anterior to posterior into 7 slices revealing a 1.7 x. 1.5 X 1.3 cm firm tan circumscribed round mass closest to the posterior/inferior margin at 0.1cm. A. second possible 0.5 x 0.3 x 0.3 cm nodule is palpated 0.5cm from the main mass that approaches the. posterior margin at 0.2cm. A portion of the specimen is submitted for tissue procurement. Representatively submitted as follows: C1: Representative sections anterior margin, slice 1. C2: Representative section, slice 2 superior. C3-C4: Representative sections, slice 3, lateral and inferior. C5-C6: Representative sections, slice 4, medial and inferior. C7-C13: Slice 5 entirely submitted, C10-C11, mass, C12-C13, possible nodule. C14-C19: Slice 6 entirely submitted, C14-C17, mass (procured), C18-C19 posterior. C20-C21: Posterior margin submitted entirely, slice 7. D. ADDITIONAL POSTERIOR LATERAL MARGIN. Received in formalin in a container labeled with matching patient identifiers is a 4.2 x 2.7 X 1.6 cm. breast tissue with orientation, the suture designates the final posterior lateral margin. This area is inked. black. The specimen is serially sectioned and submitted entirely in D1-D6. E. SENTINEL LYMPH NODE LEFT AXILLA #1. Received fresh labeled with matching patient identifiers is a fragment of adipose tissue measuring 2.5 x. 2.4. x 0.5 cm. A possible lymph node is identified measuring 1.2 x 0.5 X 0.5 cm. Touch preparation is. performed. The lymph node is submitted entirely in cassette E1. F. SENTINEL LYMPH NODE LEFT AXILLA #2. Received fresh labeled with matching patient identifiers is a fragment of adipose tissue measuring 3.3 x. 2.5 x 0.7 cm. A possible lymph node is identified measuring 1.3 x 0.5 x 0.5 cm. Touch preparation is. performed. The lymph node is submitted entirely in cassette F1. G. SENTINEL LYMPH NODE LEFT AXILLA #3. Received fresh labeled with matching patient identifiers is a fragment of adipose tissue measuring 2.9 X. 2.5 x 0.4 cm. A possible lymph node is identified measuring 0.5 x 0.5 x 0.5 cm. Touch preparation. is. performed. The entire specimen is submitted in cassettes G1-G2. H. SENTINEL LYMPH NODE LEFT AXILLA #4. Received fresh labeled with matching patient identifiers is a portion of tan-yellow possible lymphoid. tissue measuring 0.9 x 0.5 x 0.5 cm. The specimen is bisected. Touch preparation is performed. The. entire specimen is submitted in cassette H1. 1. SENTINEL LYMPH NODE LEFT AXILLA #5. Received fresh labeled with matching patient identifiers is a portion of tan-yellow possible lymphoid. tissue measuring 1.6 x 1 x 0.3 cm. The specimen is bisected. Touch preparation is performed. The. entire specimen is submitted in cassette I1. J. ADDITIONAL INFERIOR MARGIN. Received in formalin in a container labeled with matching patient identifiers is a portion of resected. breast tissue measuring 3.2 x 2.6 x 0.6 cm. The specimen is received with orientation, the suture. designates the final inferior margin. This area is inked black. The specimen is serially sectioned and. submitted entirely in cassettes J1-J3. K. ADDITIONAL POSTERIOR MARGIN. Received in formalin in a container labeled with matching patient identifiers is a portion of resected. breast tissue measuring 4.1 x 1.9 x 0.8 cm. The specimen is received with orientation, the suture. designates the final posterior margin. This area is inked black. The specimen is serially sectioned and. submitted entirely in cassettes K1-K3. SUMMARY OF IMMUNOHISTOCHEMISTRY/SPECIAL STAINS. Material: Block. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN AE1/3. Positive. Material: Block E1. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN AE1/3. Negative. Material: Block F1. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN AE1/3. Negative. The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of. staining performance and assay validation within the Immunohistochemistry Laboratory of the The use. of one or more reagents in the above tests is regulated as an analyte specific reagent (ASR). These. tests were developed and their performance characteristic determined by the. ny. it. They have not been cleared or approved by the U.S. Food and Drug Administration. line FDA has determined that such clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive. and negative controls. DIAGNOSIS: A. BREAST, RIGHT, NEEDLE LOCALIZED WIDE LOCAL EXCISION: - FOCAL ATYPICAL DUCTAL HYPERPLASIA. - FOCAL HEMORRHAGE, COLUMNAR CELL CHANGE, AND INTRADUCTAL. MICROCALCIFICATIONS. - BENIGN SKIN. B. BREAST, RIGHT, ADDITIONAL POSTERIOR MARGIN, EXCISION: - BREAST TISSUE WITH FOCAL HEMORRHAGE AND USUAL DUCTAL. HYPERPLASIA. C. BREAST, LEFT, NEEDLE LOCALIZED WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3), WITH MARKED LYMPHOCYTIC INFILTRATE. - TUMOR MEASURES 1.7 CM IN GREATEST DIMENSION. - TUMOR IS WITHIN 1 MM OF THE POSTERIOR AND INFERIOR. MARGINS (SEE NOTE). NOTE: The final posterior and inferior margins are negative for tumor (see specimens J and K). D. BREAST, LEFT, ADDITIONAL POSTERIOR-LATERAL MARGIN, EXCISION: - BREAST TISSUE, NEGATIVE FOR CARCINOMA. E. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1) (SEE NOTE). F. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1) (SEE NOTE). NOTE FOR E AND F: Cytokeratin AE1/3 stains were performed and are negative showing no evidence. of metastases. G. SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). H. SENTINEL LYMPH NODE #4, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). I. SENTINEL LYMPH NODE #5, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). J. BREAST, LEFT, ADDITIONAL INFERIOR MARGIN, EXCISION: - BREAST TISSUE WITH USUAL DUCTAL HYPERPLASIA,. NEGATIVE FOR CARCINOMA. K. BREAST, LEFT, ADDITIONIAL POSTERIOR MARGIN, EXCISION: - BREAST TISSUE WITH USUAL DUCTAL HYPERPLASIA,. NEGATIVE FOR CARCINOMA. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes - For mass. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.7cm. Tumor Site: 3:00. Margins: Negative. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/5. DCIS not present. ER/PR/HER2 Results. ER: Negative. PR: Positive. HER2: Negative by IHC. Pathological staging (pTN): pT 1c N 0. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: ER: Negative. Allred Score: 0 = Proportion Score 0 + Intensity Score. 0. PR: Negative Allred Score: 4 = Proportion Score 2 + Intensity Score 2. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30%. of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed usina the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer S instructions. This. assay was not modified. interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: Interpretation: NEGATIVE. Intensity: 1+. % Tumor Staining: 5%. Fish Ordered: METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analvsis was performed using the FDA approved Dako HercepTest (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. Pathology. Department takes full responsibility for this test's performance. CLINICAL HISTORY: Lesion on core biopsy, right breast; Left breast carcinoma. PRE-OPERATIVE DIAGNOSIS: Breast carcinoma. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 52. CLINICAL EXPERIENCE: Patients with a recurrence score of: 52 in the clinical validation study. had an average rate of Distant Recurrence at 10 years of 34%. ER Score: 3.7 Negative. PR Score: 3.3 Negative. Her2 Score: 7.6 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive >=' 11.5 Equivocal = 10.7 - 11.4. Microscopic/Diagnostic Dictation: M.D., Pathologist. Final Review: M.D., Pathologist,. Final: , M.D., Pathologist,. Addendum: M.D., Pathologist,. Addendum Final: , M.D., Pathologist.",BRCA,0,True,"Based on the report, the left breast invasive ductal carcinoma measures 1.7 cm in greatest dimension. According to the rules provided, T1 tumors are 2 cm or less in size. Furthermore, T1 is divided into three substages: T1a (less than or equal to 0.5 cm in size), T1b (greater than 0.5 cm but not greater than 1 cm), and T1c (greater than 1 cm but not greater than 2 cm). Therefore, the T stage for this report is T1c.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T1 is divided into three substages: T1a (less than or equal to 0.5 cm), T1b (greater than 0.5 cm but not greater than 1 cm), and T1c (greater than 1 cm but not greater than 2 cm).
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",T1c,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T1 is divided into three substages: T1a (less than or equal to 0.5 cm), T1b (greater than 0.5 cm but not greater than 1 cm), and T1c (greater than 1 cm but not greater than 2 cm).
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage.",12.0,1121.0,91.0,True
1336,TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00,1,"F. Pathologic Interpretation: A. Sentinel node #1 Count #. FS: Metastatic carcinoma to lymph node (1/1) with extracapsular extension. B. Sentinel node #2 count. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. C. Sentinel node #3 count. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. D. Sentinel node #4 count. FS: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. E. Sentinel node #5 count. FS: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. F. Sentinel node #6 count. FS: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. G. Axiliary fat (perm): - No malignancy seen in one lymph node (0/1). H. Skin right breast: - Skin with no specific pathologic change. I. Right breast lumpectomy (short stitch superior, long lateral ) fresh: - Invasive poorly differentiated ductal carcinoma, Nottingham grade 3 (3 + 3 + 3), 3.5 cm. Lymphovascular space invasion is not identified. - Specimen margins are negative for tumor. J. Additional deep margin (perm): - No malignancy seen. K. Right axiliary contents (perm): No malignancy seen in ten lymph nodes (0/10). L. Left breast tissue (perm): No malignancy seen. Surgical Pathology Tumor Summary. Specimen: partial breast. Procedure: Excision without wire-guided localization. Lymph node sampling: Sentinel lymph nodes, axillary dissection (partial or complete dissection). Specimen Integrity: Single intact specimen. Specimen Size: Greatest dimension: 9.5 cm. Additional dimensions: 8 x 5.5 cm. Specimen Laterality: Right. Tumor Size: Greatest dimension of largest focus of invasion over 0.1 cm: 3.5 cm. Additional dimensions: 3 x 3 cm. Skin: Invasive carcinoma does not invade into the dermis or epidermis. Skeletal Muscle: No skeletal muscle present. SURGICAL PATHOL Report. Histologic type of invasion: Invasive ductal carcinoma. Glandular (Acinar)/tubular Differentiation: Score 3: <10% of tumor are forming glandular/tubular structures. Nuclear Pleomorphism: Score 3: Vesicular nuclei, often with prominent nucleoli exhibiting marked variation in size and shape,. occasionally with very large and bizarre forms. Mitotic Count: Score 3. Overall Grade: Grade 3: scores of 8 or 9. Margins uninvolved by invasive carcinoma. Lymph-vascular invasion: Not identified. Number of lymph nodes examined: 6. Total number of lymph nodes examined (sentinel and non-sentinel): 17. Number of lymph nodes with macrometastasis (>0.2 cm): 1. Extranodal extension: Present. Method of evaluation of sentinel lymph nodes: Hematoxylin and eosin (H & E ) one level, immunohistochemistry. PT2: Tumor >20 mm but <50 mm in greatest dimension. PN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. Distant metastasis: not applicable. Estrogen Receptor: Performed on another specimen. 1. immunoreactive tumor cells present (>1%). Progesterone Receptor. Performed on another specimen. immunoreactive tumor cells present (>1%). Immunoperoxidase studies: Performed on another specimen. negative (score 0). NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2. Parvo, H. pytori, HBcore). These ASRs are clinically indicators that do. not require FDA approval. These clones are used: 105=ER, PgR 636=PR, A485=HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4. 1=AR and HPV by ISH. AI immunohiatochernich/ stains are used. with formalin or molecular fixed, parafin embedded tissue. Detection is by LSAB. The results are read by a pathologist as positive or negative. As the attending pathologiet, I attest that I: (I) Examined the relevant. preparation(s) for the specimen(s); and (d) Rendered the diegnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. B. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. C. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. D. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. E. Immunohistochemistry for Keratin stain is negative for metastatic carcinoma to the lymph node. Intraoperative Consultation. AFS. Sentinel node #1 Count #. FS: One lymph node with metastatic carcinoma. BFS. Sentinel node #2 count. FS: SURGICAL PATHOL Report. One lymph node, no carcinoma seen. CFS. Sentinel node #3 count. Adipose tissue only. No lymph node identified grossly. DFS. Seninel node #4 count. FS: One lymph node, no carcinoma seen. EFS. Sentinel node #5 count. FS: One lymph node, no carcinoma seen. FFS. Sentinel node #6 count. FS: One lymph node, no carcinoma seen. Clinical History: Patient is a. female with right breast cancer. Pre Operative Diagnosis: Right breast cancer. Specimen(s) Received: A: Sentinel node #1 Count #. FS. B: Sentinel node #2 count. FS. C: Sentinel node #3 count. 1. D: Seninel node #4 count i. FS. E: Sentinel node #5 count. FS. F: Sentinel node #6 count. FS. G: Axillary fat (perm). H: Skin right breast. I: Right breast lumpectomy (short stitch superior, long lateral ) fresh. J: Additional deep margin (perm). K: Right axillary contents (perm). L: Left breast tissue (perm). Gross Description: A. Received fresh and labeled ""sentinel node #1 count #. FS"" consists of pale yellow soft tissue measuring 1 x 0.3 x. 0.2 cm. The cassettes are submitted as follows: 1. Submitted for frozen section. 2. Remainder of the tissue. B. Received fresh and labeled ""sentinel node #2 count. FS"" consists of light brown fragments -49-count. measuring 1. x 0.2 x 0.3 cm in aggregate. The cassettes are submitted as follows: 1. Submitted for frozen section. 2. Remainder of the tissue. C. Received fresh and labeled ""sentinel node #3 count. consists of light brown soft tissue measuring 2 x 1 x 1 cm. The. specimen submitted in toto in two cassettes. D. Received fresh and labeled ""seninel node #4 count. FS"" consists of pale white tissue measuring 1 x 0.8 x 0.2 cm. Specimen as follows: 1. Submitted for frozen section. 2. Remainder of tissue. E. Received fresh and labeled ""sentinel node #5 count. FS"" consists of sift white fragment measuring 1 x. The specimen is submitted as follows: 1. Submitted for frozen section. SURGICAL PATHOL Report. 2. Remainder of tissue. F. Received fresh and labeled ""sentinel node #6 count. FS"" consists of light brown fragment measuring 0.5 x 0.3 x. 0.2. cm. The specimen is submitted as follows: 1. Submitted for frozen section. 2. Remainder of tissue. G. Received in formalin and labeled ""axiliary fat (perm)"" consists of yellow brown soft tissue measuring 4 x 2x3ccm in. aggregate. The entire specimen is submitted in toto in eight cassettes. H. Received in formalin and labeled ""skin right breast"" consists of skin tag measuring 5 x 0.5 x 0.1 cm. A representative. section of the skin tag is submitted in one cassette. I. Received in formalin and labeled ""right breast lumpectomy (short stitch superior, long lateral ) fresh"" consists of breast. tissue mass measuring 186 grams and measures 9.5 cm medial to lateral, 5.5 cm inferior superior and 8 cm anterior to. posterior. It is round to oval in shape. It is yellow in color and soft in consistency. The specimen has sutures for. orientation. The specimen is inked as follows: anterior yellow; superior blue; posterior black; inferior green; lateral orange. and medial red. Serial sectioning of the specimen reveals a well defined round to oval mass measuring 3 x 3 x 3.5 cm. It. is hard in consistency. It occupies 20% of the entire specimen. The nearest margin is at the superior margin which is 1.5. cm from the mass. Remaining margins are away from the mass. There is an area of fibrosis which is situated anterior to. the mass; it is 1 cm away from the mass. The area of fibrosis measures 1 x 1 cm. The breast parenchyma i between. the mass and the fibrosis is normal. The remaining breast parenchyma consists of the fat to stroma ratio 90: 10. The. cassettes are submitted as follows: 1. Superior margin. 2. inferior margin. 3. Anterior margin. 4. Posterior margin. 5. Medial margin. 6. Lateral margin. 7-10. Representative sections of the tumor. 11. Area of fibrosis. 12. Breast parenchyma between the tumor and fibrosis. J. Received in formalin and labeled ""additional deep margin (perm)"" consists of two yellow fragments soft in consistency. measuring 1 x 0.3 x 0.3 cm in aggregate. The entire specimen is submitted in toto in two cassettes. K. Received In formalin and labeled 'right axillary contents (perm)"" consists of a yellow brown soft tissue measuring 9 x 7 x 2. cm. Ten possible lymph nodes are extracted from the specimen and submitted in six cassettes. One lymph hode. which. measures 1 x 0.5 x 0.3 cm, bisected and submitted in cassette 1. 2. One lymph node bisected. 3. Two lymph nodes. 4&5. Three lymph nodes. 6. One lymph node. L. Received in formalin and labeled ""left breast tissue (perm)"" consists of a breast mass measuring 465 grams and. measures 8 x 5 x 2 cm in greatest dimension. It has a skin ellipse which measures 4 x 1.5 cm. The. entire. specimen. other. than skin is inked black. Serial sectioning of the mass it reveals fibrofatty tissue with fat to stoma ratio 70:30. No gross. lesions are identified. 1-5. Representative section of the fibrofatty tissue. 6. Skin tag. ICD-9(s): 174.8 196.3.",BRCA,1,True,"The tumor size is 3.5 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. The presence of lymphovascular invasion, extracapsular extension, or positive lymph nodes does not affect the T stage, so those factors are not considered in this determination.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",10.0,822.0,85.0,True
1252,TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548,1,"SPECIMENS: A. WLE RIGHT BREAST. B. RIGHT AXILLARY CONTENTS. SPECIMEN(S): A. WLE RIGHT BREAST. B. RIGHT AXILLARY CONTENTS. INTRAOPERATIVE CONSULTATION DIAGNOSIS: Part A, WLE Right breast, gross examination: Tumor 0.2-cm from posterior margin. Called to Dr. at. by Dr. GROSS DESCRIPTION: A. WLE RIGHT BREAST. Received fresh labeled with matching patient identifiers is an oriented (short-superior, long-lateral) 124. g, 9.7 (medial to lateral) x 9 x 3 cm lumpectomy with a slender fragment of tan skin 2.8 x 0.3 cm. The. specimen is inked as follows: anterior - blue, posterior - black, superior - red, inferior - orange, medial. green, lateral - yellow. The specimen is serially sectioned from medial to lateral into 7 slices revealing. a 2.8 x 2.5 x 1.4 cm ill defined firm tan mass approaching the closest posterior margin at 0.2 cm, and. superior margin at 0.5 cm. A portion of the specimen is submitted for tissue procurement. Representative sections are submitted as follows: A1-A2: Perpendicular sections medial margin. A3-A4: Section 2 anterior. A5: Section 2 posterior. A6: Section 3 inferior. A7: Section 3 anterior/superior. A8-A9: Section 3 superior. A10-A11: Section 4 lesion and posterior. A12: Section 4 anterior/inferior. A13-A16: Section 5, lesion and nearest posterior. A17-A18: Section 6, lesion and posterior/anterior. A19-A20: Section 6, lesion and superior. A21-A22: Perpendicular sections lateral margin. A23-A26: Medial margin. A27: Section 6, inferior aspect. A28: Lateral margin. A29: Lateral margin. A30: Section 5, superior margin. A31: Section 2, superior aspect. A32: Section 2, inferior aspect. A33: Section 5, inferior margin. A34: Section 2, superior aspect. B. RIGHT AXILLARY CONTENTS. Received in formalin in a container labeled with matching patient identifiers is a portion of red yellow. fibroadipose tissue measuring 10.7 x 5.9 x 2.5 cm. Multiple possible lymph nodes are identified ranging. in size from 0.3 x 0.3 x 0.3 up to 4 x 3.5 x 2 cm. Cassette summary: B1-B3: Representative sections, largest lymph node. B4: Two possible lymph nodes. B5: Two possible lymph nodes. B6: Four possible lymph nodes. B7: Four possible lymph nodes. B8: Two possible lymph nodes. B9: Two possible lymph nodes. B10: Three possible lymph nodes. B11-B15: Additional possible lymph nodes. DIAGNOSIS: A. BREAST, RIGHT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3), WITH APOCRINE FEATURES, AND SEVERAL FOCI OF. MICROINVASION ASSOCIATED WITH DCIS. - TUMOR MEASURES AT LEAST 3 CM IN GREATEST DIMENSION. INVASIVE CARCINOMA IS 2 MM FROM THE DEEP MARGIN. - EXTENSIVE LYMPHVASCULAR INVASION IS PRESENT. DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE 3,. WITH NECROSIS AND ASSOCIATED LYMPHOID INFILTRATE, INVOLVING. LOBULES. DCIS IS PRESENT AT THE LATERAL MARGIN, IS WITHIN 1 MM OF THE. ANTERIOR/MEDIAL AND ANTERIOR MARGIN, AND IS WITHIN 2 MM. OF THE DEEP MARGIN. B. AXILLARY CONTENTS, RIGHT, DISSECTION: - METASTATIC CARCINOMA TO 2 OF 25 LYMPH NODES WITH LARGEST. METASTASIS MEASURING 4 CM (2/25). - NO EXTRACAPSULAR EXTENSION IS SEEN. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive Tumor. Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor Site: Upper outer quadrant. Margins: Negative. Distance from closest margin: deep. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Axillary dissection. Lymph node status: Positive 2/25. DCIS present. Margins involved by DCIS: lateral margin. DCIS Quantity: Estimate 25%. DCIS Type: Solid. DCIS Location: Both associated and separate from invasive tumor mass. Nuclear grade: High. Necrosis: Present. ER/PR/HER2 Results. ER: Negative. PR: Negative. HER2: Positive by IHC. Performed on. Case: This case - the largest lymph node with metastasis. Pathological staging (pTN): pT 2N1. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: B2 (Lymph node with metastasis). ER: Negative. Allred Score: 0 = Proportion Score 0 + Intensity Score 0. PR: Negative. Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed usina the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer s instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: B2 (Lymph node with metastasis). Interpretation: POSITIVE. Intensity: 3+. % Tumor Staining: 100%. Fish Ordered: METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved. HercepTest (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. Pathology. Department takes full responsibility for this test's performance. CLINICAL HISTORY: :year-old woman, right breast, upper outer 4 cm mass, IDC, ER/PR negative; HER-2/neu positive,. with palpable adenopathy, here for lumpectomy and axillary lymph node dissection. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. Microscopic/Diagnostic Dictation; Pathologist,. Final Review: Pathologist,. Final Review: Pathologist,. Final: Pathologist.",BRCA,1,True,"The report states that the tumor measures at least 3 cm in greatest dimension, which falls under the T2 category of tumors that are more than 2 cm but not more than 5 cm in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",11.0,1050.0,88.0,True
1158,TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF,0,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breastiand axillary tissues. Unit in charge: Central Operating Theatre. ref. No. Expected time of examination: up to 8 working days. Clinical diagnosis: Macroscopic description: Right breast sized 21 x 15 x 3.5 cm, removed with axillary tissues sized 8 x 8.5 x 3 cm and a skin flap of 21 x 12 cm. Tumour sized. 1.2 x 1.1 x 0.8 found in the lower outer quadrant, located 3.5 cm from the upper boundary, 2 cm from the base and 0.6 cm from. the skin. Microscopic description: Carcinoma ductale invasivum - NHG3 93 + 2 +3: 21 mitoses/10 HPF - visual area 0.55 mm). Glandular tissue, apart of the tumour, showing lesions of the type mastopathia fibrosa et cystica, lipomatosis. AXILLARY LYMPH NODES. Metastases carcinomatosae in lymphonodis (No VI/XIV). Infiltratio capsulae lymphonodorum. Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. Metastases carcinomatosae in lymphonodis axillae (NO VI/XIV). (NHG3, pTIc,. pN2a). Invasive ductal carcinoma of the right breast. Cancer metastases of the axillary lymph nodes (No VI/XIV). page 2/2. Examination performed or. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. No progesterone receptors found in neoplastic cell nuclei. HER2. protein stained with HercepTestTM by DAKO. Negative reaction in invasive cancerous cells ( Score = 1+ ).",BRCA,2,True,"The tumor size is measured as 1.2 x 1.1 x 0.8 cm which is more than 2 cm but not more than 5 cm. According to the rules, this falls under the T2 category.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",11.0,1050.0,100.0,True
1351,TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588,1,"Revised. F. Pathologic Interpretation: AMENDMENT,. A. SUPERIOR MEDIAL MARGIN, RULE OUT TUMOR: - No malignancy seen. B. SENTINEL NODE #1: - Microscopic foci of carcinoma are highlighted by Keratin (1/1). C. SENTINEL NODE #2: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin is negative for carcinoma. D. SENTINEL NODE #3: - Metastatic carcinoma to one lymph node (1/1) with extracapsular extension. E. RIGHT BREAST MASS: - Invasive ductal carcinoma Nottingham grade 2 (3+2+1); 4.2 cm in greatest dimension. - Specimen margins are negative for tumor closest margins are anterior and superior, 0.2 cm (See Tumor Summary). - Lymphovascular invasion is identified. F. ADDITIONAL AXILLARY FAT: - No malignancy seen in one lymph node (0/1). G. ADDITIONAL SUPERIOR MARGIN: - Microscopic focus of invasive ductal carcinoma, 0.1 cm, adjacent to inked resection margin. The focus of invasive carcinoma is present at the inked margin adjacent to previous resection. The ""new"" inked margin is free of tumor. - Lymphatic tumor emboli are identified. H. RIGHT AXILLARY CONTENTS: - No malignancy seen in nineteen lymph nodes (0/19). I. ADDITIONAL AXILLARY CONTENTS LEVEL 2-3 LYMPH NODES: - No malignancy seen in two lymph nodes (0/2). Tumor Summary: Specimen: Partial breast. Procedure: - Excision without wire-guided localization. Lymph Node Sampling: - Sentinel lymph nodes. - Axillary dissection. Specimen Integrity: - Multiple designated specimens. Specimen Size: - Greatest dimension: 8.5 cm. Additional dimension: 6 x 5 cm. Laterality: (Right. Tumor Size: SURGICAL PATHOL Report. - Greatest dimension of largest focus of invasion over 0.1 cm: 4.2 cm. - Additional dimensions: 3.8 x 2.8 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Skin is not present. - Skeletal muscle: No skeletal muscle present. Lobular Carcinoma IN Situ (LCIS): - Not identified. Histologic Type of Invasive Carcinoma: - Invasive ductal carcinoma. Histologic Grade: - Glandular (Acinar)/Tubular Differentiation: - Score 3: <10% of tumor area forming glandular/tubular structures. - Nuclear Pleomorphism: - Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and. Shape. - Mitotic Count: - Score 1. - Overall Grade: - Grade 2: scores of 6 or 7. Margins: - Margins negative for invasive carcinoma. Lymph-Vascular Invasion: - Present. Lymph Nodes: - Number of sentinel lymph nodes examined: 3. - Total number of lymph nodes examined (sentinel and Nonsentinel): 25. - Number of lymph nodes with macrometastases (>0.2 cm): 2. Extranodal Extension: - Present. Method of Evaluation of Sentinel Lymph Nodes: - Hematoxylin and eosin (H&E), one level. - Immunohistochemistry. Pathologic Staging: - Primary Tumor: pT2: Tumor >20 mm but <50 mm in greatest dimension. - Regional Lymph Nodes: pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. - Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: - Performed on another specimen: Results: Immunoreactive tumor cells present (1%). Progesterone Receptor. - Performed on another specimen: Results: Immunoreactive tumor cells present (1%). HER2/neu. - Performed on another specimen: Results: Negative (Score 0). Clinical History: - Palpable mass. Pathologic Staging (pTNM): pT2, N1a, M-not applicable. PREVIOUSLY ISSUED DIAGNOSIS: A. SUPERIOR MEDIAL MARGIN, RULE OUT TUMOR: - No malignancy seen. B. SENTINEL NODE #1: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. C. SENTINEL NODE #2: SURGICAL PATHOL Report. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. D. SENTINEL NODE #3: - Metastatic carcinoma to one lymph node (1/1) with extracapsular extension. E. RIGHT BREAST MASS: - Invasive ductal carcinoma Nottingham grade 2 (3+2+1); 4.2 cm in greatest dimension. - Specimen margins are negative for tumor closest margins are anterior and superior, 0.2 cm (See. Tumor. Summary). Lymphovascular invasion is identified. F. ADDITIONAL AXILLARY FAT: - No malignancy seen in one lymph node (0/1). G. ADDITIONAL SUPERIOR MARGIN: - Microscopic focus of invasive ductal carcinoma, 0.1 cm, adjacent to inked resection margin. - Lymphatic tumor emboli are identified. H. RIGHT AXILLARY CONTENTS: - No malignancy seen in nineteen lymph nodes (0/19). I. ADDITIONAL AXILLARY CONTENTS LEVEL 2-3 LYMPH NODES: - No malignancy seen in two lymph nodes (0/2). Tumor Summary: Specimen: - Partial breast. Procedure: - Excision without wire-guided localization. Lymph Node Sampling: - Sentinel lymph nodes. - Axillary dissection. Specimen Integrity: - Multiple designated specimens. Specimen Size: - Greatest dimension: 8.5 cm. . Additional dimension: 6 x 5 cm. Laterality: - Right. Tumor Size: Greatest dimension of largest focus of invasion over 0.1 cm: 4.2 cm. - Additional dimensions: 3.8 x 2.8 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Skin is not present. - Skeletal muscle: No skeletal muscle present. Lobular Carcinoma IN Situ (LCIS): - Not identified. Histologic Type of Invasive Carcinoma: - Invasive ductal carcinoma. Histologic Grade: - Glandular (Acinar)/Tubular Differentiation: - Score 3: <10% of tumor area forming glandular/tubular structures. - Nuclear Pleomorphism: - Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in bothisize and. Shape. - Mitotic Count: - Score 1. - Overall Grade: - Grade 2: scores of 6 or 7. Margins: SURGICAL PATHOL Report. - Margins positive for invasive carcinoma. Specify margin and Extent of involvement: Superior margin, focal. Lymph-Vascular Invasion: - Present. Lymph Nodes: - Number of sentinel lymph nodes examined: 3. - Total number of lymph nodes examined (sentinel and Nonsentinel): 25. - Number of lymph nodes with macrometastases (>0.2 cm): 1. Extranodal Extension: - Present. Method of Evaluation of Sentinel Lymph Nodes: - Hematoxylin and eosin (H&E), one level. - Immunohistochemistry. Pathologic Staging: - Primary Tumor: pT2: Tumor >20 mm but 50 mm in greatest dimension. - Regional Lymph Nodes: pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mn. - Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: Performe. another specimen. Results: Immunoreactive tumor cells present (1%). Progesterone p. ed on another specimen: Results: Immunoreactive tumor cells present (1%). HER?. med on another specimen: Results: Negative (Score 0). Clinical History: - Palpable mass. Pathologic Staging (pTNM): pT2, N1a, M-not applicable. NOTE: Nome immunhisruchen. NO analyse specific reagents (ASRs) validated by owr lahnvatory. These ASRs are nseful indicators that do mat require FDA approval. These clomes are used: IDS-ER. 7 All stains are used with formalin or molecular frxed, paraffin emhedded rissue. Detection is by Emision Method. The rdmits are read by. pathologies as positive or negative. As the attending pathologist, / attest that 1: (i) Examined the relevant preparation(s). for the specimen(s): and (ii) Rendered the diagnosis(es). MD. Amendments. Amended. Reason: Diagnosis editing/clarification. New information provided to Dr. by physician. Previous Signout Date: Intraoperative Consultation. A. Superior medial margin, rule out tumor, FS: No tumor seen. B. Sentinel node #1, FS: Negative for carcinoma (touch prep and frozen). C. Sentinel node #2, FS: Negative for carcinoma (touch prep and frozen). D. Sentinel node #3, FS: Atypical cells on touch prep-carcinoma cannot be excluded. FS: Metastatic carcinoma in lymph node. : MD. SURGICAL PATHOL Report. MD. Clinical History: female with right breast mass. Biopsy shows invasive ductal carcinoma. Operation Performed. Lumpectomy right breast with sentinel node. Pre Operative Diagnosis: Breast cancer. Specimen(s) Received: A: Superior medial margin, rule out tumor, FS. B: Sentinel node #1, FS. C: Sentinel node #2, FS. D: Sentinel node #3, FS. E: Right breast mass. F: Additional axillary fat. G: Additional superior margin. H: Right axillary contents. I: Additional axillary contents level 2-3 lymph nodes. Gross Description: A. Received fresh are two yellow-tan tissue fragments,measuring up to 1.0 cm in length. In toto in one cassette for frozen. B. Received fresh is a light brown lymph node 1.5 x 1.0 cm. in toto in one cassette for frozen. C. Received fresh is a lymph node, measuring 2.0 x 1.5 cm. In toto in one cassette for frozen. D. Received fresh is a lymph node, measuring 1.2 x 1.0 cm. In toto in one cassette for frozen. E. Received in formalin is a yellow-tan fibroadipose tissue fragment, weighing 89 grams, measuring 8.5 x 6.0 x 5.0 cm. The. specimen is oriented with a short superior, long lateral and double stitch deep margin. Inked as follows: Superior in blue,. inferior in green, deep black, anterior yellow, lateral orange and medial red. Cross section through the specimen shows. yellow-tan cut surface. There is an ovoid, markedly firm, tumoral mass, measuring 4.2 x 3.8 x 2.8 cm. The mass is. within 2 mm from superior and anterior inferior margin. No other firm masses were grossly identified. Sections submitted. as follows: 1&2. Composite resection of the largest axis of the mass from antero-inferior to superior margin. 3-5. Additional section of the mass in relation with the antero-inferior margin. 6&7. Section of the mass in relation with the deep resection margin. 8. Medial margin. 9. Lateral margin. F. Received in formalin are multiple yellow-tan adipose tissue fragments, measuring 6.0 x 4.0 x 1.0 cm in aggregate. No. lymph nodes were grossly identified. Sections from the fat tissue in three cassettes. G. Received in formalin is a yellow-tan adipose tissue fragment (additional superior margin), measuring 6.0 x 3.0 1.0. cm. Multiple sutures orient the specimen as a true margin. The true margin in green. The opposite margin in black. Cross. section through the specimen shows a yellow-tan cut surface. No masses were grossly present. Submitted ih. toto. in. eight cassettes. H. Received in formalin are multiple yellow-tan fibroadipose tissue fragments, measuring 10.0 x 7.0 x 3.0 cm in aggregates. Twenty lymph nodes are present, measuring up to 0.8 x 0.7 cm in greatest dimension. Sections as follows: 1. Two lymph nodes in toto. 2-8. Three lymph nodes in toto per cassette. I. Received are multiple yellow-tan fibroadipose tissue fragments, measuring 5.0 x 3.0 x 1.0 cm. Four lymph nodes are. identified, measuring up to 0.6 x 0.4 cm. Sections as follows: 1&2. Two lymph nodes in toto per cassette. SURGICAL PATHOL Report.",BRCA,1,True,"The tumor size is 4.2 cm, which falls within the T2 category of tumors that are more than 2 cm but not more than 5 cm in size. This is determined by the statement in the report: 'Greatest dimension of largest focus of invasion over 0.1 cm: 4.2 cm'.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",11.0,1050.0,100.0,True
656,TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A,1,"Diagnosis: ). Two foci of a moderately differentiated invasive ductal carcinoma. (tumor diameters: 3 cm and 2 cm) with focal intraductal components and. circumscribed angioinvasion. No infiltration or ulceration of the skin. Tumor classification: NOS, G II, pT2(mult)N1aL1VOM1RO.",BRCA,1,True,"The report mentions two foci of invasive ductal carcinoma with diameters of 3 cm and 2 cm. Since neither of the tumors has a size greater than 5 cm, and there is no direct extension to the chest wall or skin, the T stage is T2 based on the size of the larger tumor (3 cm).","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The absence of lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",11.0,1050.0,34.0,False
1368,TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368,1,"Laboratory. Collected: xx. F. Received: xx. Reported: xx. Pathologic Interpretation: A. LEFT BREAST NEEDLE LOCALIZATION LUMPECTOMY: INVASIVE LOBULAR CARCINOMA with pleomorphic features, Nottingham grade 2 (3+2+2=7), measuring. 2. cm. PLEOMORPHIC LOBULAR CARCINOMA IN SITU is present. Prior biopsy site present. The invasive carcinoma is 0.1 cm from inferior and lateral margins (green, orange). B. HOT SPOT #1, AXILLAI, CT-xxx: One lymph node, negative for carcinoma (0/1). C. HOT SPOT #1, AXILLAI CT -xxx: One lymph node, negative for carcinoma (0/1). Note: Receptor studies and keratin stains to follow. See Tumor Summary. Surgical Pathology Cancer Case Summary. Procedure: Excision with wire-guided localization. Lymph Node Sampling: Sentinel lymph nodes. Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Size (for excisions less than total mastectomy): Greatest dimension: 5 cm. Additional dimensions: 4.5 x 3.5 cm. Specimen Laterality: Left. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 2 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: Skin: Skin is not present. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma in Situ (DCIS): No DCIS is present. Lobular Carcinoma in Situ (LCIS): Present (pleomorphic type). Histologic Type of Invasive Carcinoma: Invasive lobular carcinoma (pleomorphic type). Histologic Grade: Nottingham Histologic Score: Glandular (Acinar)/Tubular Differentiation. Score 3: < 10% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism. Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate. variability in both size and shape. Mitotic Count: Score 2. Overall Grade: Grade 2. Margins: Margins uninvolved by invasive carcinoma. Distance from closest margin: 1 mm. Distance from superior margin: > 5 mm. Distance from inferior margin: 1 mm. Distance from anterior margin: > 5 mm. Distance from posterior margin: > 5 mm. Distance from medial margin: 4 mm. Distance from lateral margin: 1 mm. Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy: In the Breast: No known presurgical therapy. Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 2. Total number of lymph nodes examined (sentinel and nonsentinel): 2. Number of lymph nodes with macrometastases (> 0.2 cm): 0. Number of lymph nodes with micrometastases (> 0.2 mm to 0.2 cm and/or > 200 cells): 0. Number of lymph nodes with isolated tumor cells (s 0.2 mm and S 200 cells): 0. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Pathologic Staging (pTNM): Primary Tumor (pT): pT2: Tumor > 20 mm but 50 mm in greatest dimension. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis identified histologically. Distant Metastasis (pM): Not applicable. Ancillary Studies (performed on another specimen: xxxx): Estrogen Receptor: POSITIVE (> 50%). Progesterone Receptor: NEGATIVE (less than 1% immunoreactive cells present). HER2/neu Immunoperoxidase Studies: NEGATIVE (CISH: NOT AMPLIFIED). NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2, Parvo, H. pylori, HBcore). These ASRs are clinically. useful indicators that do not require FDA approval. These clones are used: ID5=ER, PgR 636=PR, A485=HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4 1=AR and HPV. ISH. Allimmunohistochemical stains are used with formalin or molecular fixed, paraffin embedded tissue. Detection is by LSAB. The results are read by a pathologist as positive. or negative. Procedures/Addenda. Addendum. Date Complete: xx. Addendum Diagnosis. A. LEFT BREAST NEEDLE LOCALIZATION LUMPECTOMY: Immunohistochemical studies were performed on formalin fixed tissue with the following results for [invasive. carcinoma/DCIS/metastatic carcinoma] (block xx): Estrogen receptor. POSITIVE ( > 90%). Progesterone receptor. PgR 636. POSITIVE (1-10%). HER-2/neu (c-erb-B2). NEGATIVE 0. B. HOT SPOT #1, AXILLA I, CT-xx: Immunohistochemical studies were performed on formalin fixed tissue with the following results for metastatic. carcinoma (block B): Keratin: NEGATIVE (see note). Note: A single cell that appears to be keratin positive is present in the subcapsular space. However, the nuclear size. and morphology of this cell is different than the primary tumor cells. Selected slides were reviewed with Dr. XX and. concurs with the diagnosis. C. HOT SPOT #1, AXILLAI CT -xx: Immunohistochemical studies were performed on formalin fixed tissue with the following results for metastatic. carcinoma (C): Keratin: NEGATIVE. Interpretation Guidelines: For hormone receptor immunohistochemical analysis, the percent of immunoreactive. nuclei in the invasive or in-situ carcinoma is assessed manually by light microscopic examination and reported as. follows: Positive: greater than or equal to 1 percent of nuclei immunoreactive. Negative: less than 1 percent of nuclei immunoreactive. Non-neoplastic mammary epithelial cells are immunoreactive for estrogen and progesterone receptors (internal. control). For HER2/neu immunohistochemical analysis, the cell membrane staining is assessed manually by light microscopic. examination. Cytoplasmic immunoreactivity alone is scored as a negative result. Reference #1: XX. Reference #2: XX. Clinical History: Infiltrating lobular cancer in left breast. Please evaluate margins of lumpectomy. If sentinel nodes are negative, do. immunohistochemistry. Specimen(s) Received/Processing Information: Fee Codes: A: Left breast lumpectomy, 1 suture superficial margin, 2 suture medial, 3 suture. inferior H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1,. H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, Estrogen Receptor (ER) x 1,. Progesterone Receptor x 1, CERbB2, HER2/neu x 1. B: Hot spot #1, axilla I, CT-356 H&E, Initial x 1, unstained x 1, unstained x 1, unstained x. 1, unstained x 1, Desmin 33 x 1. C: Hot spot #1, axilla I CT -473 H&E, Initial x 1, unstained x 1, unstained x 1, unstained x. 1, unstained x 1, Cytokeratin Cocktail (KER) x 1. Gross Description: A. Received fresh and labeled ""Left breast lumpectomy"" is a yellow-tan irregular-shaped lumpectomy,. measuring 5.0 x 4.5 x 3.5 cm and weighing 35.0 grams. The specimen is inked as follows: superior. margin. inked blue, inferior margin inked green, medial margin inked red, lateral margin inked orange,. anterior/superficial margin inked yellow and deep margin inked black. Sections reveal an ill-defined area with. firm to hard consistency, 2.0 x 2.0 x 1.5 cm. This area is located toward the medial to posterior resection. margin at 0.2 to 0.3 cm from the deep resection margin (nearest), 0.3 cm from the inferior resection margin,. 3.0 cm from lateral resection margin, 2.0 cm from the superior resection margin, 1.0 cm from the superficial. resection margin. The remainder of the specimen is homogeneous, yellow-tan, grossly unremarkable. adipose tissue. No other suspicious lesions are present. The specimen is submitted in nine cassettes, as. follows: Cassette #1-3: Tissue with clip in toto. Cassette #4: Perpendicular section superior margin. Cassette #5: Perpendicular section inferior margin. Cassette #6: Perpendicular section medial margin. Cassette #7: Perpendicular section lateral margin. Cassette #8: Perpendicular section superficial margin. Cassette #9: Perpendicular section deep margin. B. Received in formalin and labeled ""Hot spot #1, axilla I, ct xx"" is a yellow-tan irregular-shaped soft tissue. fragment, 3.5 x 3.0 x 1.0 cm. Sections reveal one lymph node, 1.5 x 1.0 x 1.0 cm. The lymph node is bisected and. submitted in toto in one. cassette. C. Received in formalin and labeled ""Hot spot #1, axilla I, ct xx"" is a yellow-tan irregular-shaped soft tissue. fragment, 2.8 x 2.0 x 1.0 cm. Sections reveal one lymph node, 1.5 x 1.0 x 1.0 cm. the lymph node is bisected and. submitted in toto in one cassette.",BRCA,0,True,"The T stage is determined by the size of the tumor. T1 tumors are 2 cm or less in size, T2 tumors are more than 2 cm but not more than 5 cm in size, T3 tumors are more than 5 cm in size, and T4 tumors are of any size with direct extension to the chest wall or skin. In this report, the largest focus of invasion is measured as 2 cm, which falls under the T2 category.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",11.0,1050.0,76.0,False
659,TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831,1,"Diagnosis: 1. Ablated breast sample with a moderately differentiated invasive ductal. carcinoma (tumor diameter: 2.7 cm). Tumor-free dorsal resection margin. Concluding tumor classification: NOS, G II, pT2N0LOVORO.",BRCA,0,True,"The report states that the tumor diameter is 2.7 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. The T4 category is not applicable here as there is no direct extension to the chest wall or skin.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.",12.0,1190.0,94.0,True
595,TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node #1, biopsy: One lymph node with metastatic. carcinoma (1/1). B. Breast, left, mastectomy: Invasive pleomorphic lobular carcinoma,. size 2.2 cm in greatest dimension; negative margins of excision. C. Breast, left nipple core, biopsy: Negative for malignancy. D. Lymph nodes, left axilla, lymph node dissection: Nine negative. lymph nodes (0/9). Microscopic Description: Invasive carcinoma: Histologic type: Lobular (E-cadherin negative). Histologic grade: 2 (pleomorphic lobular). Overall grade: 7/9. Architectural score: 3. Nuclear score: 3 (focally - the tumor consists of a mixture of. conventional and pleomorphic lobular carcinoma, with nuclear. grade ranging from 1-3). Mitotic score: 1. Greatest dimension (pT2) : 2.2 cm. Specimen margins: Invasive carcinoma is 2 mm from the anterior. margin, and there is lobular carcinoma in-situ (nuclear grade 1-2). focally 0.5 mm from the anterior margin. Carcinoma is 1 cm from. the deep margin. Vessel invasion: Not identified. Ductal carcinoma in situ: Not identified. Comments: Prior biopsy site identified within the tumor. Lymph nodes: Keratin staining performed on negative lymph node blocks. to confirm the absence of carcinoma. Number of positive nodes of total: One of ten lymph nodes with. metastatic carcinoma (1/10). Size of largest metastasis: 7 mm. Extracapsular extension (present/absent) : Negative. pNla. Prognostic markers: See previous core biopsy,. Specimen. A. Left axillary sentinel node #1, hot, blue. B. Left breast, stitch at 12:00. C. Left nipple core. D. Left axillary contents. Clinical Information. Left breast cancer. Intraoperative Consultation. A) Metastatic carcinoma. . CFS: Nipple, core biopsy: No evidence of invasive carcinoma. Gross Description. A. Received unfixed for frozen section, labeled left axillary sentinel. node #1, hot, blue. , is a fat-replaced lymph node, 2.0 x 1.0 x 0.7. cm, bisected and frozen in two blocks. B. Received unfixed, labeled with the patient's name, medical record. number and ""left breast - stitch at 12:00.' The specimen consists of. a. nipple sparing simple mastectomy oriented by a stitch at the 12:00. position. The specimen is 14 x 14 x 3.5 cm. The deep surgical margin. is painted black and anterior margin over tumor is painted green. On. cut section at the 6:00 position there is a firm spiculated tan tumor. mass which measures 2.2 x 1.8 x 1.5 cm. A portion is submitted for. tissue procurement. The tissue surrounding the mass contains dense. fibrocystic changes. The mass comes within 4 mm of the anterior margin. and 1.5 cm of the deep margin. The remainder of the breast tissue. consists of firm fibrofatty tissue. Representative sections. BLOCK. SUMMARY 1-3: Tumor mass with anterior margin, 4: Deep margin nearest. tumor, 5, 6: Breast tissue immediately adjacent to the tumor mass, 7: Upper inner quadrant, 8: Lower inner quadrant, 9: Upper outer quadrant,. 10: Lower outer quadrant. C. Container C. is labeled with the patient's name, medical record. number and ""left nipple core"". The specimen consists of a single piece. of soft yellow tissue measuring 0.5 x 0.5 x 0.3 cm. All submitted in. D. Received fresh labeled ""left axillary contents"" is a 5.7 x 3.9 x 1.7. cm aggregate of soft, lobulated tan gold adipose tissue. Several. slightly rubbery tan-pink-red tissues in keeping with lymph nodes. measuring up to 1.9 cm are recovered. The lymphoid tissues are. entirely submitted. Summary: 1 - 4 lymph nodes, 2 - 3 lymph. nodes, 3 and 4 - one lymph node per cassette.",BRCA,1,True,"The report states that the size of the tumor is 2.2 cm, which falls within the range for a T2 tumor (more than 2 cm but not more than 5 cm in size). The presence of direct extension to the chest wall or skin is not mentioned, so T4 is not assigned. Therefore, the T stage for this patient's cancer is T2.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.",14.0,1293.0,96.0,True
637,TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62,1,"Diagnosis: 1. Ablated (right) breast sample with a moderately differentiated invasive ductal. carcinoma (tumor diameter: 3.0 cm; minimum distance to dorsal margin 0.3 cm, other. margins are 1 cm and remain free). In conclusion, this is a moderately differentiated invasive ductal carcinoma. Concluding tumor classification: NOS, G II, pT2N0(sn)LOVORO.",BRCA,0,True,"The report states that the tumor diameter is 3.0 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. The fact that the tumor extends to the dorsal margin to a minimum distance of 0.3 cm does not change the T stage, as it is still within the same range.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",15.0,1443.0,95.0,True
998,TCGA-BH-A0DH.79B22278-2BA1-4904-BCA6-2B1368C77475,1,"To: P.9/33. OIAGNOSIS: f: AXILLARY CONTENTS. LEFT. RESECTION -. A. METASTATIC ADENOCARCINOMA (1H, 1Q-1R and 13-1T) INVOLVING THREE OF TWENTY-EIGHT LYMPH. NODES (3/28), UP TO 1.5 CM (1R). WITH EXTRACAPSULAR EXTENSION (0.2 CM). B. CHANGES CONSISTENT WITH PREVIOUS FINE NEEDLE ASPIRATION SITE, SEE PRIOR. PART 2: BREAST. LEFT. SEGMENTAL MASTECTOMY -. A. INFILTRATING OUCIAL CARCINOMA (ZA thru 21, 2M thru 20 and 2S), WITH ASSOCIATED. MICROCALCIFICATIONS. THE INVASIVE TUMOR INVOLVES THE POSTERIOR RESECTION MARGIN (2A),. THE INFERIOR RESECTION MARGIN (2F, 2N and 20), AND COMES TO WITHIN 0.2 CM FROM THE ANTERIOR. RESECTION MARGIN (2H). B. THE TUMOR SIZE IS 3.5 2.5 x 1.7 CM. C. NOTTINGHAM SCORE 6/9 (TUBULES 3. NUCLFI 2, MITOSIS 1). D. LYMPHOVASCULAR INVASION IS PRESENT. E. DUCTAL CARCINOMA IN SITU, SOUD AND CRIBRIFORM TYPES, NUCLEAR GRADE 2, WITH. COMEDONECROSIS, ASSUCIATED MICROCALCIFICATIONS AND RETROGRADE CANCERIZATION OF. LOBULES, REPRESENTING ABOUT 2% OF TUMOR VOLUME. F. DUCTAL CARCINOMA IN SITU IS PRESENT ADMIXED WITH INVASIVE TUMOR. G. ALL OTHER MARGINS OF RESECTION ARE FREE OF TUMOR. H. ATYPICAL DUCTAL HYPERPLASIA. I. DUCTAL PAPILLOMAS. J. RADIAL SCARS WITH DUCTAL EPITHELIAL HYPERPLASIA AND COLUMNAR CELL CHANGES,. K. PROLIFERATIVE FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA, COLUMNAR CELL. CHANGE8 AND MULTIFOCAL SCLEROSING ADENOSIS WITH ASSOCIATED MICROCALCIFICATIONS. L. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, SEE PRIOR. M. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOD D. ICRUME RECEPTOR AND HER. 2/NEU WERE PREVIOUSLY PERFORMED ON CORE BIOPSY. AND WERG REPORTED AS. FOLLOWS: ESTROGEN RECEPTOR - POSITIVE, PROGESTERONE RECEPTOR - POSITIVE AND HER-2/NEU. NEGATIVE (SCORE 0). PART 3: BREAST, LEFT, NEW POSTERIOR-LATERAL MARGINS, EXCISION -. A. MICROSCOPIC FOCUS OF INVASIVE DUCTAL CARCINOMA (3E), COMING TO WITHIN 0.3 CM FROM THE. NEW INKED RESECTION MARGIN (9ce comment). B. ATYPICAL DUCTAL MYPERPLASIA. c. DUCTAL PAPILLOMA. D. RADIAL SCARS WITH DUCTAL EPITHELIAL HYPERPLASIA AND ASSOCIATED MICROCALCIFICATIONS. E. PROLIFERATIVE FIBROCYSTIC CHANGES. CHANGES AND EXTENSIVE SCLEROSING ADENOSIS WITH ASSOCIATED MULTIFOCAL. MICROCALCIFICATIONS. F. MEDIAL CALCIFICATIONS OF BLOOD VESSEL. G. NEW RESECTION MARGINS ARE FREE OF TUMOR. CASE SYNOPSIS: SYNOPTIC PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmentel. SIZE OF TUMOR: Not specified. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasivo component: 3.5 cm. TUMOR TYPE (Invanive componant): Ductal adenocarcinoine. NOS. NOTTINGHAM SCORE: Nuclcar grade: 2. Tubule formation: 3. Mitotic activity scoie: 1. Total Nottingham score: A. ANGIOLYMPHATIC INVASION: Nollingham grede (1. 2, 3). 2. DERMAL LYMPHATIC INVASION: Not applicable. Yes, benign zones. TUMOR TYPE. IN SITU: Yes. malignent zones. Cribriform. Solld. DCIS admixod with invasivo cancinoma. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by In situ component: 2 %. Yes, diffuse. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPM NODES POSITIVE: 3. LYMPH NODES EXAMINED: 28. METHOD(S) OF LYMPM NODE EXAMINATION;. H/E stuin. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of targuet lymph node metastaus: 15 min. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: NON-NEOPLASTIC BREAST TISSUE: ADH, Redial scar, Papillonn, FCU. pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTOR9: positive. HER2/NEU: zoro or 1+.",BRCA,1,True,"The report states that the size of the tumor is 3.5 x 2.5 x 1.7 cm. According to the rules provided, T1 tumors are 2 cm or less in size, and T3 tumors are more than 5 cm in size. Since this tumor is larger than 2 cm but not more than 5 cm, it meets the criteria for a T2 tumor.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",pT2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",15.0,1443.0,73.0,False
1211,TCGA-E2-A156.EF28484E-82C7-4988-A6E0-DDDA555652EA,0,"SPECIMENS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. D. WIDE EXCISION LEFT BREAST MASS. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. F. SKIN AT ANTERIOR MARGIN. SPECIMEN(S): A. SENTINEL LYMPH NODE #1, LEFT AXILLA. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. D. WIDE EXCISION LEFT BREAST MASS. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. F. SKIN AT ANTERIOR MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, Sentinel lymph node #1, left axilla, excision: Negative for carcinoma. TPB, Sentinel lymph node #2, left axilla, excision: Negative for carcinoma. Part D, Left breast, excisional biopsy, gross examination: Tumor approximately 0.3-cm from the posterior margin. Diagnoses called at. f and B) and. (D) by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number one left axilla"". is. a fragment of red-tan possible lymphoid tissue measuring 1 x 0.5 x 0.3-cm. Touch preparation is performed. The. entire specimen is submitted, A1. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. Received fresh labeled with the patient identification and designated ""sentinel lymph node number two left axilla"" is. fragment of red-tan possible lymphoid tissue measuring 1.3 x 0.5 x 0.2 cm. Touch preparation is performed. The. entire specimen is submitted, B1. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. Received in formalin labeled with the patient's identification and designated ""Non-sentinel lymph node left axilla"" is a. fragment of adipose tissue, 2.5 x 2.4 x 0.5 cm, consisting of one possible lymph node measuring 1 x 0.5 x 0.4 cm. The lymph node is submitted, C1. D. WIDE EXCISION LEFT BREAST MASS. Received fresh labeled with the patient's identification and designated ""wide excision left breast"" is a previously. inked, oriented, 89-g, 9 x 8.4 x 2.5 cm lumpectomy specimen. The single clip designates superior, double-lateral,. triple-anterior. ink code: Anterior-yellow, posterior-black, superior-blue, inferior-orange, medial- green, lateral-red. The specimen is serially sectioned from medial to lateral into 7 slices revealing an irregular friable soft tan mass, 3 x. 2.4 x 0.9 cm, located 0.3-cm from the nearest posterior margin (Slices 3-5). A previous hemorrhagic biopsy cavity is. identified 0.6-cm from the mass (lateral), measuring 1.4 x 0.8 x 0.7 cm. A portion of the specimen is submitted for. tissue procurement. Representatively submitted: D1-D2: Representative perpendicular sections, medial margin. D3: Slice 2, posterior. D4: Slice 2, superior. D5-D11: Slice 3, entirely submitted, D8 and D10 demonstrating tumor. D12-D15: Slice 4, posterior/superior/anterior/superior, tumor. D16-D19: Slice 5, D16-D18 demonstrating biopsy cavity. D20-D21: Slice 6, superior, remainder of biopsy cavity. D22-D25: Perpendicular sections lateral margin, entirely submitted. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. Received in formalin labeled with the patient's identification and designated ""additional new margin superior lateral"". is a previously inked, 6-g, 5.2 x 3 x 0.8 cm fragment of fibroadipose tissue. Ink code: Superior-blue, lateral-red. Sectioning shows no obvious gross abnormalities. The entire specimen is submitted, E1-E2 (superior), E3-E4. (lateral). F. SKIN AT ANTERIOR MARGIN. Received in formalin labeled with the patient's identification and designated ""skin at anterior margin"" is a slender. fragment of unoriented light beige skin measuring 2.1 x 0.6 x 0.2 cm. the entire specimen is submitted, F1. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). B. LYMPH NODE, SENTINEL #2, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, non-SENTINEL, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. BREAST, LEFT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.8-CM. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPE WITH. CENTRAL NECROSIS AND MICROCALCIFICATIONS WITH A COMPONENT OF INTRACYSTIC PAPILLARY. CARCINOMA. - SURGICAL RESECTION MARGINS NEGATIVE FOR INVASIVE TUMOR. - MICROSCOPIC FOCUS OF LOW GRADE DUCTAL CARCINOMA IN SITU AT INFERIOR SURGICAL. RESECTION MARGIN. - BIOPSY SITE CHANGES WITH FIBROSIS AND GRANULATION TISSUE. - SEE SYNOPTIC REPORT AND SEE NOTE. e. breast, left, additional superior lateral margin, excision: - fibroadipose tissue, NO TUMOR SEEN. f. skin, anterior margin, excision: - SKIN tissue, NO TUMOR SEEN. NOTE: Ductal carcinoma is identified in 5 consecutive slices. The tumor is composed of 3 components, invasive, in. situ and intracystic. The gross measurement of the tumor is a 3-cm. The largest confluent invasive tumor measures. 1.8-cm. A microscopic focus of low-grade DCIS is identified at the inferior surgical resection margin. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.8cm. Tumor Site: Not specified. Margins: Negative. Distance from closest margin: 0.3cm. deep. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/3. DCIS present. Margins involved by DCIS: inferior. DCIS Quantity: Estimate 20%. DCIS Type: Solid. Cribriform. intracystic. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. Location of CA++: DCIS. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left breast mass. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 0. CLINICAL EXPERIENCE: Patients with a recurrence score of: 0 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 3%. ER Score: 11.8 Positive. PR Score: 10 Positive. Her2 Score: 9.8 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. 1 report for further information. Microscopic/Diagnostic Dictation: Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.",BRCA,0,True,"The report states that the largest confluent invasive tumor measures 1.8 cm, which falls within the T1 category. Specifically, it is a T1c tumor as it is between 1.0 and 2.0 cm in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",15.0,1443.0,100.0,True
723,TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6,2,"F. Path Report. ACCESSION NO. : Final Diagnosis(es): (A) Left simple mastectomy: 1) Benign breast with areas of stromal fibrosis. 2) No atypia, in-situ or invasive malignancy identified,. including margins. 3) Skin and nipple unremarkable. (B) Right simple mastectomy: 1) Infiltrating lobular carcinoma, Nottingham grade Il of. III. 2) Pathologic stage pT3 psnNo pMX. 3) See Synoptic report (below) for details. (C) Right axilla sentinel lymph node #1: One lymph node. negative for metastasis (0/1). Synoptic Report: Specimen Type: Total breast (including nipple and skin). Procedure: Simple mastectomy. Lymph Node Sampling: Sentinel lymph node. Laterality: Right. Tumor Type: Lobular. Tumor Focality: Single. Tumor Site: Lower outer quadrant. Tumor Size: 7.8 x 7.0 x 6.0 cm. Nottingham Grade: II of III. Skin: Present, unremarkable. Nipple: Present, unremarkable. Skeletal Muscle: Absent. Invasive Margins: Widely negative. Lobular Carcinoma in Situ: Not present. Ductal Carcinoma in Situ: Not present. Lymphvascular Invasion: Not identified. Lymph nodes: Sentinel: 0/1 (positive/total). CK 10.11 performed on block B1. Anciliary Studies: Estrogen Receptor: Positive, strong, 95%. Progesterone Receptor. Positive, strong, 50%. Her-2/neu: 0+ (0-3+ scale). (was not sent for FISH analysis). KI-67: 25%. MD. Specimen(s) Received: A: left simple mastectomy. B: right simple mastectomy. C: right axilla sentinel lymph node # 1. Printed from: Default. Page: 1 of 5. F. Clinical History: High risk breast cancer left. (A) Short - superior, long - lateral. (B) Short superior, long - lateral. (C) Count 166. Intraoperative Consultation: FSC1-FSC2: Right axilla sentinel lymph node #1: Benign (2. blocks). M.D. Gross Description: (A) (left simple mastectomy). Specimen type: Simple mastectomy. Specimen weight and dimensions: The specimen weighs 1595 gm and. measures 23.5 x 22.5 x 6.3 cm. Skin: The overlying skin ellipse measures 22.0 x 11.0 cm. The. skin appears tan-pink and unremarkable. Orientation and inking scheme: The specimen is oriented as. follows: One short suture denoting the superior orientation and. one long suture representing the lateral left orientation. The. specimen is inked as follows: Medial - red, lateral - green. Estimated size of lesion: Sectioning of the breast demonstrates. unremarkable fibrofatty tissue with no nodules or masses seen or. palpated. Blocks submitted: A1 - section of nipple. A2-A3 - two sections from upper lateral portion of breast. A4-A5 - two representative sections of the lower lateral. quadrant. A6-A7 - representative sections of lower medial quadrant. A8-A9 - representative sections of upper medial quadrant. (B) (right simple mastectomy). Specimen type: Simple mastectomy. Specimen weight and dimensions: The specimen weighs 1670 gm and. measures 26.0 x 28.0 x 6.0 cm. Skin: The ellipse of overlying skin measure 24.5 x 9.0 cm. The. skin is pink and unremarkable. Orientation and inking scheme: The specimen is oriented as. follows: One short suture denoting the superior orientation and. one long suture representing the lateral left orientation. The. specimen is inked as follows: Deep margin - black, anterior. lateral margin - red, anterior medial margin - blue. Estimated size of lesion: The breast is serially sectioned. The. primary lesion measures approximately 7.0 x 7.8 x 6.0 cm. Appearance of lesion: The lesion is firm and tan-white, and. infiltrates into the breast parenchyma. Printed from: Default. Page: 2 of 5. F. Location of lesion: The lesion is located approximately 7.0 cm. medial to the center of the specimen in the lower lateral. quadrant. Distance from closest margin: The primary lesion is located 1.5. cm superficial to the deep margin, 4.0 cm from the anterior. margin, 6.0 cm from the lateral margin, 19.0 cm to the medial. margin, 6.0 cm to the inferior margin, and 14.0 cm to the. superior margin. Other findings: Two possible satellite lesions are located with. one central and one at 2:00. The central lesion measures 6.5 x. 3.0 x 3.0 cm. The lesion at 2:00 measures 1.5 x 2.5 x 2.5 cm. Uninvolved parenchyma: The uninvolved parenchyma demonstrates. unremarkable fibrofatty tissue. Axillary tail and lymph nodes: No axillary tail is received in. this specimen. Blocks submitted: B1 nipple. B2 - fat overlying tumor. B3 - skin overlying tumor. B4-B8 - representative sections from the primary tumor. B9-B10 - representative sections from the centrally located. possible satellite lesion. B11-B12 - two representative sections from the lesion at 2:00. B13-14 - representative sections of uninvolved parenchyma from. the upper medial quadrant. B15-B16 - representative sections of uninvolved parenchyma. B17-B18 - representative sections of the lower lateral quadrant. B19-B20 - two representative sections of uninvolved parenchyma. from the upper lateral quadrant. B21 - section of the medial margin. B22 - section of the lateral margin. B23 - section of the inferior margin. B24 - section of the superior margin of uninvolved parenchyma. (C) (right axilla sentinel lymph node #1) Received fresh for. intraoperative consultation is one piece of fatty tissue. measuring 3.3 x 2.4 x 1.0 cm. The specimen is bisected with. one-half submitted in FSC1 and the other half submitted in FSC2. for frozen section evaluation. One lymph node was received in. formalin and submitted entirely in C3. Microscopic Description: Complete microscopic evaluation has been performed. Appropriately reacting controls have been performed and. evaluated for all stains on this case as required. Histopathology has a list of IH antibodies that are regulated as. analyte specific reagents (ASR's). These assays were developed. and their performance characteristics determined by the. at. They. have not been cleared by the US Food and Drug Administration. Printed from: Default. Page: 3 of 5. F. 1. The FDA has determined that such clearance or approval is not. necessary for the ASR's. These tests are not investigational. and are used in standard clinical care. In cases where. Immunohistochemistry testing is performed, the following. antibodies and their respective clones may be used to determine. therapy for the patient: EFGR(31G7), ER(SP1), PR(1E2),. Her2neu(4B5), CD117(Poly), CD20(L26). Unless otherwise stated in the report, all tissue tested for. ERPR by IHC, Her2 by IHC and/or HER2 by FISH have been fixed as. per ANP 22998 for a minimum of 6 hours and a maximum of 48. hours. ER, PR, Ki-67, p53 are reported as a semi-quantitative. percentage of positively stained nuclei. Her-2/neu and EGFR are. scored as follows: No staining at all is scored as (0), weak,. incomplete membrane staining in any proportion of cells is. scored as (1+), less than strong but complete staining in any. proportion of cells or complete strong staining in less than 30%. of cells is scored as (2+), and strong complete staining in more. that 30% of cells is scored as (3+). All studies are performed. on tissue fixed in 10% neutral buffered formalin and embedded in. paraffin unless otherwise stated in the report. Page: 4 of 5.",BRCA,0,True,"The T stage is primarily determined by the size of the tumor. In this report, the size of the tumor is 7.8 x 7.0 x 6.0 cm, which is larger than 5 cm in the greatest dimension, corresponding to a T3 stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",T3,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.",15.0,1439.0,100.0,True
1142,TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82,0,"page 1 / 2. copy No. Examination: Histopathological examination. Gender: F. Material: 1. Multiple organ resection - left breast with axillary tissues. Expected time of examination: upto 8 working days. Clinical diagnosis: Cancer of the left breast. Macroscopic description: Left breast sizedi21 x 18 x 3 cm removed along with axillary tissues sized 10 x 5 x 2 cm and a 15 x 6 cm skin flap. Weight 520 g. Tumour sized 1.9 x 1.6 x 1.7 cm in the middle part, 1.5 cm from the upper boundary, 1.6 cm from the base and 0 cm from. the skin. Microscopic description: Carcinoma ductale invasivum - NHG2 (2+3+2/10 mitoses/10 HPF - visual area: 0.55mm). Foci of carcinoma ductale in situ (DCIS) found within the tumour (solid and cribrate type, with medium nuclear atypia,. without necrosis and with calcifications of below 5% of the tumour). Infiltratio carcinomatosa mamillae. Focus of carcinoma ductale invasivum found in the glandular tissue (inner lower quadrant - diameter 0.1 cm). Also showing also lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (UDH). AXILLARY LYMPH NODES: Metastases carcinomatosae in lymphonodis (No VI/XVIII). Infiltratio capsulae lymphonodi. Preliminary result: Final response to be given after whole of the material is analysed. I. Results of immunohistochemical. examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive cancerous cells ( Score = 1+ ). Examination: Histopathological examination. page 2 / 2. Gender: F. Histopathological diagnosis: Carcinoma ductale invasivum bifocal et ductale in situ mammae sinistrae. Invasive ductal bifocal carcinoma and ductal in situ carcinoma of the left breast. Metastases carcinomatosae in lymphonodis axillae (No VI/XVIII) (NHG2, pT1c, pN2a). Cancer Metastases in axillary lymph nodes.",BRCA,2,True,"The report states that the size of the largest tumor is 1.9 x 1.6 x 1.7 cm, which is smaller than 2 cm in any dimension. Therefore, the T stage is T1 according to the rule 'T1 tumors are 2 cm or less in size'.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.",17.0,1611.0,94.0,True
1354,TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025,1,"F. Pathologic Interpretation: A. Left breast lumpectomy with needle localization (short stith- superior, long lateral): - Invasive ductal carcinoma, Nottingham grade 2 (3+2+2), 2.5 cm in greatest linear dimension. Associated ductal carcinoma in situ, intermediate grade (DIN2), cribriform type with necrosis. - The margins are free from tumor. - Distance from the nearest margin is 1.8 cm (superior). - Lymphovascular space invasion is identified. - No malignancy seen in skin. - Microcalcifications. - Previous biopsy site. B. Skin left breast: - No malignancy seen in skin. C. Additional tissue superior to the two small nodules blue Indicates true margin: - Invasive ductal carcinoma, 0.4 cm in greatest linear dimension. - The distance from the true margin is 1.0 cm. D. Left axillary contents;. - Metastatic carcinoma in one out of thirteen lymph nodes with extranodal extension (1/13). - Size of metastatic tumor is 2.0 cm. E. Right breast tissue: - No malignancy seen in skin. - Fibroadenoma. Tumor Summary (Invasive Carcinoma of the Breast): Specimen Type: Partial breast. Procedure: Excision with wire-guided localization. Lymph Node Sampling: Axillary dissection (partial or complete dissection). Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Size: Greatest dimension: 16cm. Additional dimensions: 12 x 3 cm. Specimen Laterality: Left. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 2.5 cm. Additional dimensions: 2x1 cm. Tumor Focality: Multiple foci of invasive carcinoma. Number of focl: 2. Sizes of individual foci: 2.5 cm and 0,4 cm. Macroscopic and Microscopic Extent of Tumor: Skln: Invasive carcinoma does not invade into the dermis or epidermis. Nipple: DCIS does not involve the nipple epidermis. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma in Situ: DCIS is present. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise specified). Histologic Grade: Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 2. Mitotic Count: Score 2. Overall Grade: Grade 2. Margins: Uninvolved by invasive carcinoma. Distance from closest margin: 1.0 cm (superior). Lymph-Vascular Invasion: Present. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: SURGICAL PATHOL Report. Number of sentinel lymph nodes examined: 0. Total number of lymph nodes examined (sentinel and nonsentinel): 12. Number of lymph nodes with macrometastases: 1. Number of lymph nodes with isolated tumor cells: 2.0 cm. Extranodal Extension: Present. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Pathologic Staging (pTNM). Primary Tumor: pT2. Regional Lymph Nodes: pN1a. Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: Performed on another specimen. Specify specimen: Results: Immunoreactive tumor cells present. Progesterone Receptor: Performed on another specimen. Specify specimen: Results: Immunoreactive tumor cells present. Her2: Performed on another specimen. Specify specimen: Results: Negative (Score 0). Microcalcifications: Present in invasive carcinoma. NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2, Parvo, H. pylori, HBcore). These ASRs are clinically useful indicators that. do. require FDA approval. These clones are used: ID5=ER, PgR 636=PR, A485=HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4 1=AR end HPV by ISH. All immunohistochemical stains are used. with formalin or molecular fixed, paraffin embedded tissue. Detection is by LSAB. The results are read by a pathologist as positive or negative. '. MD. As the attending pathologist, / attest that I: (i) Examined the relevant. preparation(s) for the specimen(s); and (1) Rendered the diagnosis(es). Clinical History: Female with left breast cancer. Pre Operative Diagnosis: Left breast cancer. Specimen(s) Received: A: Left breast lumpectomy with needle localization (short stith- superior, long lateral ) fresh. B: Skin left breeast (perm). C: Additional tissue superior to the two small nodules blue indicates true margin (perm). D: Left axillary contents (perm). E: Right breast tissue (perm). Gross Description: A. Received fresh and labeled ""left breast lumpectomy with needle localization (short stith- superior, long lateral fresh"". specimen is inked for evaluation of margins as follows: posterior, black; anterior, yellow; superior, blue; Inferior, green;. lateral, orange; medial, red. The specimen weighs 299.0 grams and measures 16.0 cm from medial to lateral, 12.0 cm. Inferior to superior and 3.0 cm anterior to posterior. It is oval in shape, yellow in color, soft in consistency. The specimen. has an ellipse of skin measuring 3.0 x 1.0 cm. Serial sectioning of the specimen reveals an oval mass with infiltrating. borders and measures approximately 2.5 x 2.0 X 1.0 cm. The mass occupies 10% of the entire specimen. It is white in. color and firm in consistency. The distance of the mass from the margin is as follows: posterior 2.0 cm, inferior 2,0 cm,. anterior 3.0 cm, superior 3.0 cm, medial 10.0 cm, lateral 9.0 cm. The remaining of the breast parenchyma appears. unremarkable with fat to stroma ratio 90:10. The mass has a clip. A section of mass was submitted to tissue bank. Sections submitted as follows: SURGICAL PATHOL Report. 1-8. Sections of the mass in toto. 9&10. Representative section from the superior margin). 11&12. Representative section from inferior margin. 13&14. Representative section from lateral margin. 15&16. Representative section from medial margin. 17&18. Representative section from posterior margin. 19820. Representative section from anterior margin. 21. Representative section from the remaining breast parenchyma. 22. Representative section of the skin. B. Received in formalin and labeled ""skin left breast"" is a skin tag measuring 5.0 x 1.0 cm. Representative section submitted. in one cassette. C. Received in formalin and labeled ""additional tissue superior to the two small nodules blue indicates true margin (perm)"" is. oval in shape. The surgeon inked the true margin in blue. Resident inked true margin in black. It measures 3.0 x 1.0 x 1.0. cm. it is submitted in toto in eight cassettes. D. Received in formalin and labeled ""left axillary contents (perm)"" is axillary contents measuring 10.0 x 8.0 x 3.5 cm. It is. yellow in color and soft in consistency. There are 13 lymph nodes. The largest lymph node measures 2.0 x 2.0 cm. The. lymph nodes are submitted as follows: 1-8. One lymph node per cassette. 9. Two lymph nodes. 10. Three lymph nodes. E. Received in formalin and labeled ""right breast tissue (perm)"" is a soft, yellow breast tissue measuring 14.0 x 5.0 x 3.0 cm. Serial sectioning does not reveal any gross lesions. The breast parenchyma appears to be normal with fat to stroma ratio. 90:10. It has a skin tag measuring 3.0 x 1.0 cm. Sections are submitted as follows: 1. Section from skin. 2-4. Representative section of stroma. MD. ICD-9(s): 174.8 196.3 217.",BRCA,1,True,"The report states that the largest focus of invasion of the invasive carcinoma is 2.5 cm in greatest linear dimension, which puts it in the T2 category according to the rule 'T2 tumors are more than 2 cm but not more than 5 cm in size'.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
T stage is primarily determined by the size of the tumor, with modifications based on the presence of direct extension to the chest wall or skin.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",18.0,1797.0,93.0,True
1118,TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2,1,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: 1. Multiple organ resection - right breast and axillary tissue. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Score = 2+, FISH verification recommended. Examination performed or. Macroscopic description: Left breast sized 19,5 x 12 x 4 cm removed along with axillary tissues sized 6 x 5 x 3 cm and a 15.5 x 4 cm skin flap. Tumour. sized 3.0 x 2.1 x 1.3 cm on the boundary of outer quadrants, 5.0 cm from the lower boundary, 0.1 cm from the base and 0.5. cm from the skin. Microscopic description: Carcinoma invasivum - NHG2 (3 + 2 + 1/0 mitoses/10 HPF, visual area diameter 0.55 mm). Foci of carcinoma ductale in situ DCIS found within and outside the tumour (solid and cribrate type with medium nuclear. atypia, comedo necrosis and calcifications, 10% of the tumour). Additionally, lesions of the type carcinoma lobulare in situ (LCIS). Mamilla sine laesionibus. Glandular tissue showing lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (UDH), adenosis. sclerosans, calcifications, columnar cell changes CCC). AXILLARY LYMPH NODES. Metastases carcinomatosae in lymphonodis No I/VIII. Infiltratio capsulae lymphonodi et telae perinodalis. Preliminary result: Carcinoma ductale invasivum et ductale in situ lobulare in situ (LCIS). Metastases carcinomatosae in lymphonodo axillae (NHG2, pT2, pN1a). page 2 / 2. Gender: F. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND. Histopathological diagnosis: Carcinoma ductale invasivum et ductale in situ. Invasive ductal carcinoma and ductal carcinoma in situ. Metastases carcinomatosae in lymphono axillae (No I/VIII). Cancer metastases in axillary lymph nodes (No I/VIII). (NHG2, pT2, pN1a). Immunophenotype: E-cadherin+, CK7-.",BRCA,1,True,"The T stage is primarily determined by the size of the tumor. In this report, the tumor size is 3.0 x 2.1 x 1.3 cm. According to the rules, T2 tumors are more than 2 cm but not more than 5 cm in size. Therefore, the T stage is T2.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",pT2 pN1a,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",17.0,1651.0,96.0,True
875,TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61,0,"Breast, left, wide local excision: Infiltrating ductal carcinoma, Nottingham grade II (of III), forming a 1.5 x 1.4 x 1.2 cm. mass. (AJCC pTlc). Associated ductal carcinoma in situ, intermediate nuclear grade, compromises approximately 20% of the tumor. Resection margins are free of tumor. Separately submitted lateral, deep, inferior and superior margins are free of tumor. Lymph nodes, left axillary sentinel Nos. 1, 2, and 3, excision: Multiple (3) left axillary sentinel lymph nodes without blue dye are. negative for tumor. [AJCCpNO(i-)] Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel. lymph node tissue and confirms the H&E impression.",BRCA,0,True,"The tumor size is 1.5 x 1.4 x 1.2 cm, which falls within the T1 category of tumors that are 2 cm or less in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor grade is not used to determine T stage.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor grade is not used to determine T stage.",18.0,1697.0,99.0,True
651,TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4,2,"Diagnosis. 1. Left-sided ablated breast tissue with a poorly differentiated invasive ductal breast. carcinoma measuring a maximum of 6 cm with focal invasion of the lymph vessels, extension. to the base of the nipple and the pectoral muscle and excision extending just into the healthy. tissue in the basal epidermis. No pagetoid tumor propagation or skin infiltration. Tumor classification: M-8500/3, G 3, pT3, pN2a (5/13), pMX, stage III A. R0.",BRCA,2,True,"The T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin. In this report, the tumor measures a maximum of 6 cm and has extended to the base of the nipple and the pectoral muscle, which qualifies it as a T3 tumor according to the rule 'T3 tumors are more than 5 cm in size, or tumors of any size with direct extension to the chest wall or skin.', ignoring any substaging information.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size, or tumors of any size with direct extension to the chest wall or skin.
T4 tumors are of any size with direct extension to the chest wall or skin and invasion of the skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.",T3,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor grade is not used to determine T stage.",18.0,1697.0,51.0,False
978,TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A,0,"FINAL DIAGNOSIS: PART 1: LEFT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). PART 2: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 3, (TUBULE FORMATION - 3, NUCLEAR GRADE -. 3, MITOTIC RATE - 3, TOTAL SCORE: 9/9). B. INVASIVE CARCINOMA MEASURES 1.8 CM IN GREATEST DIMENSION (SLIDE 2B). C. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID AND MICROPAPILLARY TYPES WITH. COMEDO NECROSIS AND ASSOCIATED CALCIFICATIONS. D. DCIS IS PRESENT OUTSIDE OF INVASIVE CARCINOMA COMPONENT (see comment). E. MARGINS OF RESECTION ARE NEGATIVE FOR INVASIVE CARCINOMA, INVASIVE CARCINOMA IS 0.9 CM. FROM CLOSEST (ANTERIOR) MARGIN OF RESECTION. F. DCIS IS PRESENT AT INFERIOR MARGIN OF RESECTION. G. NO LYMPHOVASCULAR INVASION IS IDENTIFIED (see comment). H. ATYPICAL DUCTAL HYPERPLASIA. I. FIBROCYSTIC CHANGES WITH COLUMNAR CELL CHANGE AND DUCTAL EPITHELIAL HYPERPLASIA. J. INVASIVE CARCINOMA IS NEGATIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND NEGATIVE. FOR HER-2/NEU WITH A SCORE OF 0, AS PER PREVIOUS PATHOLOGY REPORT. COMMENT: The in situ carcinoma is noted outsite of invasive carcinoma component, near the inferior margin, focally involving the. inferior margin, in three out of fifty-eight slides. Entire specimen was submitted for histological evaluation. No definite lymphovascular invasion was seen in the current specimen. No lymphatic invasion was seen in the previous. biopsy specimen confirmed by D2-40 stain. However, vascular space invasion was seen in the previous biopsy. confirmed by CD31 stain. This data will be used for filling the synoptic template.",BRCA,0,True,"The report states that the invasive carcinoma measures 1.8 cm in greatest dimension. According to the rules provided, T1 tumors are 2 cm or less in size. Therefore, the T stage for this patient's cancer is T1.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor grade is not used to determine T stage.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor grade is not used to determine T stage.",18.0,1697.0,100.0,True
1214,TCGA-E2-A15C.04FF2CF1-737B-4FD2-8A1D-F9B5488DE510,0,"SPECIMENS: TESA-E2-A15C-01A-PR. A. WLE RIGHT BREAST NEEDLE LOCALIZATION. B. SENTINEL L.N. #1 RIGHT AXILLA. C. SENTINEL L.N. #2. D. SENTINEL L.N. #3. E. SENTINEL L.N. #4. SPECIMEN(S): A. WLE RIGHT BREAST NEEDLE LOCALIZATION. B. SENTINEL L.N. #1 RIGHT AXILLA. C. SENTINEL L.N. #2. D. SENTINEL L.N. #3. E. SENTINEL ..N. #4. GROSS DESCRIPTION: A. WLE RIGHT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and ""WLE right breast needle localization"" is a previously. inked 70g, 8 x 5 x 4cm needle localized lumpectomy with radiograph. Ink code: anterior-yellow, posterior-black,. superior-blue, inferior-orange, medial-green, lateral-red. Specimen is serially sectioned from lateral to medial into 9. slices revealing a tan white firm stellate 1.9 x 1.6 x 1.5cm mass, 0.7cm from the closest posterior margin in slices 3-. 6. Representatively submitted: A1-A2: lateral margin slice 1. A3: next to mass slice 2. A4-A8: slice 3 with mass - deep margin A4. A9: mass with deep margin slice 4. A10: inferior margin slice 4. A11-A12: slice 5. A13: mass with deep margin slice 6. A14: slice 7. A15: slice 8. A16: medial margin slice 9. B. SLN #1 RIGHT AXILLA. Received fresh is a tan pink lymph node 0.5 x 0.5 x 0.5cm. The specimen is sectioned and a touch prep is taken. Toto B1. C. SLN #2 RIGHT AXILLA. Received fresh is a tan pink lymph node 0.8 x 0.6 x 0.6cm. The specimen is sectioned and a touch prep is taken. Toto C1. D. SLN #3 RIGHT AXILLA. Received fresh is a tan pink lymph node 0.9 x 0.5 x 0.5cm. The specimen is sectioned and a touch prep is taken. Toto D1. E. SLN #4 RIGHT AXILLA. Received fresh is a tan pink lymph node 0.6 x 0.6 x 0.5cm. The specimen is sectioned and a touch prep is taken. Toto E1. DIAGNOSIS: A. BREAST, RIGHT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.7-CM, INVOLVING SKELETAL MUSCLE. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, CRIBRIFORM TYPE. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - BIOPSY SITE CHANGES WITH FIBROSIS AND GRANULATION TISSUE. - SEE SYNOPTIC REPORT. B. LYMPH NODE, SENTINEL #1, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, SENTINEL #2, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. LYMPH NODE, SENTINEL #3, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). E. LYMPH NODE, SENTINEL #4, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.7cm. Tumor Site: Not specified. Margins: Negative. Distance from closest margin: 0.3cm. inferior. Tubular Score; 2. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/4. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 1%. DCIS Type: Cribriform. DCIS Location Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Pending. Performed on Case: Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: None provided. INTRAOPERATIVE CONSULTATION: A. GROSS EXAMINATION: WLE right breast- 1. 9cm mass 0.7cm from closest deep margin. Diagnosis called to Dr. at. by Dr. TPB-TPC-TPD-TPE: Negative for carcinoma. Diagnosis called to Dr. at. by Dr. ADDENDUM: SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: A9. Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 20%. Fish Ordered: Yes on Date. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis. was performed using the FDA approved Dako HercepTest (TM) test kit. 1 using rabbit anti-. human HER2. This assay was not modified. External kit-slides provided by the manufacturer (cell lines with high,. low and negative HER2 protein expression) and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. Adequate, well preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2 immunohistochemical stain is guided by published results in the medical literature,. information provided by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from ASCO and CAP. and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology Department takes full responsibility. for this test's performance. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the Pathology. Core Facility by Dr. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used. A9. Source of case: Tissue fixation formalin-fixed tissueOutside Case No: NA. Tissue source breast Results interpreted: yes. HER2/CEP17 ratio: 1.02. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. No. treatment decision for stage II, node-positive breast cancer patients should be based on HER-2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin theranv is being considered. These tests were performed in the. under the direction. of Dr. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 19. CLINICAL EXPERIENCE: Patients with a recurrence score of: 19 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 12%. ER Score: 10.2 Positive. PR Score: 8.8 Positive. Her2 Score: 8.9 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >=1 11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,. Addendum: Pathologist, 1. Addendum Final: Pathologist,.",BRCA,0,True,"The report states that the size of the invasive ductal carcinoma is 1.7 cm, which falls within the T1 category of tumors that are 2 cm or less in size. Therefore, the T stage for this patient is T1.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor grade is not used to determine T stage.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor grade is not used to determine T stage.",18.0,1697.0,100.0,True
489,TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21,1,"Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST B: LEFT BREAST C: SENTINEL LYMPH NODE #1. D: LEFT AXILLARY CONTENTS E: NON SENTINAL , ,LT AXILLARY L.N. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - BENIGN BREAST TISSUE WITH FIBROCYSTIC CHANGES INCLUDING SCLEROSIS,. MICROCYST FORMATION, USUAL DUCTAL HYPERPLASIA, DUCT ECTASIA, AND. FOCAL MICROCALCIFICATION . B. BREAST, LEFT, MASTECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: III/III. NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3). TUMOR SIZE (GREATEST DIMENSION OF INVASIVE COMPONENT) : 3.5 CM. (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT. VENOUS / LYMPHATIC INVASION: IDENTIFIED. MARGINS : - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.4 CM, FROM THE. SUPERFICIAL LOWER OUTER QUADRANT (BLUE INK) MARGIN. INTRADUCTAL COMPONENT: MULTIFOCAL, HIGH GRADE, SOLID AND COMEDO TYPE. EXTENDING WELL BEYOND THE INVASIVE COMPONENT. NIPPLE INVOLVEMENT: NOT IDENTIFIED. LYMPH NODES 1 OF 22 POSITIVE FOR TUMOR (PARTS C-E). SKIN INVOLVEMENT: NOT IDENTIFIED. ESTROGEN RECEPTORS : POSITIVE (STRONG, >75% OF CELLS, FROM. HER 2 NEU by IHC: NEGATIVE (1+ STAINING, FROM. PROGESTERONE RECEPTORS: NEGATIVE (WEAK, <5% OF CELLS, FROM. PATHOLOGIC STAGE: pT2 N1 MX. ADDITIONAL PATHOLOGIC CHANGES: FIBROCYSTIC CHANGES INCLUDING MICROCYST. FORMATION, FOCAL DUCT ECTASIA, SCLEROIS, USUAL DUCTAL HYPERPLASIA, AND. APOCRINE METAPLASIA. C. LYMPH NODE, LEFT SENTINEL, EXCISION: - AND ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY HEMATOXYLIN. EOSIN AND IMMUNOHISTOCHEMICAL (CYTOKERATIN) STAINS. Specimen #: FINAL DIAGNOSIS (continued) : D. LYMPH NODE, LEFT AXILLA, EXCISION: - TWENTY (20) LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA. E. LYMPH NODE, LEFT NON-SENTINEL, EXCISION: - ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. COMMENT: confirmed on the permanent sections. In specimen ""E"" the frozen section diagnosis of metastic carcinoma is. CLINICAL DIAGNOSIS AND HISTORY: year old white female with history of left breast cancer. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE:LYMPH NODE (SPECIMEN ""E"") . REPORTED TO: AND. # BLOCKS : 1. # SCRAPE PREPS : 1. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received in fresh labeled with the patient's name. of labeled a 927 ""RIGHT BREAST SHORT STITCH SUPERIOR, LONG STITCH LATERAL consists. and gram mastectomy specimen oriented with a short stitch superior. pigmented 1.0 superficial skin ellipse measures 17 x 11.5 cm and. superior to inferior, and 5 cm anterior to posterior. The lightly. long lateral. The specimen measures 24 cm medial to lateral, 19 cm. The deep cm centrally located everted nipple. No discharge or scar displays is noted. a. tan margin is inked in black. Serial sections reveal lobulated yellow. tissue. adipose tissue admixed with 10% moderately dense tan white fibrous. catted grey cysts measuring up to 0.4 cm in greatest dimension. blue The fibrous tissue is predominantly centrally located and shows. 1. Specimen #: GROSS DESCRIPTION (continued) : discrete mass or lesion identified. No lymph nodes are identified. Cassette summary : A1: skin. A2: central. A3: upper outer quadrant. A4: lower outer quadrant. A5: lower inner quadrant. A6: upper inner quadrant. A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant. All: representative section of nipple. Matched sections of A1-A6 are submitted in OCT for CBCP protocol. B. Received fresh labeled with the patient's name. designated ""LEFT BREAST SHORT STITCH SUPERIOR, LONG LATERAL"" is a 954. gram mastectomy specimen oriented with a short stitch superior and long. lateral. The specimen measures 24 cm medial to lateral, 18 cm superior. inferior, and 6 cm anterior to posterior. The lightly pigmented. to. superficial located skin ellipse measures 19 x 12.5 cm and displays a medially. deep inked margin is inked black and the superficial lower outer quadrant is. 1.5 cm everted nipple free of discharge. No scar is noted. The. located lobulated pink white indurated mass with focal hemorrhage. The mass. blue. Serial sections reveal 3.5 x 3.2 x 2.8 cm well defined. deep the margin and 0.4 cm of the inked superficial surface. The remainder. within the lower outer quadrant and comes within 3.5 cm of the is. tissue which is diffusely nodular and focally cystic. The admixed. specimen is composed of approximately 50% dense tan white fibrous. of. adipose tissue is unremarkable. No additional masses are identified. No. lymph nodes identified. Cassette summary: B1: skin. B2: lower outer quadrant mass. B3: lower outer quadrant. B4: upper outer quadrant. B5: upper inner quadrant. B6: lower inner quadrant. B7: representative section of closest deep margin. blue B8-B9: ink representative sections of mass with closest point of approach to. margin. 10: representative section of nipple. 10CF. Specimen #: GROSS DESCRIPTION (continued) : C. Received fresh labeled with the patient's name. designated. SENTINEL LYMPH NODE #1"" consists of a 2.0 x 1.7 x 1.0 cm. pink yellow fatty lymph node. The specimen is trisected. Two thirds of the. lymph node are placed in cassette C1 and C2. Matched section of C1 is. placed in. for CBCP protocol. D. Received fresh labeled with the patient's name. designated ""LEFT AXILLARY CONTENTS"" consists of an unoriented irregular. portion of adipose tissue measuring 9.0 x 9.0 x 2.0 cm. Sectioning reveals. multiple pink yellow fatty lymph nodes ranging in size from 0.4 to 2.4 cm. in greatest dimension. Cassette summary. D1-D3: one lymph node each. D4-D7: one lymph node bisected. D8: two lymph nodes bisected, one inked black. D9: four intact lymph nodes. D10: one lymph node bisected. D11: two lymph nodes. D12: four possible lymph nodes. 12CF. E. Received fresh labeled with the patient's name. designated ""NON SENTINEL CLINCALLY SUSPICOUS LEFT AXILLARY LYMPH NODE'. consists of a 1.7 x 1.5 x 1.3 cm lymph node. Cut surface is homogeneous. and firm. A portion is submitted for frozen section. 1C1.",BRCA,1,True,"The report states that the size of the tumor in the left breast is 3.5 cm, which falls under the T2 category of tumors that are more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage, and the tumor grade is not used to determine T stage.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",17.0,1651.0,99.0,True
547,TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5,1,"Specimen #: (Age: F Race: Physician (s) : AMENDED. SPECIMEN: LEFT BREAST MASTECTOMY AND AXILLARY CONTENTS. FINAL DIAGNOSIS: A. BREAST, LEFT RADICAL MASTECTOMY: - RESIDUAL INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED BY. COMBINED HISTOLOGIC CRITERIA, PRESENT IN THE AREA OF BIOPSY CAVITY. AND LOWER OUTER QUADRANT. ESTIMATED TUMOR SIZE BASED ON PREVIOUS NEEDLE LOCALIZATION. BIOPSIES AT LEAST 3.0 CM. - SEPERATE TUMOR MASS IN THE UPPER OUTER QUADRANT: INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. TUMOR SIZE: 2.0 CM (GROSS). MARGIN: TUMOR WITHIN 1MM OF SUPERIOR SUPERFICIAL MARGIN. DUCTAL CARCINOMA IN SITU, INTERMEDIATE-GRADE, PREDOMINANTLY SOLID. AND CRIBRIFORM TYPES. DEEP MARGIN: TUMOR (DCIS) EXTENDS WITHIN 1.0 MM OF DEEP SURGICAL. MARGIN IN ONE SECTION (SLIDE A12) . - METASTASIS TO 6/10 AXILLARY LYMPH NODES WITH EXTRA CAPSULAR. EXTENSION. - SKIN AND NIPPLE NEGATIVE FOR CARCINOMA. - FIBROCYSTIC CHANGES. BIOPSY SITE CHANGES. - AJCC STAGE: T2N2MX. COMMENT:The amendment is made to report that there is a seperate tumor. mass in the upper outer quadrant and also the deep margin status. The amendment is made in the absence of the primary pathologist. Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: Left breast carcinoma. GROSS DESCRIPTION: Received fresh is a 167 gm modified radical mastectomy specimen with the. following measurements: breast 12.6 x 11.6 x 1.6 cm, overlying ellipse of. nipple-bearing skin 7.2 x 5.5 cm, attached axillary contents 12.5 x 3.5 x. 0.9 cm. Ink code: blue = superior superficial, green = inferior. superficial, black = posterior. The skin is notable for a 2.0 cm well. healed scar near the lateral edge of the ellipse. Examination of the. axilla reveals multiple firm lymph nodes. A seperate mass is present in. the upper outer quadrant measuring 2.0 x 1.4 x 1.4 cm. The breast is then serially sectioned revealing extensive white fibrous. tissue with a 1.2 cm multiloculated biopsy cavity with associated. hemorrhage and fat necrosis in the lower outer quadrant . Sections of the tumor mass and skin and breast samples for. protocol with matching paraffin sections are follows: cassette A1 grossly. normal skin (medial tip). cassettes A2 and A3 2.0 cm tumor mass from upper. outer quadrant, cassette A4 1.7 cm lymph node, high axilla (grossly. positive), cassette A5 1.8 cm grossly normal lymph node, high axilla,. cassette A6 biopsy cavity site, lower outer quadrant, cassette A7 grossly. normal fibrous tissue, lower outer quadrant (approximately 2.0 cm from. biopsy cavity) cassette A8 grossly normal fibrous tissue, upper outer. quadrant, cassette A9 grossly normal fibrous tissue upper inner quadrant,. cassette A10 grossly normal fibrous tissue lower inner quadrant, cassette. A11 representative sections of nipple and scar from skin, cassette A12. biopsy cavity deep margin lateral, cassette A13 biopsy cavity superior. medial, A14 biopsy cavity inferior medial, A15 four additional lymph nodes. from axillary tail, A16 two additional lymph nodes from axillary tail,. cassette A17 one lymph node bisected from axillary tail.",BRCA,2,True,"The report mentions a tumor size of 2.0 cm in the upper outer quadrant (Cassette A2 and A3). According to the rules provided, T2 tumors are more than 2 cm but not more than 5 cm in size. Therefore, the T stage for this report is T2.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",17.0,1651.0,100.0,True
1286,TCGA-E9-A1R2.5B9C0E4A-3958-4ECF-B8B2-E758E04E7722,1,"OC ID: Gross Description: Labeled left breast lumpectomy. Received is an 85 g unoriented ovoid. portion of lobulated tan fibroadipose tissue measuring 8 x 7 x 3.5 cm. The. specimen contains 2 needle localization wires and there is an accompanying. specimen mammogram, which is used to orient the specimen and select the. sections. The radiologist has circled two areas of concern marked 1 and 2,. both of which are associated with microcalcifications. The margins are. inked blue for microscopic evaluation. Upon sectioning, area 1 is present. near the midpoint of the long axis and consists of a 2.4 x 1.9 x 1.4 cm. irregular mass. The cut surfaces of the mass are white-tan, smooth and have. well-defined borders. The mass grossly abuts the inked margin. At one end. of the mass is a 0.7 x 0.3 cm biopsy cavity containing collagen material. and a small metal clip as well as adjacent focal hemorrhage. Area 2 is. present at one end of the specimen and consists of a 1.2 x 0.9 cm ovoid. portion of firm white fibrous tissue that is slightly more dense than the. adjacent white fibrous tissue. This area comes to within 0.7 cm of the. nearest inked margin. The remaining cut surfaces are tan and lobulated with. interspersed areas of condensed white fibrous tissue comprising. approximately 25% of the specimen. Poorly-defined areas of blue staining. are also present. Microscopic Description: Microscopic sections of the principal mass (grossly area 1) demonstrate. an infiltrating markedly pleomorphic epithelial neoplasm with a brisk. mitotic rate that is arranged in nests. Occasional areas of intratumoral. high grade ductal carcinoma in situ are. Diagnosis Details: INVASIVE BREAST CARCINOMA CHECKLIST. 1). Tumor focality: Single focus. 2). Tumor size: 2.4x1.9cm. 3). Histologic type: Ductal. 4). Nottingham Combined Histologic Grade: Poorly differentiated. a). Ductule formation: 3. b). Nuclear features: 3. c). Mitotic index: 2. 5). Angiolymphatic invasion: Present. 6) Margins: a). Not involved by tumor. b). Distance from closest margin: 1.9 cm (thickness of part B tissue). 7). Lymph nodes: 17 positive/ 19 found. 8) Size of largest metastatic deposit: 2.1 x 1.2 cm. 9). Extracapsular invasion of lymph nodes: No. 10) Extensive DCIS component (>25%): No. 11) DCIS component, extratumoral: No. 12) TNM: pT2 pN3a MX. 13). ERA/PRA: Positive/negative on prior biopsy. 14). Her-2/neu over-expression: Negative (score 2) by FISH on prior biopsy. Comments: BREAST TISSUE CHECKLIST. Specimen type: Lumpectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2.4x1.9x1.4cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Lymph nodes: 17/19 positive for metastasis (Axillary 17/19). Extracapsular invasion of the lymph nodes: No. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Minimal less that 10% (score=3). Nuclear pleomorphism: Marked variation in size, nucleoli, etc (score=3). Mitotic count (25x): 10 to 20 mitoses per 10 HPF (score=2). Mitotic count (40x): Not specified. Total Nottingham Score: Grade III (poorly differentiated): 8-9 points. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Left, upper outer quadrant.",BRCA,3,True,"The T stage is determined by the size of the tumor. The report states that the size of the tumor is 2.4x1.9x1.4 cm, which falls under the T2 category of tumors that are more than 2 cm but not more than 5 cm in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.",19.0,1984.0,91.0,True
698,TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A,1,"MRN : OV. MD. Laboratory Patient Report. Print Date/Time: Histopathological Examination. 4. - Received: ; Complete. Pre-op Diagnosis : Left Breast Car. MD. Specimens. Breast, left. Frozen Diagnosis. : GROSS EXAMINATION: The specimen is received in a container labeled with the. name of the patient and labeled as breast, left. The. specimen consists of a mastectomy designated left which. measures en bloc 31 x 20 x 5.5 cm and weighs 1515 g. Anteriorly located is an ellipse of brown skin which. measures 22 x 17 cm. Centrally located is a 4.5 cm diameter. areolar complex with slightly retracted nipple which is. sampled in block 1. The deep margin is inked and the. specimen is serially sectioned and shows a gray-tan firm. mass in the upper outer quadrant. This mass measures 2.8. x. 2.5 x 2.3 cm and grossly extends to within 1 cm of the inked. deep margin. A section of skin overlying the mass is. submitted in block 2. A section of the Inked deep margin is. submitted in block 3. Sections of the mass are submitted in. block 4-7. The remaining breast is composed of yellow. lobulated adipose tissue admixed with islands of gray-white. rubbery tissue. The breast is divided into four quadrants;. upper inner, lower inner, upper outer and lower outer and. sampled in blocks 8-11. The attached axillary tissue is. dissected for lymph nodes with the lower part sampled in. blocks 12-14 in the upper part sampled in blocks 15-16. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION: SPECIMEN TYPE: Modified radical mastectomy. LYMPH NODE SAMPLING: Axillary dissection. LATERALITY Left. TUMOR SITE: Upper outer quadrant. SIZE OF INVASIVE COMPONENT: Greatest dimension. 2.8 cm. ADDITIONAL DIMENSIONS: 2.5 x 2.3 cm. HISTOLOGIC TYPE: Invasive ductal carcinuna. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. Path # : 4. Visit # : HISTOLOGIC GRADE: Nottingham histologic score 3/3. DUCT IN SITU COMPONENT: Not identified. MICROCALCIFICATIONS Not identified. EXTENT OF INVASION. PRIMARY TUMOR (PT) : pT2: Tumor more than 2.0 cm but not more. than 5.0 cm in greatest dimension. REGIONAL LYMPH NODES (PN) : pN2a: Metastases in 4 to 9. axillary lymph nodes. NUMBER EXAMINED: 23. NUMBER INVOLVED: 6. DISTANT METASTASIS (PM) : PMX. MARGINS : Uninvolved by invasive carcinoma. DISTANCE TO NEAREST MARGIN: 1.0 cm to deep margin. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L) : Present. Summary of pathologic staging: pT2N2aMXG3 . Intradepartmental consultation obtained. COMMENT: Immunohistochemical stains for estrogen and. progesterone receptors and HER2 are pending and will be. supplementally reported when complete. M.D. ., MD. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. Path # : of 2. Visit # :",BRCA,2,True,"The size of the invasive component of the tumor is 2.8 cm, which falls within the T2 category of tumors that are more than 2 cm but not more than 5 cm in size.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",20.0,2071.0,98.0,True
771,TCGA-AN-A0XO.3423E8AE-CE73-4212-BB72-2AF92FD0BC2D,1,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 1 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,BRCA,2,True,"The report specifies a T Stage of 2, which indicates that the tumor is more than 2 cm but not more than 5 cm in size. This is consistent with the definition of a T2 tumor according to the rules provided.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",19.0,1855.0,94.0,True
1235,TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20,1,"SPECIMENS: A. SENTINEL NODE 1 RIGHT AXILLA. B. WLE RIGHT BREAST NEEDLE LOCALIZATION. SPECIMEN(S): A. SENTINEL NODE 1 RIGHT AXILLA. B. WLE RIGHT BREAST NEEDLE LOCALIZATION. GROSS DESCRIPTION: A. SENTINEL NODE 1 RIGHT AXILLA. Received fresh is a tan pink lymph node 1.8 x 1.1 x 0.5cm. The specimen is serially sectioned and three. touch preps are taken. Toto A1. B. WLE RIGHT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and ""WLE right breast needle localization"" is an. oriented 98g, 8 x 4.5 x 4cm needle localized lumpectomy with radiograph. Ink code: anterior-yellow,. posterior-black, superior-blue, inferior-orange, medial-green, lateral-red. Specimen is serially sectioned. from superior to inferior into 11 slices revealing a tan white firm stellate mass 2.3 x 1.8 x 1.7cm, 0.4cm. from the closest medial margin and 0.5cm from the anterior margin in slices 8-10. A portion of the. specimen is submitted for tissue procurement. Representatively submitted: B1: superior margin slice 1. B2: slice 2. B3-B4: slice 3. B5-B7: slice 4. B8-B10: slice 5. B11-812: slice 6. B13-B16: slice 7. B17-B20: slice 8 with mass in B17. B21: mass slice 9. B22: superior margin slice 9. B23: anterior margin slice 9. B24: anterior margin slice 9. B25: inferior margin slice 9. B26: deep margin slice 9. B27: mass slice 10. B28-B29: slice 10. B30: perpendicular sections of inferior margin slice 11. DIAGNOSIS: A. SENTINEL NODE 1, RIGHT AXILLA: - ONE REACTIVE LYMPH NODE (1), NO METASTATIC CARCINOMA IS SEEN. B. WIDE LOCAL EXCISION, RIGHT BREAST, NEEDLE LOCALIZATION: - INVASIVE DUCTAL CARCINOMA, SEE SYNOPTIC REPORT. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.3cm. Additional dimensions: 1.8cm x 1.7cm. Margins: Negative. Distance from closest margin: Less than 0.2cm. anterior. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: Indeterminate. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Lymph node status: Negative 0/1. Micrometastases: Non-neoplastic areas: fibrocystic disease. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 2%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Low. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT2pNO pT 2 N. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY: female with right breast mass, biopsy shows ? ductal carcinoma. PRE-OPERATIVE DIAGNOSIS: Right breast carcinoma. INTRAOPERATIVE CONSULTATION: TPA- SLN #1 right axilla: Negative for tumor cells. Diagnosis called to Dr. at. Dr. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 10. CLINICAL EXPERIENCE: Patients with a recurrence score of: 10 in the clinical validation study. had an average rate of Distant Recurrence at 10 years of 7%. ER Score: 11.1 Positive. PR Score: 10 Positive. Her2 Score: 8.9 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive 11.5 Equivocal = 10.7 - 11.4. >=. See separate. report for further information. Final Review:., Pathologist. Final:., Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.",BRCA,0,True,"The report states that the 'Tumor size: 2.3cm.' This meets the criteria for a T2 tumor, which is 'T2 tumors are more than 2 cm but not more than 5 cm in size.'","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",19.0,1855.0,100.0,True
1333,TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717,0,"F. Pathologic Interpretation: A. Sentinel node #1 CT. -Metastatic carcinoma in one lymph node. Please see comment. Comment: The tumor is seen on deeper section. Tumor is not identified in frozen section slide. Immunostain for keratin Is used in the interpretation. B. Sentinel node#2. -No malignancy seen In one lymph node (0/1). -Imunostain for keratin is negative. C. Right breast: -Invasive tubulolobular carcinoma, low nuclear grade, Nottingham histologic score grade I. Resection margins are free of tumor. -Microcalcifications are present. Dr. concurs. Please see Tumor Summary. TUMOR SUMMARY: Specimen Type: Mastectomy. Lymph Node Sampling: Sentinel lymph node(s) only. Laterality: Right. Tumor Site: Upper inner quadrant. Size of invasive component: Greatest dimention: 1 cm. Additional dimensions: 1 x 0.6 cm. Histologic Type: Invasive tubulolobular. Histologic Grade: Nottingham Histologic Score: Tubule Formation: Moderate (score=2). Nuclear Pleomorphism: Small (score=1). Mitotic count: Less than 10 mitoses per 10 HPF (score =1). Total Nottingham Score: Grade I. Pathologic Staging: Primary Tumor: pT1b. Regional lymph nodes: pN1a. Distant Metastasis: pMX. Margins: Margins uninvolved by invasive carcinoma. Distance from closest margin: 4 mm. Specify margin: Deep (posterior). Venous/lymphatic: Absent. Comments: Tumor cells are positive for ER and PR and negative for Her2 and by immunohistochemistry. NOTE: Some immunohistochemical antibodies are analyte specific reagente (ASRs) validated by our laboratory (Her 2. Pervo, H. pylori, H8core). Thase ASRs are clinically useful indicators that. do. not require FDA approval. These clones are used: IDS-ER, POR 636-PR, A485-HER2. H-11=EGFR, CCH2/DOG9=CMV, F30.4 THAR and HPV by ISH. All immunohistochemical stains are used. with formalin or molecular fixed, paraffn embedded tiesue. Detection is by LSAB. The reaults are read by a pathologiet as positive or negative. SURGICAL PATHOL Report. As the attending patthologist, / attest that I: (i) Examined the relevent. preparation(s) for the specimen(s); and ("") Rendered the diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. C. The tumor cells are positive for E-Cadherin by immunohistochemistry. This immunophenotype is most consistent with an infiltrating ductal carcinoma. Intraoperative Consultation. AFS: No malignancy seen in one lymph node examined. BFS: No malignancy seen in one lymph node examined. Clinical History: Patient is a -year-old female with right breast cancer. Pre Operative Diagnosis: Not Provided. Specimen(s) Received: A: sentinel node #1 CT (. B: sentinel node#. C: right breast ( 1 suture superior, 2 sutures lateral ). Gross Description: A. Received fresh and labeled ""sentinel node #1 CT. )"" is a fragment of adipose tissue measuring 2.0 x 1.0 x 0.5 cm. The lymph node is bisected and submitted in toto for frozen section. B. Received fresh and labeled ""sentinel node#. is a fragment of adipose tissue measuring 0.6 x 0,5 x 0.5 cm. The. lymph node is bisected and submitted in toto for frozen section. C. Received in formalin and labeled ""right breast (1 suture superior, 2 sutures lateral)"" is oriented with one suture superior. and two sutures lateral. The specimen weighs 127.0 grams and measures 16.0 x 11.0 x 0.9 cm. The specimen consists. of a nipple and areola, which measures 3.3 x 2.5 cm. There is no retraction or scar. The specimen is inked as follows: superior, blue; inferior, green; medial, red; lateral, orange; posterior (tip), black; anterior, yellow. Cut section revealed a. scar-like, firm lesion is identified in the upper inner quadrant, which measures 1.0 x 1.0 x 0.6 cm. It is located 0.4 cm from. the deep margin, 2.0 cm from the superior margin, 3.0 cm from the medial margin, and 6.2 cm from the inferior margin. The stroma to fat ratio is 70:30. No other masses or lesions are identified. Sections are submitted as follows: 1-4. Mass in toto. 5. Upper inner quadrant. SURGICAL PATHOL Report. 6. Lower inner quadrant. 7. Upper outer quadrant. 8. Lower outer quadrant. 9. Nipple. ICD-9(s): 196.3 174.2.",BRCA,1,True,"The report states that the size of the invasive component of the tumor is 1 cm, which falls under the category of T1 tumors (T1 tumors are 2 cm or less in size). Therefore, the T stage for this patient is T1.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",T1,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",19.0,1855.0,100.0,True
1329,TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F,1,"Gross Description: There is a quadrant of the breast with tumor up to 3.5 x 3 cm in size. Lymph nodes. are soft hyperemic. Microscopic Description: Mucinous adenocarcinoma of the breast, G-2. Ten examined lymph nodes. demonstrated sinus histiocytosis. Diagnosis Details: Tumor Features: Indeterminate, Tumor Extent: T2 tumor size more than 2cm not. more than 5 cm, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: BREAST TISSUE CHECKLIST. Specimen type: Partial mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3 x 0 x 3.5 cm. Grossly evident lesion: Yes. Histologic type: Adenocarcinoma, mucinous type. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Axillary 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right.",BRCA,0,True,"The report states that the tumor size is 3 x 0 x 3.5 cm, which falls in the T2 category of being more than 2 cm but not more than 5 cm in size. The presence of direct extension to the chest wall or skin is not mentioned, so the T stage is determined solely by the size of the tumor.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",T2,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
The absence of venous/lymphatic (large/small vessel) invasion indicates an V/L0 stage.",18.0,1738.0,97.0,True
894,TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3,2,"Final Diagnosis. Breast, right, wide local excision: Infiltrating lobular carcinoma, Nottingham grade II (of. III)[tubules 3/3, nuclei 2/3, mitoses 1/3; Nottingham score 6/9], forming a 5.2 x 3.0 x 2.6 cm. mass. Lobular carcinoma in situ is present and represents less than 5% of the overall tumor. volume. Angiolymphatic invasion is present. The non-neoplastic breast parenchyma show. nonproliferative fibrocystic changes. Calcifications present in benign ducts and acini. Biopsy. site changes present. The inferior and medial margins are positive for invasive carcinoma. Breast, right, total mastectomy: Infiltrating lobular carcinoma, Nottingham grade II (of III),. involving the medial aspect of the biopsy cavity. Two additional nodules of Nottingham grade II. (of III) invasive lobular carcinoma are identified in the lower outer quadrant (0.7 x 0.6 x 0.5 cm,. located 1.4 cm from the deep margin; and 0.5 x 0.4 x 0.4 cm, located 1.2 cm from the deep. margin). Lobular carcinoma in situ is present and represents less than 5% of the overall tumor. volume. Angiolymphatic invasion is present. The non-neoplastic breast parenchyma shows. proliferative fibrocystic changes. Biopsy site changes present. The tumor does not involve the. nipple, overlying skin, or underlying chest wall. All surgical resection margins, including the. deep margin, are negative for tumor (residual tumor in the biopsy cavity is located 2.2 cm from. the deep margin). Lymph nodes, right axillary, dissection: Multiple (5 of 18) right axillary lymph nodes are. positive for metastatic carcinoma [AJCC pN2]. The largest is represented by a matted mass of. lymph nodes and measures 4.2 x 2.6 x 2.4 cm. Extranodal extension is present. Comment: Final (mastectomy) surgical margins are widely free of involvement.",BRCA,2,True,"The T stage is primarily determined by the size of the tumor. In this report, the largest tumor size measures 5.2 x 3.0 x 2.6 cm, which is larger than 5 cm in the greatest dimension. Therefore, the T stage is T3.","T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.",T3,"T stage is determined by the size of the tumor.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor size is the primary factor in determining T stage, unless there is direct extension to the chest wall or skin.
Tumor grade is a measure of how abnormal the cancer cells and tissue look under a microscope and how quickly the cancer is likely to grow and spread. It is ranked from 1 to 3, with grade 3 being the most aggressive.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
The T category is based on the size of the tumor, unless there is direct extension to the chest wall or skin, in which case T4 is assigned.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.",18.0,1570.0,87.0,True
852,TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547,1,"Final diagnosis. Breast, left, simple mastectomy: Medullary carcinoma forming a 4.5 x 2.0 x 2.0 cm well. circumscribed mass (AJCC p T2) in the upper outer quadrant associated with prior biopsy site. The surgical margins are widely negative. Seen with Dr. Lymph nodes, left axillary sentinel, excision: Multiple (5) left axillary sentinel lymph nodes are. negative for tumor. Blue dye is not identified in any of the five left axillary sentinel lymph nodes. (AJCC pN0(i-)). Immunohistochemical cytokeratin stain was performed on the paraffin. embedded sentinel lymph node tissue and confirms the H&E impression.",BRCA,0,True,"The T stage is T2, as the tumor measures 4.5 x 2.0 x 2.0 cm, which is more than 2 cm but not more than 5 cm in size (rule: T1 tumors are 2 cm or less in size, T2 tumors are more than 2 cm but not more than 5 cm in size). The N stage is N0 as there is no lymph node involvement (rule: No lymph node involvement indicates an N0 stage). The M stage is M0 as there is no distant metastasis (rule: The absence of distant metastasis indicates an M0 stage). The tumor grade is not explicitly mentioned in the report, but it is still important diagnostic information (rule: Tumor grade is not used to determine T stage, but it is still important diagnostic information). Therefore, the pathologic stage is II (rule: Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis).","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.",II,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.",15.0,1157.0,80.0,True
995,TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B,1,"FINAL DIAGNOSIS: RART SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY -. 1: CARCINOMA INVOLVING ONE LYMPH NODE (1/1). A. METASTATIC METASTATIC FOCUS MEASURES 3.0 CM IN GREATEST DIAMETER 0.1 (ENTIRE CM. LYMPH NODE). B. c. EXTRACAPSULAR EXTENSION IS IDENTIFIED MEASURING 0.2 X. PART 2: BREAST, LEFT, SIMPLE MASTECTOMY -. A. DUCTAL EPITHELIAL HYPERPLASIA. B. PREDOMINANTLY ADIPOSE BREAST PARENCHYMA. c. SKIN AND NIPPLE HISTOLOGICALLY UNREMARKABLE. PART 3: A. BREAST. INVASIVE RIGHT, DUCTAL MODIFIED CARCINOMA RADICAL 3.0 MASTECTOMY 3/3, CM NUCLEAR (GROSS) NOTTINGHAM PLEOMORPHISM - GRADE 2/3, MITOTIC 3 (COMBINED ACTIVITY NOTTINGHAM 3/3) WITH. TUBULE. LYMPHOPLASMACYTIC SCORE 8/9: INFILTRATE AND NECROSIS. B. DEFINITIVE LYMPHOVASCULAR. C. DUCTAL CARCINOMA IN SITU IS NOTIBENTIFIED. D. RESECTION MARGINS FREE. E. DUCTAL EPITHELIAL HYPERPLASIAL. F. G. SKIN TWENTY-TWO AND NIPPLE, LYMPH HISTOLOGICALLY NODES, NEGATIVE UNREMARKABLE FOR METASTATIC CARCINOMA (0/22). H. PATHOLOGIC STAGE (see comment): I. RECEPTOR STATUS (see comment). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 3.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 8. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 23. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 30.0 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): T STAGE, PATHOLOGIC: p12. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.",BRCA,1,True,"The report states that the maximum dimension of the invasive component of the tumor is 3.0 cm. According to the rules provided, T2 tumors are more than 2 cm but not more than 5 cm in size. Therefore, the tumor in this report falls into the T2 category.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor grade is not used to determine T stage.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor grade is not used to determine T stage.",16.0,1203.0,98.0,True
1373,TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943,1,"x. Pathologic Interpretation: A. LEFT BREAST SENTINEL NODE 1. One lymph node, negative for carcinoma (0/1). Immunohistochemistry for keratin is pending. B. LEFT BREAST SENTINEL NODE 2. One lymph node, negative for carcinoma (0/1). Immunohistochemistry for keratin is pending. C. LEFT BREAST LUMPECTOMY: INVASIVE LOBULAR CARCINOMA, moderately differentiated, Nottingham grade 2 (3+2+1=6), 2.1 cm. in. greatest dimension. Immunohistochemistry performed on previous core needle biopsy demonstrated the following staining. pattern in the lesional cells: ER: POSITIVE (> 50%). PR: POSITIVE (10-50%). HER2: NEGATIVE (0). E-Cadherin: NEGATIVE (0). Resection margins are negative for carcinoma. Prior biopsy site changes present. Atypical ductal hyperplasia. See Surgical Pathology Cancer Case Summary. Surgical Pathology Cancer Case Summary. Procedure. Excision without wire-guided localization. Lymph Node Sampling. Sentinel lymph node(s). Specimen Laterality. Left. Tumor Site: Invasive Carcinoma. Position: 1 o'clock. Histologic Type of Invasive Carcinoma. Invasive lobular carcinoma. Tumor Size: Size of Largest Invasive Carcinoma. Greatest dimension of largest focus of invasion >1 mm: 21 mm. Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation. Score 3: <10% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism. Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate. variability in both size and shape. Mitotic Rate. Score 1 (<3 mitoses per mm). Overall Grade. Grade 2: scores of 6 or 7. Tumor Focality (required only if more than 1 focus of invasive carcinoma is present). Single focus of invasive carcinoma. Ductal Carcinoma In Situ (DCIS) (select all that apply). No DCIS is present. Lobular Carcinoma In Situ (LCIS). Not identified. Margins. Invasive Carcinoma. Margins uninvolved by invasive carcinoma. Distance from closest margin: 2.5 mm. Specify margin: Anterior. Lymph Nodes (required only if lymph nodes are present in the specimen). Number of sentinel lymph nodes examined: 2. Total number of lymph nodes examined (sentinel and nonsentinel): 2. Number of lymph nodes with macrometastases (>2 mm): 0. Number of lymph nodes with micrometastases (>0.2 mm to 2 mm and/or >200 cells): 0. Method of Evaluation of Sentinel Lymph Nodes (select all that apply). Hematoxylin and eosin (H&E), 1 level. H&E, multiple levels. Immunohistochemistry to follow. Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy. In the Breast. No known presurgical therapy. In the Lymph Nodes. No known presurgical therapy. Lymph-Vascular Invasion. Not identified. Dermal Lymph-Vascular Invasion. No skin present. Pathologic Staging (based on information available to the pathologist) (pTNM). Primary Tumor (Invasive Carcinoma) (pT). pT2: Tumor >20 mm but <50 mm in greatest dimension. Regional Lymph Nodes (pN). Modifier (required only if applicable). (sn): Only sentinel node(s) evaluated. pNO: No regional lymph node metastasis identified histologically. Distant Metastasis (pM). Not applicable. Ancillary Studies. (required only if available at time of report completion) (select all that apply). Performed on another specimen. Specify specimen (accession number): --. Estrogen Receptor (ER). Results and interpretation: Positive Immunoreactive tumor cells present (>50%). Progesterone Receptor (PgR). Results and interpretation: Positive Immunoreactive tumor cells present (10-50%). HER2. Immunoperoxidase Studies. Negative (Score 0). Microcalcifications (select all that apply). Present in invasive carcinoma. AJCC Classification (7th edition): pT2, (sn)pNo, pMn/a. Final AJCC classification will be issued after the keratin immunostain. Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. A. Immunohistochemistry for keratin is negative. B. Immunohistochemistry for keratin is negative. Final AJCC pT2 sn NO (i-) Mn/a. Intraoperative Consultation. A. Sentinel node 1,. FS: No malignancy seen. However, final diagnosis pending Immunohistochemical. stains. B. Sentinel node 2,. FS: No malignancy seen. However, final diagnosis pending Immunohistochemical. stains. Clinical History: Lobular carcinoma, ER+, RR+, HER (-). Operation Performed. Left lumpectomy with sentinel node biopsy and possible axillary dissection. Pre Operative Diagnosis: None Provided. Specimen(s) Received/Processing Information: Codes: A: LEFT BREAST SENTINEL NODE 1. Frozen section x 1, FS Perm x 1, Touch. Prep Histology x 1, Cytokeratin Cocktail (KER) x 1. A: B: B: LEFT BREAST SENTINEL NODE 2. Frozen section x 1, FS Perm x 1, Touch. Prep Histology x 1, Cytokeratin Cocktail (KER) x 1. C: LEFT BREAST LUMPECTOMY 1 SUPERIOR 2 LATERAL 3 DEEP H&E, Initial x 1,. H&E, Initial x 1, H&E, Initial x 1, H&E, Initial X 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x. 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial. x 1. Gross Description: A. Received fresh labeled ""Sentinel lymph node count 1 containing 1.3 x 1.0 x 1.0 cm pale yellow soft. lymph node. Bisected and submitted in toto in one cassette for frozen section. B. Received fresh labeled ""Sentinel node 2 count containing 1.3 x 1.0 x 1.0 cm pale yellow, soft lymph. node. It is. bisected and submitted in toto in one cassette for frozen section. C. Received in formalin labeled ""Left breast lumpectomy, 1 superior, 2 lateral 3 deep"" is a lumpectomy. specimen of the breast weighing 180 grams. It is oriented with sutures by the surgeon. It measures 7.5 cm. in superior to inferior, 7.0 cm medial to lateral surface, 3.5 cm anterior to the posterior surface. The. specimen is inked as follows: Blue superior, green inferior, red medial, orange lateral, black posterior,. yellow anterior. Upon sectioning, there is a 2.0 x 1.6 x 1.2 cm tan-white, firm gritty mass with stellate. borders. It is approximately round to oval in shape. The mass contains a metallic clip measuring 3 mm. The mass is closest to the anterior margin which is 0.7 cm away. It is 3.0 cm away from the posterior. margin, 2.0 cm from the superior margin, 2.6 cm from the inferior margin, 4.0 cm from the medial margin and. 2.5 cm from the lateral margin. The rest of the breast parenchyma is yellow and soft with fat to stroma ratio. 90's to 30. A piece of tumor measuring approximately1.0 x 1.0 cm is submitted to the tissue bank. Sections. are submitted as follows: Cassettes #1-6. Mass in toto (cassette 1 mass with clip). Cassette #7. Anterior margin. Cassette #8. Posterior margin. Cassette #9. Medial margin. Cassette #10. Lateral margin. Cassette #11. Superior margin. Cassette #12. Inferior margin. Cassette #13. Stroma.",BRCA,0,True,"The tumor size is 2.1 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. The report specifies that the size of the largest invasive carcinoma is 21 mm, which is equivalent to 2.1 cm.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor grade is not used to determine T stage.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor grade is not used to determine T stage.",16.0,1203.0,100.0,True
755,TCGA-AN-A0FD.F124155D-6131-47F6-8320-46A41AB125D3,1,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Right breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,BRCA,0,True,"The report indicates that the patient is female and was diagnosed with infiltrative ductal carcinoma in the right breast. The T stage is 2, as the tumor is more than 2 cm but not more than 5 cm in size. The N stage is 0, as there is no lymph node involvement. The M stage is also 0, as there is no distant metastasis. The tumor grade is 2, which is not used to determine T stage but is still important diagnostic information. Based on these findings, the patient's pathologic stage is II.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.",II,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.",15.0,1157.0,98.0,True
962,TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72,0,"FINAL DIAGNOSIS: PART 1: BREAST, EET-SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULE FORMATION - 3, NUCLEAR GRADE - 2,. MITOTIC RATE - 2; TOTAL SCORE 7/9). B. INVASIVE CARCINOMA MEASURES 2.0 CM IN GREATEST DIMENSION. C. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2-3, CRIBRIFORM, SOLID AND MICROPAPILLARY. TYPE, WITH COMEDONECROSIS. D. DCIS IS PRESENT ADMIXED AND OUTSIDE OF THE INVASIVE COMPONENT IN 8 OUT OF 19 SLIDES AND. COMPRISES APPROXIMATELY 50% OF THE TOTAL TUMOR VOLUME. E. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. F. MARGINS OF RESECTION ARE NEGATIVE FOR INVASIVE COMPONENT, WITH ALL THE MARGINS BEING. MORE THAN 1 CM AWAY. G. MARGINS OF RESECTION ARE NEGATIVE FOR DCIS; HOWEVER, DCIS IS LESS THAN 1 MM FROM. ANTERIOR MARGIN AND 1.5 MM FROM POSTERIOR MARGIN OF RESECTION. H. FIBROCYSTIC CHANGES WITH FIBROADENOMATOID NODULE. I. BIOPSY SITE CHANGES. J. INVASIVE TUMOR CELLS ARE WEAKLY POSITIVE FOR ESTROGEN RECEPTOR, NEGATIVE FOR. PROGESTERONE RECEPTOR, AND POSITIVE FOR HER-1/NEU (SCORE 3+), AS PER PREVIOUS. PART 2: LEFT AXILLARY LYMPH NODE, DISSECTION -. A. TWO OUT OF TWELVE LYMPH NODES, POSITIVE FOR METASTATIC CARCINOMA (2/12). B. THE SIZE OF THE LARGEST METASTASIS IS OVER 2 CM (see comment). C. NO EXTRACAPSULAR EXTENSION IS SEEN. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: TUMOR TYPE, IN SITU: Cribriform. Solid. Micropapillary. DCIS admixed and outside of invasive carcinoma component. Percent of tumor occupied by in situ component: 50 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 1 mm. LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 12. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 20 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: negative. HER2/NEU: 3+.",BRCA,1,True,"The report states that the size of the largest dimension of the invasive component is 2.0 cm. According to the rules provided, T1 tumors are 2 cm or less in size. Since this tumor is 2.0 cm, it falls under the T1 category. Furthermore, there is no direct extension to the chest wall or skin, so it is not a T2, T3, or T4 tumor. The 'c' subcategory is used for tumors that are 1.1 to 2.0 cm in size, so the T stage for this report is T1c.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.",T1c,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.",17.0,1421.0,90.0,True
1236,TCGA-E2-A1IE.95443906-A63B-4E07-8C4A-ED0A918B88F8,1,"SPECIMENS: A. SENTINEL LYMPH NODE RIGHT AXILLA #1. B. SLN RIGHT AXILLA #2. C. SLN RIGHT AXILLA #3. D. EXC. RIGHT BREAST CA. SPECIMEN(S): A. SENTINEL LYMPH NODE RIGHT AXILLA #1. B. SLN RIGHT AXILLA #2. C. SLN RIGHT AXILLA #3. D. EXC. RIGHT BREAST CA. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE RIGHT AXILLA #1. Received fresh is a tan pink lymph node 0.5 x 0.5 x 0.3cm. The specimen is bisected and 2 touch preps. are taken. Toto A1. B. SLN RIGHT AXILLA #2. Received fresh is a tan pink lymph node 1.5 x 0.5 x 0.5cm. The specimen is bisected and 2 touch preps. are taken. Toto B1. C. SLN RIGHT AXILLA. Received fresh is are 3 tan pink lymph nodes ranging from 0.5cm to 1.2cm in greatest dimensions. Each specimen is bisected and touch preps are taken. Toto C1. D. EXCISION RIGHT BREAST: Single Stitch-Anterior/Double Stitch-Lateral/Triple Stitch-Superior. Received fresh is a 59g oriented tan pink WLE breast specimen, 7.0cm from superior to inferior, 6.0cm. from anterior to posterior and 5.5cm from medial to lateral. The specimen is inked as follows: Red-. Superior, Orange-inferior, Blue-Anterior, Black-Posterior, Green-Medial, Yellow-Lateral. The specimen. is serially sectioned from lateral to medial into 7 slices; slice 1 being most lateral, slice 7 being most. medial. The cut surface reveal a gray white firm well circumscribed mass 2.1 x 1.7 x 1.5cm, 0.6cm from. the closest superior margin, located in slices 3, 4 and 5. A surgical clip is identified in slice 3. The. mass is 0.9cm from the deep margin and greater than 10cm from the remaining margins. The. remaining cut surfaces reveal yellow lobulated adipose tissue interspersed with gray white fibrous. tissue. A portion of the specimen is submitted for tissue procurement. Representative sections are. submitted as follows: D1: lateral margin, perpendicular sections taken from superior to inferior, slice 1. D2: area adjacent to mass with deep margin, slice 2. D3: mass with anterior/superior margin, slice 3. D4: mass with superior/deep margin, clip identified, slice 3. D5: anterior/inferior margin, slice 3. D6: inferior/deep margin, slice 3. D7: mass with superior and anterior margin, slice 4. D8: anterior/inferior, slice 4. D9: mass with superior and deep margin, slice 4. D10: inferior/deep margin, slice 4. D11: superior/deep margin, slice 5. D12: anterior/superior margin, slice 5. D13: anterior margin, slice 5. D14: area next to mass with anterior and deep margin, slice 6. D15: anterior margin, slice 6. D16: deep margin, slice 6. D17: medial margin, perpendicular sections submitted from superior to inferior, slice 7. As per attached diagram. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). B. SENTINEL LYMPH NODE #2, RIGHT AXILLA, BIOPSY: - MICROMETASTATIC CARCINOMA (1.5 MM) IN ONE LYMPH NODE (1/1). (SEE NOTE). NOTE: The metastasis is subcapsular. No extranodal extension is seen; however, there is cautery. artifact at one edge of the metastasis limiting evaluation. The touch prep slides were reviewed and. show no evidence of metastasis. Dr. has reviewed specimen B. C. SENTINEL LYMPH NODE #3, RIGHT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). D. BREAST, RIGHT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED. (SBR GRADE 2) WITH FOCAL NECROSIS (SEE NOTE). - TUMOR MEASURES 2.1 X 1.7 X 1.5 CM. INVASIVE CARCINOMA IS 0.3 CM FROM POSTERIOR MARGIN. - LYMPHVASCULAR INVASION IS IDENTIFIED. DUCTAL CARCINOMA IN SITU (DCIS), SOLID AND CRIBRIFORM TYPES,. NUCLEAR GRADE 2-3, WITH FOCAL NECROSIS. - ATYPICAL DUCTAL HYPERPLASIA. NOTE: Microcalcifications are seen in vessels and non-neoplastic breast tissue. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.1cm. Additional dimensions: 1.7cm x 1.5cm. Tumor Site: 9:00. Margins: Negative. Distance from closest margin: 0.3cm. deep. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Present. Vascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Positive 1 / 3. Micrometastases: Non-neoplastic areas: columnar cell change. DCIS present. Margins uninvolved by DCIS :0.5 cm from the superior margin. DCIS Quantity: Estimate 20%. DCIS Type: Solid. Cribriform. DCIS Location: Both associated and separate from invasive tumor mass. Nuclear grade: Intermediate. Necrosis: Present. Location of CA++: Benign epithelium. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Pending by FISH. Pathological staging (pTN): pT 2N1. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: ER: Positive. Allred Score: 8. = Proportion Score 5 + Intensity Score 3. PR: Positive Allred Score: 6 = Proportion Score 3 + Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer S instructions. This. assay was not modified. interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 20%. Fish Ordered: Yes, on Date. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved Dako HercepTes (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The L. takes full responsibility for this test's performance. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. PRE-OPERTATIVE CONSULTATION: TPA/TPB/TPC: Negative for carcinoma. Diagnosis called to Dr. at. Dr. D. Gross Inspection Diagnosis: 2.1 cm tumor at 0.6cm from closest superior margin. Diagnosis called to. Dr. at. by Dr. ADDENDUM: PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. by Dr.. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used D9. Source of case: RPCI. Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.05. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapy is being considered. These tests were performed in the. Institute under the direction. of. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation:., Pathologist, l. Final Review:. Pathologist,. Final Review:. Pathologist. Microscopic/Diagnostic Dictation:., Pathologist,. Final Review:, Pathologist. Final:., Pathologist,. Addendum: Pathologist,. Addendum Final:. Pathologist,.",BRCA,1,True,"The tumor measures 2.1 x 1.7 x 1.5 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage. Angiolymphatic invasion and positive surgical margins are also not factors in determining T stage.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.",18.0,1482.0,98.0,True
1057,TCGA-BH-A18P.D24BB508-6E9A-4CF7-93C6-975E79F6E86D,0,"PAIIENI MISTOKY: The patient is. a -year-old female. Clinical history is not provided Site Code : breast, lower inner quadrant. PRE-OP DIAGNOSIS: Left breast cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Left total mastectomy. +$. ADDENDA: Addendum. Fluorescence in situ hybridization analysis was performed on block 1D using the DNA probe for Her-2/neu gene. The. ratio of Her-2/neu gene signals to chromosome 17 centromere signals was determined to be 2.05. Therefore, the. interpretation is: borderline amplification of the Her-2/neu gene. que. ves. My signature is attestation that I have personally reviewed the submitted materiali. Addendum. ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT. Using appropriate positive and negative controls, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method, and reported according to the consensus statement on adjuvant. therapy for breast cancer, of. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER positive. Percent cells staining as: (0 95%; 1+ 5%, 2+ 0%, 3+ 0%). PR negative. Percent cells staining as: (0 100%, 1+ 0%, 2+ 0%, 3+ 0%). HER-2/NEU DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE. THAN 10% OF THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE ISCORE 2+I. NOTE: Her-2/Neu FISH was ordered and will be subsequently reported. The Her-2/neu and estrogen/progesterone receptor assays were performed with FDA approved. methods. FIAL DIAGNOSIS: PART 1: LEFT BREAST, TOTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, 2.0 CM, NOTTINGHAM SCORE 7/9 (tubules 3, nuclei 2, mitosis 2),. LOCATED IN THE LOWER INNER QUADRANT AND EXTENDING TO THE LOWER OUTER QUADRANT. B. TUMOR COMES TO WITHIN 0,1 CM FROM THE INNER LOWER OF QUADRANT MARGIN. C. MICROCALCIFICATION ASSOCIATED WITH TUMOR. D. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 2, SOLID TYPE WITH COMEDO NECROSIS,. REPRESENTING 10-15% OF THE TUMOR VOLUME. E. MARGINS FREE OF TUMOR. F. REMAINING BREAST TISSUE WITH FIBROCYSTIC CHANGES, SCLEROSING ADENOSIS AND. MICROCALCIFICATION. G. SKIN AND NIPPLE NOT REMARKABLE. H. THREE LYMPH NODES NEGATIVE FOR TUMOR. PART 2: LEFT AXILLA, SENTINEL LYMPH NODE #1, EXCISIONAL BIOPSY. ONE LYMPH NODE NEGATIVE FOR TUMOR, CONFIRMED BY NEGATIVE AE1/AE3 IMMUNOSTAIN. PART 3: LEFT AXILLA, SENTINEL LYMPH NODE #2, EXCISIONAL BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR, CONFIRMED BY NEGATIVE AE1/AE3 IMMUNOSTAIN. COMMENT: Estrogen and Progesterone receptors and HER-2/Neu will be performed on block 1D and the result will follow in a. separate report.",BRCA,0,True,"The report states that the size of the infiltrating ductal carcinoma is 2.0 cm, which falls within the T1 category. T1 tumors are 2 cm or less in size. Therefore, the T stage for this patient's cancer is T1.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.",T1,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.",18.0,1482.0,100.0,True
1331,TCGA-E9-A6HE.649E6215-36F9-4BEB-9EE9-683E4FC75C42,2,"Gross Description: A. ""Right axilla palpable node."" A 2.2 X 1.5 X 0.6 cm portion of lymph node bearing. fat contains a 0.5 X 0.5 X 0.5 cm hard white nodule. Imprints are prepared, and a portion is selected for. frozen section examination. B. ""Right breast stitch marks axillary tail."" A he 14.9 X 13.5 X 4.0 cm right. breast with an overlying 8.0 X 4.0 cm keyhole-shaped skin. The areolar complex is unremarkable. There. is a 0.3 cm skin lesion (grossly consistent with seborrheic keratosis), 0.5 cm and located 0.6 cm medial to. the nipple. There is a stellate mass within the central breast 5.7 x 4.0 X 2.0 cm, located 2.0 cm from the. deep margin and occupies the upper and lower outer quadrants as well as the upper inner and outer. quadrants. There is a biopsy marker recognize in the lower outer quadrant (8 o'clock aspect), 3.7 cm. from the deep margin. A second biopsy marker is recognized and approximately 1 o'clock, 3.5 cm from. the deep margin. Superior to the main mass is a satellite nodule attached by fibrous strands, 0.7 X 0.5 x. 0.5 cm, located 2.0 cm from the deep margin and 1.8 cm superior to the main mass at approximately 12. o'clock. The remaining breast tissue is centrally dense. There are no intramammary lymph nodes. The. margin is a blue. C. ""Level 1 and 2 right axillary lymph nodes."" A 7.0 x 5.0 x 2.0 cm aggregate of adipose. tissue fragments containing 11 lymph nodes up to 1.5 cm. The lymph nodes all appear involved by. tumor with the largest metastasis measuring 1.4 cm. Extracapsular extension is noted. Microscopic Description: Biopsy type: Mastectomy. Tumor site: Central. Size: 5.7 cm. Specimen Margin: Free of invasive carcinoma by 20 mm (deep) Site R Breast NOS (509. Tumor grade (SBR/Nottingham):N/A. Tubule formation: N/A. Nuclear atypia: 2. Mitotic rate: 2 (focal). Lymphovascular invasion: Present (focal). In situ component: Lobular carcinoma in situ. Calcifications: Absent. Non-neoplastic breast: Atrophic with intramammary metastases. Estrogen (ER) and Progesterone (PR) Receptors (IMPX): ER strongly positive, PR strongly positive on. previous biopsyHer-2/Neu (H2N). Amplification: Negative on previous biopsy. Nipple involvement: Present. Skin involvement: No. Skeletal muscle: Not present. Lymph nodes: Axillary (specimens A and C): 12 metastases (12 nodes examined) The largest metastasis. is 14 mm; there is extensive extracapsular extension. PTNM Stage: pT3 N3. Diagnosis Details: Subcutis (right axilla): Metastatic invasive lobular carcinoma (presumable an effaced. lymph node) Breast (right): Invasive lobular carcinoma, pleomorphic type with intramammary and. axillary metastases. Comments: Multiple axillary lymph nodes exhibit effacement by invasive lobular carcinoma, with. extensive involvement of extranodal adipose tissue. Invasive lobular carcinoma extends to the. cauterized margin of axilla specimen. Formatted Path Reports: BREAST TISSUE CHECKLIST. Specimen type: Mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 5.7 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating lobular carcinoma. Histologic grade: Not specified. Tumor extent: Nipple. Lymph nodes: 12/12 positive for metastasis (Axillary 12/12). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right breast. Reviewer.",BRCA,3,True,"The tumor size is 5.7 cm, which falls under the 'T3' category of tumors that are more than 5 cm in size. This is determined by the rule 'T3 tumors are more than 5 cm in size.'","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.",T3,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.",16.0,1385.0,85.0,True
1132,TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42,0,"page 1 / 2. copy No. 2. Examination: Intraoperative examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breast. Expected time of examination: 20 minutes (from receipt of the material). Clinical diagnosis: Suspected cancer of the right breast. Lesion on the boundary of the upper quadrants. Examination performed or. Result of intraoperative examination: Carcinoma probabiliter invasivum. Final diagnosis after paraffin specimens are analysed. Compliance validated by: (. Macroscopic description: Surgical specimen sized 5 x 4 x 2 cm with a skin flap of 4 x 0.5 cm. Minimum side margin 0.2 cm. Result of intraoperative examination: Carcinoma papillare probabiliter invasivum. Foci DCIS typus cribrosus cum atypia gradus levioris ad mediocrum sine necrosis. Final diagnosis after immunohistochemical tests. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive cancerous cells ( Score = 0). Examination: Intraoperative examination. page 2 / 2. Gender: F. Histopathological diagnosis: Carcinoma papillare probabiliter invasivum NHG1 (2 + 2 +1/0 mitoses/ 10 HPF, visual area diameter: 0.55 m). Corresponds to invasive papillary carcinoma of the right breast. Solitary foci of DCIS (cribrate type with medium nuclear atypia, without necrosis). The immunohistochemical test showed the absence of a myoepithelial cell stratum around the foci of the. invasive lesion (p63-, SMA'). The cells show negative reaction withCK5/6. Cytokeratin 7 present in part of the. cells. Suplementary test. Expression of the Ki67 proliferation antigen showed in 5% of cellular nuclei (20% in hot spots).",BRCA,0,True,"The report mentions that the surgical specimen size is 5x4x2 cm. According to the rules provided, T2 tumors are more than 2 cm but not more than 5 cm in size. Therefore, the T stage for this patient's cancer is T2.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.",16.0,1385.0,100.0,True
751,TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7,1,Sex: Female Ethnicity (Race): (. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Radical mastectomy Grade: 2. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,BRCA,0,True,"The report indicates that the patient is female and was diagnosed with infiltrative ductal carcinoma in the left breast. The T stage is 2, as the tumor is more than 2 cm but not more than 5 cm in size. The N stage is 0, indicating no lymph node involvement. The M stage is also 0, meaning there are no distant metastases. The tumor grade is 2, which is not used to determine T stage but is still important diagnostic information. Based on the T, N, and M categories, the patient's pathologic stage is II.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.",II,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.",17.0,1498.0,96.0,True
969,TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F,1,"FINAL DIAGNOSIS: PART 1: SENTINEL LYMPH NODE NUMBER 1, LEFT, BIOPSY -. A. ONE OF THREE LYMPH NODES, POSITIVE FOR METASTATIC LOBULAR CARCINOMA (1/3). B. METASTATIC TUMOR MEASURES 1.4 CM IN LARGEST DIMENSION. C. NO DEFINITE EXTRACAPSULAR EXTENSION IDENTIFIED. PART 2: BREAST, LEFT, MODIFIED RADICAL MASTECTOMY -. A. MULTIFOCAL ND MULTICENTRIC INVASIVE LOBULAR CARCINOMA, NOTTINGHAM GRADE 2 (TUBULAR. FORMATION 3, NUCLEAR POLYMORPHISM 2, MITOTIC FIGURES 1, TOTAL SCORE 6/9). B. INVASIVE TUMOR MASS RANGING IN SIZE FROM 1.5 TO 2.7 CM; THE LARGEST TUMOR MASS MEASURING. 2.7 CM IN LARGEST DIMENSION (GROSS MEASUREMENT). C. INVASIVE LOBULAR CARCINOMA INVOLVES ALL FOUR QUADRANTS. D. LOBULAR CARCINOMA IN SITU, NUCLEAR GRADE 2, CONSTITUTING 25% OF TOTAL TUMOR MASS,. ADMIXED AND AWAY FROM THE INVASIVE COMPONENT. E. NO LYMPHOVASCULAR INVASION IDENTIFIED. F. DEEP RESECTION MARGIN IS POSITIVE FOR INVASIVE LOBULAR CARCINOMA IN LOWER INNER. QUADRANT (SLIDE 2F). G. FIVE OF TWENTY-ONE AXILLARY LYMPH NODES POSITIVE FOR METASTATIC LOBULAR CARCINOMA. (5/21). H. METASTATIC TUMOR MEASURES 0.8 CM IN LARGEST DIMENSION AND WITH FOCAL EXTRACAPSULAR. EXTENSION. I. NIPPLE SHOWING LOBULAR CARCINOMA IN SITU WITH DUCTAL EXTENSION, 5 MM TO THE SKIN. SURFACE (SLIDE 2A). J. BIOPSY SITE CHANGES. K. FIBROCYSTIC CHANGE WITH DUCTAL EPITHELIAL HYPERPLASIA. LATERALITY: Leit. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. Upper inner quadrant. Lower outer quadrant. Lower inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 2.7 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 7.9 cm. TUMOR TYPE (invasive component): Infiltrating lobular carcinoma. HISTOLOGIC TYPE: Classical. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Yes, focal. LYMPH NODES POSITIVE: 6. LYMPH NODES EXAMINED: 24. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 14 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONF RECEPTORS. positive.",BRCA,2,True,"The largest tumor mass measures 2.7 cm in largest dimension, which falls under the 'T2 tumors are more than 2 cm but not more than 5 cm in size' rule.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.",20.0,1799.0,91.0,True
1369,TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F,2,"F. Pathologic Interpretation: A. RIGHT BREAST TOTAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA, moderately differentiated, Nottingham grade 2 (3+2+2=7), 5.5 cm in. greatest dimension. Margins are negative for carcinoma, closest margin is posterior (3.5 cm). Negative for lymphovascular invasion. Lobular carcinoma in situ is present. Skin and nipple with no significant pathologic changes. See Surgical Pathology Cancer Case Summary. B. RIGHT BREAST AXILLA SENTINEL NODE #1: Negative for carcinoma in one lymph node examined (0/1). Keratin immunostains will follow. Surgical Pathology Cancer Case Summary: INVASIVE CARCINOMA OF THE BREAST: Specimen: Total breast (including nipple and skin). Procedure: Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph node(s). Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Size: Greatest dimension: 25 cm. Additional dimensions: 15.5 x 5.6 cm. Specimen Laterality: Right. Tumor Site: Invasive Carcinoma: Central. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 5.5 cm. Additional dimensions: 3.5 x 3.0 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: Skin: Invasive carcinoma does not invade into the dermis or epidermis. Nipple: DCIS does not involve the nipple epidermis. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma In Situ (DCIS): No DCIS is present. Histologic Type of Invasive Carcinoma: Invasive lobular carcinoma. Histologic Grade: Nottingham Histologic Score: Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 2. Mitotic Count: Score 2. Overall Grade: Grade 2. Margins: Uninvolved by invasive carcinoma. Distance from closest margin: 35 mm, all other margins >5 cm. Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy: In the breast: No known presurgical therapy. Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 1. Total number of lymph nodes examined (sentinel and nonsentinel): 1. Number of lymph nodes with macrometastases: 0. Number of lymph nodes with micrometastases: 0. Number of lymph nodes with isolated tumor cells: 0. Method of Evaluation of Sentinel Lymph Nodes: H&E, multiple levels. Pathologic Staging: Primary Tumor: pT3. Regional Lymph Nodes: pNO. Distant Metastasis: Not applicable. Ancillary Studies: Estrogen Receptor: Performed on another specimen (xxxx). Results: POSITIVE (>50%). Progesterone Receptor: Performed on another specimen (xxxx). Results: POSITIVE (>50%). HER2/neu: Immunoperoxidase Studies: Performed on another specimen. Results: Equivocal (Score 2+). Chromogenic In Situ Hybridization (CISH) for HER2/neu: Performed on another specimen (xxxx). Results: Not amplified (HER2 gene copy <4.0 or ratio <1.8). Comment(s): AJCC Classification (7th edition): pT3, NO, Mn/a. NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory. These ASRs are clinically useful indicators that do not require FDA approval. These clones are used: IDS=ER, PgR 636=PR, A485=HER2, H-11=EGFR. All immunohistochemical stains are used with formalin or molecular fixed, paraffin embedded tissue. Detection is by. Envision Method. The results are read by a pathologist as positive or negative. As the attending pathologist, I attest that I: (i) Examined the. relevant preparation(s) for the specimen(s); and (ii) Rendered the. diagnosis(es). X. Clinical History: cT3 NX MX infiltrating lobular carcinoma, low-grade, right breast. Please evaluate sentinel nodes on permanent with IHC. Axillary node dissection will be done today only if no sentinel. lymph nodes can be identified and removed. Operation Performed. Right total mastectomy, Sentinel node biopsy, Possible axillary node dissection. Pre Operative Diagnosis: Infiltrating lobular carcinoma >5 cm. Specimen(s) Received/Processing Information: Fee. Codes: A: RIGHT BREAST MASS (2 SUTURES MEDIAL, 1 SUTURE SUPERIOR) H&E, Initial x. A: IHC, IHC, IHC,. 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial. x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, E-CADHERIN x 1, Beta. IHC, IHC, IHC,. Catenin x 1, Vimentin x 1, Cytokerat. IHC. B: IHC, IHC. B: RIGHT BREAST SENTINEL NODE AXILLA # 1, COUNT 5356 H&E, Initial x 1, H&E,. Initial X 1, Cytokeratin Cocktail (KER) x 1, Cytokeratin Cocktail (KER) x 1. Gross Description: A. Received in formalin labeled ""Right breast mass"" is a 1050-gram mastectomy specimen (25.0 x 15.5 x 5.6. cm) with a tan-. white skin ellipse (25.4 x 10.0 cm) and nipple (1.8 x 1.6 x 0.4 cm) and two sutures indicating medial and one. suture. indicating superior. There are no visible lesions or scars present. The specimen was previously serially. sectioned with. black ink added on the posterior aspect. There is a hard tan-white, ill-defined centrally located (5.5 x 3.5 x. 3.0 cm),. located 3.5 cm from the deep margin and more than 5.0 cm from the remaining margins. The remaining. breast stroma is. markedly fibrotic with cystic areas filled with a clear fluid measuring up to 0.6 cm in greatest diameter. The. stroma to. adipose ratio is 50:50. Representative sections are submitted in eleven cassettes as follows: Cassette #1. Deep margin. Cassette #2. Upper outer. Cassette #3. Upper inner. Cassette #4. Lower outer. Cassette #5. Lower inner. Cassettes #6-10. Composite section of mass. Cassette #11. Nipple. B. Received in formalin labeled ""Right breast sentinel node, axilla #1 count 5356"" is a segment of adipose. tissue (4.0 x 3.7 x. 1.3 cm). Sectioning reveals a possible lymph node measuring 1.6 x 1.0 x 0.5 cm. The lymph node is. trisected and. submitted in toto in two cassettes.",BRCA,1,True,"The tumor size is 5.5 cm, which falls under the 'T3' category of 'Tumors are more than 5 cm in size.' This is based on the measurement of the largest invasive carcinoma: 'Greatest dimension of largest focus of invasion: 5.5 cm' as mentioned in the report.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors",T3,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors",21.0,1881.0,98.0,True
795,TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD,1,"Clinical Diagnosis & History: y/o female with right invasive lobular carcinoma. Specimens Submitted: 1: SP: Right breast. DIAGNOSIS: 1). BREAST, RIGHT; MASTECTOMY: - INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE, MEASURING 0.4 CM IN. LARGEST DIMENSION MICROSCOPICALLY. FOCAL DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, WITH SQUAMOID. MORPHOLOGY, SOLID TYPE WITH INTERMEDIATE NUCLEAR GRADE AND MINIMAL NECROSIS,. IS PRESENT ADJACENT TO BIOPSY CAVITY. LOBULAR CARCINOMA IN SITU (LCIS) IS ALSO IDENTIFIED, CLASSICAL TYPE (TYPE. A). - THE NIPPLE BASE IS INVOLVED BY INVASIVE CARCINOMA. - CALCIFICATIONS ARE PRESENT IN BENIGN BREAST PARENCHYMA. - NO VASCULAR INVASION IS NOTED. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY INVASIVE CARCINOMA IS. IDENTIFIED. - THE SKIN SHOWS AN ULCER. THE ATTACHED SKELETAL MUSCLE IS UNINVOLVED BY CARCINOMA. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES. - FOUR BENIGN INTRAMAMMARY LYMPH NODES (0/4). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: MD. M.D. 1) The specimen is received fresh labeled, ""right breast"" and consists of. a. breast without attached axillary tail. The breast measures 30.5 x 17.5. x. 7.5 cm with overlying skin ellipse measuring 30.5 x 8 cm. The nipple. measures 1.2 x 1.2 x 1 cm and areola measures 5 x 5 cm. Two centimeters. above the nipple (upper inner quadrant), there is a well healed scar,. measuring 8 cm. A skin defect and ulceration is identified in the axillary. area, measuring 1.0 x 0.5 cm. The skin is slightly red, suggestive of a. possible surgical draining site. At the posterior aspect of the specimen,. there is a fibrotic area, measuring 6.5 x 3.5 cm. A suture demarcates the. axilla. The posterior surface of the breast is inked blue. Serial. sectioning of the specimen reveals a biopsy cavity under the scar, measuring. 4. x 4 cm. The biopsy cavity is about 0.3 cm from the posterior inked margin. The cavity is lined by hemorrhagic fibrotic tissue with bright yellow, fat. necrosis. No gross nodule is identified. Under the skin defect, there is a. hemorrhagic area, measuring 1 x 0.4 cm. This area is very close to the. posterior fibrosis. Sectioning the rest of the breast reveals a fatty cut. surface. A few intramammary lymph nodes are identified. Representative. sections are submitted. Summary of sections: N - nipple. NB - nipple base. S - skin with scar. SD -skin defect. F -posterior fibrotic area. D - deep margin. Bx -biopsy cavity. L -lesion under the skin defect. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrantLN - intramammary lymph nodes, entirely submitted. Summary of Sections: Part 1: SP: Right breast. Block. Sect. Site. PCs. 12. BX. 12. 1. D. 1. 1. F. 1. 2. L. 2. 2. LIQ. 2. 3. LN. 3. 2. LOQ. 2. 1. N. 1. 1. NB. 1. 1. S. 1. SD. 1. 2. UIQ. 2. 2. UOQ. 2.",BRCA,3,True,"The report states that the invasive lobular carcinoma measures 0.4 cm in largest dimension, which falls under T1 tumors being 2 cm or less in size. Specifically, it is less than or equal to 0.5 cm, which corresponds to T1a.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.",T1,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.",22.0,1921.0,99.0,True
601,TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219,1,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel lymph node, resection: No evidence of metastasis in one lymph node (0/1) . B. Left breast, simple mastectomy: Infiltrating ductal carcinoma, grade 3, 3.2 cm in greatest dimension. Surgical margins negative but close, less than 2 mm. C. Left axillary contents, resection: No evidence of metastasis in 7 lymph nodes (0/7). Microscopic Description: Microscopic examination performed. A. Sections of the sentinel lymph node demonstrate no evidence of. metastatic disease. The node is examined by multiple sectioning with. hematoxylin and eosin and by immunohistochemistry for pankeratin. Invasive Carcinoma: present. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Overall grade: 3. Architectural score: 2. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 3.2 cm,. pT2. Specimen margins: Negative but close, less than 2 mm over a. distance of 5 mm. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Proliferative fibrocystic. changes with intraductal papillomatosis. Comments: None. Prognostic markers: Previously performed. C Sections of the left axillary contents demonstrate no evidence of. metastasis in 7 lymph nodes. Specimen. A. Left sentinel node-axillary. B. Left breast-tumor at 7 o'clock. C. Axillary contents. Clinical Information. Carcinoma left breast, core biopsy positive here. Intraoperative Consultation. AFS left axillary sentinel lymph node, excision: No evidence of metastasis in one lymph node. Gross Description. A. Container a is labeled with the patient's name, medical record. number and ""sentinel lymph node"". The specimen consists of a single. piece of fatty tissue which when bisected holds a single lymph node. measuring 1.0 x 0.0 0. cm. Bisected and submitted in block AFS. B. Received fresh labeled ""left breast"" is a 25.5 cm (medial to. lateral) by 17.0 cm (superior to inferior) by 4.5 cm (anterior to. posterior) soft, lobulated tan-white-gold portion of fibroadipose. tissue oriented per placement of designated tumor as stated previously. A 19.3 x 8.5 cm wrinkled tan skin ellipse with an eccentric, 1.0 x 1.0. x 0.5 cm nipple is present along the anterior aspect. A palpable mass. is evident at 7 o'clock, corresponding to the lower inner quadrant. The antero-inferior surface of the specimen in the vicinity of the mass. is inked blue. The intact deep margin is inked black and the specimen. is sectioned. There is a well-circumscribed, 3.2 cm (medial to. lateral) by 2.4 cm (anterior to posterior) by 2.0 cm (superior to. inferior) rubbery tan-white tumor mass within the lower outer quadrant. On sectioning the tumor appears to extend to within 0.2 cm of the. inked anteroinferior surface and 1.5 cm of the inked deep margin. A. portion of tumor and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consist predominantly of soft, lobulated tan. gold adipose tissue with a minimal amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality is. identified. Summary: 1 - tumor to inked deep margin, 2 through 4 - tumor to inked. anteroinferior margin, 5 and 6 - tumor to adjacent parenchyma, 7 -. random upper outer quadrant, 8 - upper inner quadrant, 9 - lower inner. quadrant, 10 - lower outer quadrant, 11 - junction of the 4 quadrants,. 12 - nipple. C. Received fresh labeled ""Axillary contents"" is a 9.3 x 7.8 x 1.7 cm. portion of soft, lobulated tan gold adipose tissue. A few slightly. rubbery pale tan to tan pink tissues in keeping with lymph nodes. measuring up to 3.4 cm in greatest dimension are recovered. The. lymphoid tissues are entirely submitted. RS 4. Summary: 1 - 2 lymph nodes, 2 - 1 bisected lymph node, 3 and 4 -. bisected largest lymph node. the. Criteria. Discrepancy. Temar S. Discripancy. PIP.",BRCA,0,True,"The report states that the size of the tumor is 3.2 cm, which falls within the T2 category of tumors that are more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage, and the tumor grade is not used to determine T stage. The T stage is determined solely by the size of the tumor.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.",23.0,1982.0,98.0,True
1285,TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB,0,"OC ID. Gross Description: Microscopic Description: Diagnosis Details: Comments: BREAST TISSUE CHECKLIST. Specimen type: Mastectomy. Site: breast, NOS C50.9 4/8/u for. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2 x 1.5 x 1.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 1/12 positive for metastasis (Axillary 1/12). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",BRCA,1,True,"The tumor size is 2 x 1.5 x 1.5 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage, and tumor grade is not used to determine T stage. Angiolymphatic invasion, extracapsular extension in lymph nodes, and the number of lymph nodes examined are also not factors in determining T stage.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumor size is the primary factor in determining T stage.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumor size is the primary factor in determining T stage.",24.0,2039.0,99.0,True
1161,TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981,1,"page 1 / 2. Examination: Histopathological examination (cito). Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breas with axillary tissues. Unit in charge: : Expected time of examination: 5 working days. Clinical diagnosis: Macroscopic description: Right breast, sized 24.8 x 19.3 x 5.2 cm, removed with axillary tissues sized 8.0 x 7.5 x 3.0 cm and a skin flap of 28.6 x 14.6 cm. Tumour sized 2.2 x 1.7 x 2.4 found in the lower outer quadrant, located 5.2 cm from the lower boundary, 1.7 cm from the base. and 0 cm from the skin. Microscopic description: Carcinoma ductale invasivum NHG3 (3+3+2: 10 mitoses/10 HPF - visual area 0.55 mm). Mamillae sine laesionibus. Glandular tissue showing parenchymal atrophy. Axillary lymph nodes: Lymphonodulitis chronica (No VII). Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the right breast. (NHG3, pT2, pNO). Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in less than 10% of neoplastic cell. nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) rabbit antibody. Score=2+, FISH verification. recommended. Examination: Histopathological examination (cito). page 2 / 2. Gender: F. Result of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.",BRCA,0,True,"The T stage is primarily determined by the size of the tumor. In this report, the tumor size is measured as 2.2 x 1.7 x 2.4 cm, which falls within the T2 category of tumors that are more than 2 cm but not more than 5 cm in size. Therefore, the T stage for this patient is T2.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.",22.0,1921.0,97.0,True
1335,TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31,1,"F. Pathologic Interpretation: A. Right breast short stich superior long lateral right single mastectomy: - Benign mammary parenchyma, no malignancy seen. B. Left breast and level I and II of axilla to tumor short superior, left lateral: - Invasive ductal carcinoma, Nottingham grade 3 (3+3+2), 2.8 cm in greatest linear dimension, focally presert at the. anterior specimen margin. - Ductal carcinoma in situ, high grade (DIN 3) solid type. - Organizing previous biopsy cavity. - Lymphovascular space invasion is present. - Metastatic carcinoma in four out of nine lymph nodes (4/9). - Receptors to follow. C. Additional fat above left breast tumor: - No malignancy seen in adipose tissue. D. Left level III axilla: - No malignancy seen in four lymph nodes (0/4). Tumor Summary (Invasive Carcinoma of the Breast): Specimen Type: Total breast (including nipple and skin). Procedure: Total mastectomy (including nipple and skin). Lymph Node Sampling: Axillary dissection (partial or complete dissection). Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Laterality: Left. Tumor Site: Lower outer quadrant; Lower inner quadrant. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 2.8 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: Skin: Invasive carcinoma does not invade into the dermis or epidermis. Nipple: DCIS does not involve the nipple epidermis. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma in Situ: DCIS is present. Architectural Patterns: Solid. Nuclear Grade: Grade III (high). Lobular Carcinoma in Situ: Not identified. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise specified). Histologic Grade: Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 3. Mitotic Count: Score 2. Overall Grade: Grade 3. Margins: Uninvolved by invasive carcinoma. Distance from posterior margin: 2 cm. Uninvolved by DCIS (if present). Lymph-Vascular Invasion: Present. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 0. Total number of lymph nodes examined (sentinel and nonsentinel): 13. Number of lymph nodes with macrometastases: 4. Size of largest metastatic deposit: 2.0 cm. Extranodal Extension: Not identified. SURGICAL PATHOL Report. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Pathologic Staging (pTNM). TNM Descriptore: m (multiple foci of invasive carcinoma). Primary TumorpT2. Regional Lymph Nodes: pN2. Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: Pending. Progesterone Receptor: Pending. Her2: Pending. NOTE: Some immunohistochemical antibodies are analyte spectific reagents (ASRs) validated by our laboratory (Her 2, Pervo, H. pylori, HBcore). These ASRs are clinically indicators that do. not require FDA approval. These clones are used: ID5=ER, POR 636=PR, A485HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4 1=AR and HPV by ISH. All immunohistochemidelt stains are used. with formalin or molecular fixed, paraffin embedded fissue. Detection is by LSAB. The results are read by a pathologist as positive or negative. As the attending pathologist, / attest that 1: (i) Exemined the relevent. preperation(s) for the specimen(s); and (i) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. The tumor cells are positive for ER and PR and negative for HER2 by immunohistochemistry. Immunohistochemistry for p63 was. used in the evaluation of the specimen. Clinical History: female with left breast cancer. Pre Operative Diagnosis: Left breast cancer. Specimen(s) Received: A: Right breast short stich superior long lateral right single mastectomy (fresh). B: Left breast and level 1 and Il of axilla to tumor short superior, left lateral (fresh). C: Additional fat above left breast tumor (perm). D: Left level III axilla (perm). Gross Description: A. Received fresh and labeled ""right breast short stich superior long lateral right single mastectomy (fresh)"" is a breast. specimen measuring 18.0 x 15.0 x 5.0 cm. It has a white-tan ellipse of skin measuring 4.0 x 1.0 cm. The nippl measures. 1.0 x 1.0 cm. The skin is unremarkable and nipple is unremarkable. Deep margin is smooth, facial plane without any. SURGICAL PATHOL Report. skeletal muscle. Deep margin is inked in black. Serial sectioning of the mastectomy specimen does not reveal any gross. lesion. Specimen submitted as follows: 1&2. Sections from upper outer quadrant. 3&4. Representative section from lower outer quadrant. 5&6. Representative section from upper inner quadrant. 7&8. Representative section from lower inner quadrant. 9&10. Representative section from central quadrant. 11. Representative section from nipple. B. Received fresh and labeled ""left breast and level 1 and II of axilla to tumor short superior, left lateral (fresh)"" is a. mastectomy specimen measuring 19.0 x 17.0 x 3.0 cm. It has a white-tan ellipse of skin measuring 2.5 x 2.0 cm. The. axillary tail measures 13.0 x 9.0 cm. The skin and nipple are unremarkable. Deep margin is smooth, facial plane without. any skeletal muscle. Deep margin is inked black, superior margin is inked blue, medial margin is inked red and inferior. margin is inked green. Serial sectioning of the mastectomy specimen reveals a 2.8 x 2.0 x 1.5 cm firm gray mass located. in the lower outer quadrant, less than 0.1 cm from the inked anterior specimen margin. There is also a 1 x 1 1 cm. mass. in the lower inner quadrant. The mass is well defined. It has a clip in it. in the upper inner quadrant, there is an area of. necrosis measuring 2.0 x 2.0 x 1.0 cm. it is brown in color and soft in consistency. Remainder of the breast parenchyma is. predominantly white and firm with small cyst measuring up to 0.3 cm in greatest dimension. The axillary tail is yellow and. soft. There are 13 possible lymph nodes. The largest measures 3.0 cm in greatest dimension. Sections submitte as. follows: 1-8. Mass in the lower inner quadrant. 9&10. Area of necrosis. 11&12 Representative section from upper outer quadrant. 13&14 Representative section from lower outer quadrant. 15&16 Representative section from upper inner quadrant. 17&18 Representative section from lower inner quadrant. 19820. Representative section from the central quadrant. 21. Representative section from the nipple. 22-24. Contains representative section from the largest lymph node. 25-37. One fymph node per cassette. 38-41. Additional section of mass in lower outer quadrant. C. Received in formalin and labeled ""additional fat above left breast tumor"" is a soft fragment measuring 2.5 x 1.0x 1.0 cm. Submitted in toto in three cassettes. D. Received in formalin and labeled ""left level III axilla"" is a pale yellow, soft tissue fragment measuring 4.0 x 3.0 x 2.0 cm. Four possible lymph nodes are bisected and submitted in toto in four cassettes. ICD-9(s);. 174.5 174.3 196.3.",BRCA,2,True,"The report indicates that the size of the largest invasive carcinoma is 2.8 cm, which falls within the T2 category of tumors that are more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage, and the presence of lymphovascular space invasion, metastatic carcinoma in four out of nine lymph nodes, and extranodal extension are not factors in determining T stage. The number of lymph nodes examined or the method of lymph node examination are also not factors in determining T stage.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.",23.0,1982.0,98.0,True
1487,TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E,0,"FINAL PATHOLOGIC DIAGNOSIS. A. Sentinel lymph node, right axillary #1; excisional biopsy: - Five reactive lymph nodes, no evidence of tumor (0/5) (HE and CKAE1/AE3). - Lymphovascular invasion is seen in a lymph node vessel of the lymph node. sinus (0.12 mm tumor cell cluster), see comment. B. Sentinel lymph node, right axillary #2; excisional biopsy: - One reactive lymph node, no evidence of tumor (0/1) (HE and CKAE1/AE3). C. Sentinel lymph node, right axillary #3; excisional biopsy: - One reactive lymph node, no evidence of tumor (0/1) (HE and CKAE1/AE3). D. Breast, right, additional anterior margin; excision: - Columnar cell changes. - Blunt duct adenosis. - Apocrine metaplasia. E. Breast, right; wire-guided lumpectomy: - Invasive ductal carcinoma, SBR grade III, with necrosis, see parameters. below. - Ductal carcinoma in situ, high nuclear grade, solid type. - Biopsy site changes. - Margins of resection are negative. Breast Pathologic Parameters. 1. Invasive carcinoma: A. Gross measurement: 1.9 x 1.7 x 1.5 cm. B. Composite histologic (modified SBR) grade: III. - Architecture: 3. - Nuclear grade: 3. - Mitotic count: 3. C. Associated intraductal carcinoma in situ (DCIS): - Adjacent to invasive carcinoma (forming < 5% of tumor volume). 2. Intraductal carcinoma: A. Microscopic measurement: Adjacent to invasive carcinoma. B. Type: Solid. C. Nuclear grade: High. D. Associated features: Necrosis / Cancerization of lobules. 3. Excisional biopsy margins: Free of tumor. - Invasive carcinoma 3.0 mm from posterior (closest) margin. - Ductal carcinoma in situ distant to all margins. - Additional margin (anterior) negative. 4. Blood vessel and lymphatic invasion: Present. - Present in axillary lymph node. 5. Nipple: N/A. 6. Skin: N/A. 7. Skeletal muscle: N/A. 8. Axillary lymph nodes: Seven sentinel lymph nodes, no evidence of tumor (0/7). 9. Special studies. - ER: Negative. - PR: Negative. - Her2/neu antigen (FISH): Non-amplified (1.23). 10. pTNM (AJCC, 7th edition, 2010): pT1cNO(sn)MX. Clinical History: The patient is a. -year-old female with breast cancer undergoing wire guided. lumpectomy and sentinel node biopsy. Comment. A. Present on HE slide A2 Lev 3 and CK stain. Reviewed intradepartmentally. Specimens Received: A: Right sentinel node #1. B: Right sentinel node #2. C: Right sentinel node #3. D: Rt breast additional anterior margin. E: Right breast wire guided; lumpectomy. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, 'right breast sentinel. node #1'. Received fresh and placed in formalin are 2 fragments of ovoid yellow. to brown rubbery tissue. The first measures 4.0 x 2.0 x 1.3 cm and the second is. 4.5 x 1.5 X 1.2 cm. A number of lymph node candidates are identified the largest. of which measures 4.0 x 1.5 x 1.0 cm. The specimen is submitted as follows: A1: 3 lymph node candidates. A2: One lymph node candidate. A3-A4: One lymph node candidate bisected. B. The second container is additionally identified as, 'right breast sentinel. node #2'. Received fresh and placed in formalin is an ovoid fragment of. yellow-tan fibroadipose tissue measuring 1.8 x 1.6 x 0.5 cm. A brown-tan lymph. node is identified that measures 1.1 x 0.5 x 0.3 cm. It is bisected and entirely. submitted in cassette B1 along with the surrounding fat. C. The third container is additionally identified as, 'right breast sentinel. node #3'. Received fresh and placed in formalin is a fragment of rubbery. yellow-tanto brown tissue measuring 1.3 x 0.5 x 0.3 cm. It is entirely. submitted in cassette C1. D. The fourth container is additionally identified as, 'additional anterior. margin'. Received fresh and placed in formalin is a rectangular fragment of soft. to rubbery yellow-tan tissue measuring 2.3 x 1.7 x 0.6 cm. A double suture marks. the final anterior margin. This margin is inked blue and the remainder of the. specimen is inked black. The specimen is then serially sectioned and entirely. submitted in cassettes D1-D2. E. The fifth container is additionally identified as, 'right breast wire guided. lumpectomy'. Received fresh on a radiographic grid is a 45.4 gm lumpectomy. specimen measuring 7 cm from medial to lateral, 5.8 cm from superior to inferior. and 2.7 cm from anterior to posterior. The specimen is oriented with a short. suture designating the superior pole and a long suture designating the lateral. pole. Accompanying the specimen is an x-ray demonstrating a metallic clip. located in grid coordinate D3. There is a circled mass in grid positions C4, C3,. and D3, and D4, centered on the clip. The wire enters the specimen in grid. coordinates C3 and terminates in D4. The margins are inked as follows: anterior - black;. posterior - red;. superior - blue;. inferior - green;. medial - yellow;. lateral - violet. The specimen is serially sectioned from medial to lateral into 8 slices. The. metallic clip is identified in slice 4. The wire enters the specimen in slice 3. and terminates in slice for. There is a firm, tan, irregular, 1.9 x 1.7 x 1.5 cm. lesion located in slices 3 through 4. The lesion is located 1.5 cm from the. anterior (black) margin, 0.3 cm from the posterior (red) margin, 1.3 cm from the. superior (blue) margin, 1.2 cm from the inferior (green) margin, 1.7 cm from the. medial margin, and 4 cm from the lateral margin. The remainder of the breast. parenchyma is white-yellow and lobulated with no additional masses or lesions. Block summary: E1: medial margin, slice 1. E2: lateral margin, slice 8. E3: mass, slice 3 with red margin. E4: Surrounding margins from slice 3. E5-E6: mass, slice 4 with red margin, surrounding clip. E7: Surrounding margins from slice 4. E8: Slice 2 next to mass. E9: Slice 5 next to mass. E10: Section from grossly unremarkable breast parenchyma, slice 6.",BRCA,0,True,"The report indicates that the largest tumor size is 1.9 x 1.7 x 1.5 cm. According to the rules provided, T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm. Since the tumor size is greater than 1 cm but less than or equal to 2 cm, the T stage is T1c.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2",T1c,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2",24.0,2053.0,98.0,True
1359,TCGA-EW-A1PF.0D24479F-2F86-43AC-AAB1-83AAD99542C4,0,"F. Pathologic Interpretation: A. SENTINEL NODE #1: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. B. SENTINEL NODE #2: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. C. SENTINEL NODE #3: - No carcinoma seen in two lymph nodes (0/2). - Immunohistochemistry for keratin is pending. D. RIGHT BREAST, ONE STITCH SUPERIOR, TWO STITCHES LATERAL: - INFILTRATING DUCTAL CARCINOMA, moderately differentiated, Nottingham grade 2 (2+3+2=7), 2.0 cm in greatest. dimension. - Margins are free of invasive carcinoma. - Lymphovascular invasion is not identified. - Prior biopsy site. - See tumor summary. - DUCTAL CARCINOMA IN SITU, high nuclear grade (DIN 3) with expansive comedo necrosis, solid type, present in 2/10. slides and representing less than 5% of submitted tissue. - Margins free of DCIS. E. NON-SENTINEL LYMPH NODE: - No carcinoma seen in two lymph nodes (0/2). F. SENTINEL NODE #4: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. G. SENTINEL NODE #5: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. H. SENTINEL NODE #6: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. I. SENTINEL NODE #7: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. J. SENTINEL NODE #8: - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin is pending. TUMOR SUMMARY. Specimen: - Total breast (including nipple and skin). Procedure: - Total mastectomy (including nipple and skin). Lymph Node Sampling: SURGICAL PATHOL Report. - Sentinel lymph node(s). - Axiliary dissection (partial or complete dissection). Specimen Integrity: - Single intact specimen (margins can be evaluated). Specimen Laterality: - Right. Tumor Site: Invasive Carcinoma. - Upper outer quadrant. - Central. Tumor Size: Size of Largest Invasive Carcinoma. - Greatest dimension of largest focus of invasion over 0.1 cm: 2.0 cm. - Additional dimensions: 2.0 x1.0 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Invasive carcinoma does not invade into the dermis or epidermis. - Skeletal muscle: Skeletal muscle is present and is free of carcinoma. Ductal Carcinoma In Situ (DCIS): - DCIS IS PRESENT. - Extensive intraductal component (EIC) negative. Size (Extent) of DCIS: -Estimated size (extent) of DCIS (greatest dimension using gross and microscopic evaluation) is at. least: 5 cm. Number of blocks with DCIS: 2. Number of blocks examined: 10. - Architectural Patterns: Solid. - Nuclear Grade: Grade III (high). - Necrosis: Present, central (expansive ""comedo"" necrosis). Lobular Carcinoma in Situ (LCIS). - Not identified. Histologic Type of Invasive Carcinoma: - Invasive ductal carcinoma (no special type or not otherwise specified). Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation: Score 2. Nuclear Pleomorphism: Score 3. Mitotic Count: Score 2. Overall Grade: Grade 2: score 7. Margins: - Margins uninvolved by invasive carcinoma. Distance from closest margin: 6 mm (deep). - Margins uninvolved by DCIS. Distance from closest margin: 14 mm (deep). Treatment Effect: Response to Presurgical (Neoadjuvant) therapy: In the Breast: No known presurgical therapy. - In the Lymph Nodes: No known presurgical therapy. Lymph-Vascular Invasion: Not identified. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 9. Total number of lymph nodes examined (sentinel and nonsentinel): 11. Number of lymph nodes with macrometastases (>0.2 cm): 0. Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells): 0. Number of lymph nodes with isolated tumor cells (50.2 mm and $200 cells): 0. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Immunohistochemistry pending. Pathologic Staging (PTNM): pTic NO Mx. Primary Tumor: pT1c. Regional Lymph Nodes: pNO. Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: - Performed on another specimen. ; Results: Immunoreactive tumor cells present (21%). Progesterone Receptor: Performed on another specimen. ); Results: Immunoreactive tumor cells present (1%). SURGICAL PATHOL Report. Her2: - Performed on another specimen. Ii Results: Negative. AJCC classification (1th ed) (pTNM): pTic NO Mx. NOTE. Some antibodies are analyle specific reagents (ASRs) validated by our laboralory. These ASRs are clinically useful indicators that do not require FDA approval. These clones are used: IDS-ER, Pgl 636=PR,A485=HER2, All imunohistochemical stains are used with formalin or molecular fixed. paraffin embedded tissue. Detection is by Envision Method. The results are read by a. pathologist. a. positive or negative. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Proceldures/Addenda. Adderidum. Date Complete: Addendur Diagnosis. A: Immunohistochemistry for keratin is negative. B: Immuhohistochemistry for keratin is negative. C: Immunohistochemistry for keratin is negative. F: Pending Immunohistochemistry (keratin). G: Immunohistochemistry for keratin is negative. H: Immunohistochemistry for keratin is negative. I: Immurjohistochemistry for keratin is negative. J: Immunohistochemistry for keratin is negative. Intraoperative Consultation. A. Sentinel node #1, FS: No carcinoma seen. B. Sentinel node #2, FS: No carcinoma seen. C. Sentinel node #3, FS: No carcinoma seen. F. Sentinel node # 4, FS: No carcinoma seen. G. Sentinel node # 5, FS: No carcinoma seen. H. Sentinel node #6, FS: No carcinoma seen. I. Sentinel node #7, FS: No carcinoma seen. J. Senthel node #8, FS: No carcinoma seen. MD. SURGICAL PATHOL Report. Clinica History: None provided. Operation Performed. Right total mastectomy with sentinel node and possible axillary dissection. Pre Operative Diagnosis: Right breast carcinoma. Specimen(s) Received: A: Sentinel node #1, FS. B: Sentinel node #2, FS. C: Sentinel node #3, FS. D: Right|breas one stitch superior, two stitches lateral. E: Non sentinel lymph node. F: Sentinel node # 4. FS. G: Sentinel node # 5, FS. H: Sentinel node #6, FS. I: Sentinel node #7, FS. J: Sentinel node #8, FS. Gross Description: A. Received fresh is a yellow-tan tissue, measuring 1.6 x 1.1 x 0.2 cm. Bisected and submitted in toto in one cassette for. frozen section. B. Received fresh is a tan-yellow tissue, 1.9 x 0.9 x 0.3 cm. Bisected and submitted in toto in one cassette for frozen. section. C. Received fresh are fragments of tan tissue, 3.1 x 2.1 x 0.3 cm. Sections are submitted as follows: 1. Possible lymph node, bisected, for frozen section. 2. Remaining tissue in toto. D. Received in formalin is a total mastectomy weighing 450 grams, measuring 20.0 x 16.0 x 2.6 cm with a portion of skin. 16.5 x 7.0 cm. The areola is 2.0 cm. in the upper outer portion of the breast 0.6 cm from the deep margin and 1.6 cm. posterior to the skin at approximately 11 o'clock is an ill-defined fibrotic area 2.0 x 2.0 x 1.0 cm in dimension. No other. lesions are grossly identified. Resection margins inked in black. Stroma to fat ratio is 5 to 95%. Sections submitted as. follows: 1. Nipple (base of nipple) and tip in perpendicular sections. 283. Composite section of the ill-defined mass in relation to the deep margin and to the anterior skin (Cassette 2. contains skin, cassette 3 contains deep margin). 485. Additional sections of lesion in relation to deep margin. 6&7. Additional sections of lesion in relation to surrounding breast tissue. 8. Section from lower outer quadrant. 9. Section from upper inner quadrant. 10. Lower inner quadrant. E. Received in formalin are multiple fragments of adipose tissue, 1.6 x 1.3 x 0.4 cm. The specimen is submitted in toto in. one cassette. F. Received fresh is a tan-red tissue fragment, 0.9 x 0.6 x 0.2 cm. The specimen is bisected and submitted in toto in one. cassette for frozen section. G. Received fresh is a tan tissue fragment, 1.1 x 0.6 x 0.4 cm. The specimen is bisected and submitted in toto in one. cassette for frozen section. H. Received fresh is tan tissue fragment, 1.1 x 0.6 x 0.3 cm. The specimen is bisected and submitted in toto in one cassette. for frozen section. Received fresh is a tan tissue fragment, 0.6 x 0.5 x 0.3 cm. The specimen is bisected and submitted in toto in one. cassette for frozen section. SURGICAL PATHOL Report. J. Received fresh is a tan tissue fragment, 0.7 x 0.4 x 0.3 cm. The specimen is submitted in toto in one cassette for frozen. section.",BRCA,0,True,"The report states that the largest focus of invasion is 2.0 cm, which falls within the range for T1 tumors (2 cm or less). More specifically, it is a T1c tumor as it is greater than 1 cm but less than or equal to 2 cm.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2",T1c,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2",24.0,2053.0,100.0,True
1131,TCGA-D8-A1JP.1B61F1C1-8B19-4D9C-B6B9-87EEE350A472,0,"page 1 / 1. copy No. Examination: Histopathological examination (cito). Examination No. PESEL. Gender: F. Material: Multiple organ resection - left breast. Expected time of examination: 5 working days. Clinical diagnosis: Macroscopic description: Right breast sized 20.3 x 14.4 x 4.6cm removed, without axillary tissues and with a skin flap of 17.8 x 9.4 cm. Weight 300g. Site of tumour removal sized 8 x 8 x 3 cm found on the boundary of inner quadrants, placed 4.0. cm from the upper edge, 0.1 cm from the base and 0.2 cm from the skin. Status after tumour removal (examination No. Microscopic description: Status post resectionem tumoris. Mamilla sine faesionibus. Glandular tissue showing Parenchyma atrophy. Histopathological diagnosis: (including test No. Carcinoma ductale invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast. (NHG2, pT1c, pNo/sn/).",BRCA,0,True,"The report mentions that the tumor size is 2.1-5.0 cm, which falls under the T2 category. However, it also specifies that the tumor is pT1c, indicating a T1 stage tumor with a size between 1.1 and 2.0 cm. Therefore, the T stage for this report is T1.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm",T1,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm",25.0,2120.0,98.0,True
1084,TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26,1,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MAST AND AXILL NODE DISS. CLINICAL HISTORY: MATERIAL SUBMITTED: A) RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. routine sutures. B) RIGHT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: FROZEN SECTION: Right breast tissue; 8.0 by 8.0 by 3.0 cm. Tumor is 2.6 by 2.6 by 2.5 cm. Margins grossly. free. Frozen Section Diagnosis: Infiltrating ductal carcinoma. ER/PR taken. FINAL DIAGNOSIS: FINAL DIAGNOSIS: AEAFS) RIGHT BREAST MASS. - INFILTRATING DUCTAL CARCINOMA, NOT OTHERWISE SPECIFIED, HISTOLOGIC GRADE 3, NUCLEAR GRADE POOR, VASCULAR. INVASION PRESENT, TUMOR NECROSIS REPRESENTING 30% OF TUMOR MASS; TUMOR GREATEST DINGTER 2.6 BY 1.6 BY 2.5. CM. - INKED MARGINS FREE OF TUMOR. B) RIGHT AXILLARY NODES: - TWENTY-NINE (29) LYMPH NODES, FREE OF TUMOR. Criteria. Diagnusis riscrepancy. Primary Tumor Site Discivinary. enor Millenancy Hi tory. must/syrchionous useis (circle): initials MA Date jewed /. Re.",BRCA,0,True,"The report states that the tumor size is 2.6 x 2.6 x 2.5 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. Therefore, the T stage is T2.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.",26.0,2177.0,99.0,True
1324,TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78,1,"Laterality:Left-UOC. Path Report: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3.5 X 3.5 x 3.5 cm. Grossly evident lesion: Yes. Histologic type: Lobular carcinoma. Histologic grade: Not specified. Tumor extent: Not specified. Lymph nodes: 4/8 positive for metastasis (Axillary 4/8). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: ER,PR-8 points, HER2NEU-O.",BRCA,1,True,"The report indicates that the tumor size is 3.5 x 3.5 x 3.5 cm, which falls within the T2 category of 'more than 2 cm but not more than 5 cm in size'. Therefore, the T stage for this patient's cancer is T2.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.",26.0,2177.0,100.0,True
833,TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4,1,"Diagnosis. A: Sentinel lymph node, right axillary #1, removal. - No evidence of metastatic carcinoma in one lymph node (0/1). - See comment. B: Breast, right, total mastectomy. Tumor type: Infiltrating ductal carcinoma. Nottingham combined histologic grade 3. Tubule formation score: : 3. Nuclear Pleomorphism Score: 2. Mitotic count score: 3. Focality of tumor: unifocal. Tumor size (greatest dimension) : 35 mm. Lymphovascular invasion: not identified. In Situ Component: Minor component of ductal carcinoma in situ,. cribriform and solid types, nuclear grade 2 with necrosis, 2mm. in linear extent. Extensive intraductal component absent. Nipple/skin involvement: not identified. Margin status: Invasive component: negative, widely clear; 1.5 cm to closest. posterior. margin. In Situ component : negative; widely clear of all margins. Axillary lymph nodes: Total number with metastasis: 0. Total number examined: 14 ( see parts A & C). Microcalcifications not identified. Other findings: gynecomastia, biopsy site changes. See report of prior biopsy (. ') for results of ER, PR and. HER2 immunohistochemical studies. AJCC PATHOLOGIC TNM STAGE: pT2 pNO. Note: This pathologic stage assessment is based on information. available at the. time of this report, and is subject to change pending clinical. review and. additional information. C: Lymph nodes, right axillary, removal. - No evidence of metastatic carcinoma in 13 lymph nodes (0/13). - See comment. Comment: The axillary lymph nodes reveal lymphoid paracortical expansion,. which is. favored to be reactive in nature by H & E stains. Scattered. pigmented. histocytes are present suggestive of dermatopathic. lymphadenitis. Additional. immunohistochemical stains are pending to further evaluate this. process, results. of which will follow in an addendum report. Intraoperative Consult Diagnosis: Frozen section consultation was requested at. on. by in OR. FSA1,A2: Lymph node, right axillary SLN #1, biopsy. - No tumor seen. Drs. at. Frozen Section Pathologist: MD. Clinical History: with right poorly differentiated invasive. ductal carcinoma, Grade 3. Gross Description: Received are three appropriately labeled containers. Container A is additionally labeled ""right axillary SLN #1, hot. + blue. "" The. specimen is a 6 X 4.5 x 1.5 cm fatty soft tissue fragment. Examination of the. fat reveals a 2.0 X 2.0 x 1.0 cm blue lymph node candidate. This. candidate is. serially sectioned and submitted entirely in blocks FSA1 and. FSA2. Container B: Specimen fixation: formalin. Time in fixative: 28.5 hours. Type of mastectomy: simple mastectomy. Weight of specimen: 950 grams. Size of specimen: 26.0 cm medial to lateral, 26.7 cm superior to. inferior,. 4.0 cm anterior to posterior. Orientation of specimen: Sutures: Short=superior, long=lateral. Inking: anterior=blue, posterior=black, lateral=yellow. Skin ellipse dimensions: 18.6 x 9.3 cm. Nipple/areola Nipple, 1.0 cm; areola, 3.1 cm. Axillary tail: submitted separately. Biopsy site: present; Location is central breast/lower outer. quadrant;. Size: 0.8 X 0.5 X 0.5 cm. Appearance: Biopsy site (clip identified) is in the center of a. white/tan, firm area. Hemorrhage and fat necrosis. are noted in this area. Additional residual tumor is present. Discrete Mass (es) : present. Number of discrete masses: one. Size of mass (es)/biopsy site: 2.5 x 2.0 x 3.5 cm. Location of mass (es) : subareola/lowe outer quadrant. Distance of mass/biopsy site from surgical margin: The mass. measures 1.9 cm to. posterior margin, 8.5 cm to inferior margin, 10.5. cm to superior margin, 2.8 cm to anterior margin and is widely. clear. of medial/lateral margins. Gross involvement of skin or fascia/muscle by tumor: absent. Descript. remaining breast: consistent with yellow/tan. fibroad. issue. with increased fibrous areas noted in the subareolar. area; no other masses are identified. Other remarkable features: none. Tissue submi+ ed for special investigations: yes; Tumor to. Tissue Pr ment. Block Summary: (Inking: blue=anterior, black=posterior, yellow=lateral. B1 - nipple. B2 - areola. B3 - biopsy site. B4 - medial aspect of mass. B5-B8 - - central portion of mass. B9 - lateral aspect of mass. B10 - mass to posterior margin. B11 - representative dense fibrous tissue posterior to nipple. and anterior to mass. B12 - closest skin margin (inferior areola). B13 - upper inner quadrant. B14 - lower inner quadrant. B15 - lower outer quadrant. B16 - upper outer quadrant. B17 - mass to normal breast, superior. B18 - mass to normal breast, inferior. Container C is additionally labeled ""right axillary contents. "". The specimen. consists of two fragments of yellow/tan fibroadipose tissue that. measures 9.5 X. 6.5 x 3.0 cm in aggregate. Within the fibroadipose tissue,. fifteen lymph node. candidates are identified. These range in size from 0.4 up to. 1.5 cm in greatest. dimension. The largest lymph node candidate measures 2.3 X 1.5 x. 1.0 cm. Block summary: C1 - six lymph node candidates. C2 - five lymph node candidates (bisected node inked black). C3 - three lymph node candidates (bisected nodes inked black,. blue and. yellow). C4 - one lymph node candidate, sectioned. C5 - one lymph node candidate, sectioned. C6 - one lymph node candidate, sectioned. C7,C8 - largest lymph node candidate, sectioned. Procedures/Addenda: Addendum. Addendum. Immunohistochemical studies were performed on representative. blocks of axillary. lymph nodes (C6 and C7) and the results are as follows: CD20: Highlights many small lymphocytes in a generally nodular. distribution. CD3: Highlights majority of lymphocytes with focal expansion of. the paracortex. Interpretation: The immunohistochemical studies highlight an. essentially normal. pattern of distribution of B cells and T cells in the lymph. nodes, with primary. follicles composed predominantly of small B lymphocytes and. a. paracortex. populated by predominantly small T lymphocytes. Morphologic and. immunohistochemical findings are compatible with reactive lymph. nodes and do not. support a diagnosis of a lymphoproliferative disorder. The mild. paracortical. expansion can be seen as a feature of dermatopathic. lymphadenopathy.",BRCA,0,True,"The report states that the tumor size (greatest dimension) is 35 mm, which falls within the range for T2 tumors (more than 2 cm but not more than 5 cm in size).","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.",28.0,2374.0,96.0,True
825,TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9,0,"Clinical Diagnosis & History: IDC on core biopsy of left breast. Specimens Submitted: 1: SP: Sentinel node #1 level 1 left axilla (fs). 2: SP: Sentinel node #2 level 1 left axilla (fs). 3: SP: Sentinel node #3 level 1 left axilla (fs). 4: SP: Left breast mass. 5: SP: Superior margin left breast. 6 : SP: Medial margin left breast. 7: SP: Inferior margin left breast. 8: SP: Lateral margin left breast. 9: SP: Deep margin left breast. 10: SP: Additional suspicious lymph node left axilla. DIAGNOSIS: 1). SENTINEL LYMPH NODE #1, LEVEL I, LEFT AXILLA; EXCISION: ONE LYMPH NODE SHOWING MICROSCOPIC CLUSTER OF TUMOR CELLS. (APPROXIMATELY 8 CELLS: < 0.2 MM) WITHIN CAPSULAR LYMPHATIC VESSEL. - THE TUMOR IS IDENTIFIED ON CYTOKERATIN STAINS AND CORRESPONDING DEEPER. LEVEL H&E AND NEGATIVE CONTROL SLIDE. 2). SENTINEL LYMPH NODE #2, LEVEL I, LEFT AXILLA; EXCISION: - BENIGN LYMPH NODE (0/1). - ADDITIONAL HEE-STAINED SECTIONS AND STAINS FOR. CYTOKERATINS (AE1:AE3) SHOW NO EVIDENCE OF METASTATIC TUMOR. 3. SENTINEL LYMPH NODE #3, LEVEL I. LEFT AXILLA; EXCISION: - BENIGN LYMPH NODE (0/1). - ADDITIONAL H&E-STAINED SECTIONS AND IMTUNOHISTOCHEMCAL STAINS FOR. CTOKERATINS (AE1:AE3) SHOW NO EVIDENCE OF METASTATIC TUMOR. 4). BREAST. LEFT NASS: EXCISION: - INVASIVE DUCTAL CARCINOMA, POORLY DIFPERENTIATED. HISTOLOGIC GRADE. III/III, NUCLEAR GRADE III/III, MEASURING 1.9 CM MICROSCOPICALLY. - FOCAL DUCTAL CARCINOMA IN SITU (DCIS). SOLID AND CRIBRIFORM TYPE. WITH INTERMEDIATE TO HIGH. NUCLEAR GRADE AND NECROSIS. THE DCIS CONSTITUTES < 25% OF THE TOTAL. TUMOR MASS, AND IS PRESENT ADMIXED WITH AND ADJACENT TO THE INVASIVE. Criteria. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXANINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1. The specimen is received fresh for frozen section consultation, labeled,. ""Sentinel node #1, level 1, left axilla"", and consists of one lymph. node. measuring 1.0 x 2.6 x 0.5 Cm, which is bisected and entirely submitted. Summary of sections: FSC -- frozen section control (one node). 2. The specimen is received fresh for frozen section consultation, labeled,. ""Sentinel node #2, level 1, left axilla"", and consists of one lymph. node. measuring 1.1x 0.4 x 0.3 Cm, which is entirely submitted. Summary of sections: FSC -- frosen section control (one node). 3. The specimen is received fresh for frozen section consultation, labeled,. Sentinel node #3, level 1, left axilla', and consists of two possible. lymph nodes measuring 0.3 x 0.3 x 0.2 cm in aggregate. Entirely submitted. Summary of sections: FSC -- frozen section control (two possible nodes). 4) - The specimen in received unoriented, labeled ""Left breast mass "" and. consists of a piece of fibrofatty tissue measuring 6 x 3.8 x 2.5 cm. The. specimen is entirely inked black. Serial sectioning reveals a 1.5 x 1 x 1. cm tan-white firm mass with central hemorrhage. Sectioning through the. remaining tissue reveals fatty breast parenchyma. The tumor is entirely. submitted and the remaining tissue is representatively submitted. Summary of sections: NT - tumor and closest tissue edge. SS - serial sections of remaining tissue. dimension. All idantified lymph nodes are submitted. Summary of sections: BLN - bisacted lymph nodes. Summary of Sections: Part 1: SP: Sentinel node #1 level 1 left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: SP: Sentinel node #2 level 1 left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 3: SP: Sentinel node #3 level 1 left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 4: SP: Left breast mass. Block. Sect. Site. PCs. mt. 3. 4. s$. 4. Part 5: SP: Superior margin left breast. Block. Sect. Site. PCs. 4. as. 4. Part 6: SP: Medial margin left breast. Block. Sect. Site. PCs. ss. 4. Part 7: SP: Inferior margin left breast. Block. Sect. Site. PCs. 2. ss. 2. Part 8: SP: Lateral margin left breast. Block. Sect. Site. PCs. 2. ss. 2. Part 9: SP: Deep margin left breast. Block. Sect. Site. PCs. Specimens Submitted: 1: LEFT BREAST (. Test Performed: FISH for detection of gene amplification. PROBE (s) : LSI HER2 so/ CEP 17 SG DNA probes. DIAGNOSTIC INTERPRETATION: HER2/ CEP 17: 1.4/ NOT AMPLIFIED. Her-2/neu gene amplification is NOT detected. (cut off ratio: > 2.2 HER2 gene amplified; < 1.8 HER2 gene not amplified;. 1.8 2.2 equivocal). LAB NOTES: Block #4 (MT3). Specimen fixative type: Formalin. Adequate number of invasive tumor cella present: Yes. Number of invasive tumor cells counted: 20 + 20. Average number of HER2 probe signals per nucleus: 2.4. Average number of CEP17 chromosome probe signals per nucleus: 1.7. Average HER2/CEP 17 ratio: 1.4. The PathVysion HER2 DNA probe kit (Vysis) is an FDA-approved method for. assessment of HER2 gene amplification in breast cancer specimens The HER2. test results are reported in accordance with the ASCO/CAP guideline. recommendations for HER2 testing in breast cancer (J Clin oncol 2007; 25. (1):118-145). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT x HAVE REVIEWED AND APPROVED. THIS REPORT. xeport Electronically wuch.",BRCA,1,True,"The report states that the largest size of the tumor is 1.9 cm, which falls within the T1 category. Specifically, it is classified as T1c since it is greater than 1 cm but less than or equal to 2 cm.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.",T1,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.",31.0,2674.0,94.0,True
699,TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554,1,"Print -. Back to List. TEST: Surgical Patholoav. Date & Time: REPORT STATUS: Final. FACILITY: See Addendum. Patient Name : }. ...ge: Service: Surgery. Gender : F. Takeit. Physician (s) : Speciment (s) Received. A: Left sentinel nodes. B: Left sentinel node #2. C: Left breast tissue. D: Left axillary contents. Pathologic Diagnosis. ""A"" -. Left sentinel node: Metastatic carcinoma in one. (of one) lymph node. Two foci of metastatic tumor are present,. the larger measuring 0.: cm. The metastatic tumor is to. confined. the lymph node. ""B"". Left sentinel lymph node #2: One lymph node negative. for malignancy. C. Meft breast tissue;. Histologic Type: t Invasive ductal carcinoma (NOS). Modified B-R Grade: 3. Tubular score: 3. Nuclear score: 3. Mitosis score: 3. Tumor Size: Greatest dimension: 2.5 cm. Additional dimensions: 1.! 5 x. Regional Lymph Nodes: Number of lymph nodes examined: 13. Number of lymph nodes involved: 1. Metastasis dectected by light microscopy. Margins of Invasive Carcinoma: Negative. Invasive carcinoma is located: 3 cm. away from the deep margin. Lymphovascular Invasion : Absent. Ductal Carcinoma In Situ: Absent. Paget's Disease: Absent. Distant Metastasis: Cannot be assessed. Print. Microcalcificatior. Absent. Additional Pathologic Findings : Fibroadenomas. Specimen Type: Mastectomy. Specimen Size: Greatest dimension: 28 cm. Tumor Laterality: Left. Tumor Site: Upper inner quadrant. Lower inner quadrant. Lymph Node Sampling: Sentinel lymph nodes and axillary. dissection. Comment. In Part ""C"", one contiguous lymph node is negative. for. malignancy. H&E and cytokeratin stains examined. pT2 pN1a pMX. ""D"" -. Left axillary contents: Ten lymph nodes negative for. malignancy. Left axillary contents: ESTROGEN AND PROGESTERONE RECEPTOR SYNOPSIS. Estrogen and progesterone receptor immunohistochemistry stains. are performed utilizing the 6f11 (ER) and 1A6 clones (PR) along. with the iview detection kit. The stains are performed on. formalin-fixed paraffin-embedded sections. Both special stains. have adequate controls. ESTROGEN RECEPTORS: Infiltrating malignant cells showing positive staining: 60. PROGESTERONE RECEPTORS: Infiltrating malignant cells showing positive staining: 10. %. ESTROGEN RECEPTOR RESULTS: Positive. PROGESTERONE RECEPTOR RESULTS: Positive. Note: Consensus. Statement on Adjuvant Therapy for Breast Cancer: Any positive nuclear ER immunostaining is considered a positive. result. These mmunohistochemistry reaction patterns were. developed and their performance characteristics determined by. They have not been cleared or. approved by the U.S. Food and Drug Administration. The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be. regarded as investigational or for research. This laboratory is. certified under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. laboratory testing. Primary Pathologist: Addendum. Results from. HER2 by FISH: 1.4/Not Amplified. Clinical History. Left breast cancer. Intraoperative Consultation. A - Left sentinel node: Metastatic cancer. (Microscopic frozen. section) . B - Left sentinel node #2: Negative. (Microscopic frozen. section). Gross Description. A - The specimen is received fresh for frozen section labeled. ""left sentinel node. The specimen consists of a pink-tan lymph. node measuring 2.5 x 1.5 x 0.9 cm. The specimen is bisected and. entirely frozen in cassette ""FS-A1."" "". B - The specimen is received fresh for frozen section labeled. ""left sentinel node.' The specimen consists of a pink-tan lymph. node measuring 3 x 2 x 1.1 cm. The specimen is bisected and. entirely frozen in cassette ""FS-B1. "". C - The specimen is received in formalin and .labeled ""left breast. suture at 6 o'clock.' The specimen consists of a mastectomy. specimen without axillary tissue measuring 28 x 23.5 x 50 cm and. weighing 1559 gm. There is an overlying tan ellipse of skin. measuring 22 x 7 cm and showing an eccentric wrinkled brown. areola measuring 4. x 4.5 cm. Within the center of the areola. there is an inverted soft brown nipple measuring 1.1 x 1.1 x 0.9. cm. There are grossly no healed incisions or biopsy sites on the. skin surface however the medial edge of the areola is partially. stained with blue dye. Attached suture marks the 6 S'clock. margin. The deep margin is inked black and the specimen is. serially sectioned to reveal an irregular firm tumor between the. upper-inner and lower-inner quadrants approximately 1 cm from the. nipple measuring 2.5 x 2 x 1.5 cm. The tumor comes to within 3. cm of the deep margin and within 2 cm of the superficial margin. (inked blue) Further sectioning reveals a well-circumscribed. nodule within the lower-outer quadrant 3.5 cm from the nipple. measuring 1.5 x 1 x 1 cm. This nodule comes to within 3 cm of. the deep margin. The remaining specimen consists of lobulated. fat interspersed with a large amount of tan-white. irregularly-indurated tissue with scattered cysts filled with. clear fluid measuring up to 0.4 cm in diameter. A lymph node is. identified at the axillary margin measuring 1 x 1 x 0.7 cm. Representative sections are submitted in 12 cassettes. Block summary: ""1"" - vertical section of nipple, ""2"". cross-section of nipple, ""3-4"" - tumor, ""5"" - superficial and. deep margin nearest to tumor, ""6"" - nodule within the lower-outer. quadrant, ""7"" - upper-inner quadrant, ""8"" - lower-inner quadrant,. ""9"" - lower-outer quadrant, ""10"" - upper-outer quadrant, ""11"" -. tissue underlying the nipple stained with blue dye, ""12"" -. bisected lymph node at the axillary margin. D - The specimen is received in formalin and labeled ""left. axillary contents. "" The specimen consists of a tan-yellow portion. of axillary fatty tissue measuring 8 x 5.5 x 3.5 cm and weighing. 53 gm. Sectioning reveals 11 potential lymph nodes ranging from. 0.4 to 2.3 cm in greatest dimensions. The lymph nodes are. totally submitted in 4 cassettes. Block summary: ""1"" - 7 lymph nodes 1 of which is bisected, ""2"". 2 bisected lymph nodes, ""3"" - 1 bisected lymph node, ""4"" - 1. bisected lymph node. Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic.",BRCA,1,True,"The T stage is determined by the size of the tumor. In this report, the greatest dimension of the tumor is 2.5 cm, which falls in the T2 category of tumors that are more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage. Angiolymphatic invasion and the presence of positive surgical margins are also not factors in determining T stage.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.",31.0,2674.0,74.0,False
1035,TCGA-BH-A0HO.C9AD69EB-506A-4442-B1C2-C8F09B519CB2,0,"FINAL DIAGNOSIS: 1: BREAST, RIGHT, SEGMENTAL MASTECTOMY AT 10 O'CLOCK. PART. A. INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE, WITH ABUNDANT CALCIFICATIONS. B. NOTTINGHAM GRADE 2 (TUBULE FORMATION: 2, NUCLEAR PLEOMORPHISM: 2, MITOTIC ACTIVITY: 2;. TOTAL SCORE = 6/9). C. THE INVASIVE TUMOR MEASURES 1.8 CM IN LARGEST DIMENSION. D. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 2, CRIBRIFORM TYPE WITH CALCIFICATIONS. E. THE DUCTAL CARCINOMA IN SITU CONSTITUTES 5% OF THE TOTAL TUMOR VOLUME AND IS PRESENT. ADMIXED WITH THE INVASIVE COMPONENT. F. LYMPHOVASCULAR SPACE INVASION IS NOTED. G. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. H. INVASIVE CARCINOMA IS 0.1 CM FROM THE NEAREST (ANTERIOR) MARGIN AND IS 0.2 CM FROM THE. POSTERIOR MARGIN (PLEASE SEE PART #2 FOR NEW ANTERIOR MARGIN). I. THE NON-NEOPLASTIC BREAST SHOWS FIBROCYSTIC CHANGES AND COLUMNAR CELL CHANGES. J. PREVIOUS BIOPSY SITE CHANGES. K. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTORS (H SCORE OF 200),. PROGESTERONE RECEPTOR (H SCORE OF 290) AND NEGATIVE FOR HER-2 AS PER PREVIOUS. PART 2: BREAST, RIGHT, NEW ANTERIOR MARGIN, RE-EXCISION -. BENIGN BREAST TISSUE. PART 3: LYMPH NODES, RIGHT AXILLA, SENTINEL #1, EXCISION -. A. METASTATIC CARCINOMA INVOLVING ONE OF TWO LYMPH NODES (1/2). B. THE METASTATIC FOCUS MEASURES 0.1 CM IN LARGEST DIMENSION. C. NO EXTRACAPSULAR EXTENSION IS IDENTIFIED. PART 4: LYMPH NODES, RIGHT AXILLA, SENTINEL #2, EXCISION -. THREF I YMPH NODES, NEGATIVE FOR METASTATIC TUMOR (///). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Upper outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 1.8 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 2. Mitouc acurity -. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 5. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 1 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNX. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+. Comment: The tumor N stage is at least pN1mi. If a sentinel node is positive, then a final ""N. stage"" can be assigned only after complete lymph node dissection.",BRCA,1,True,"The report states that the maximum dimension of the invasive component of the tumor is 1.8 cm. According to the rules, T1 tumors are 2 cm or less in size, with T1c being greater than 1 cm but less than or equal to 2 cm. Therefore, the T stage for this patient is T1c.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.",T1c,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.",31.0,2674.0,100.0,True
865,TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149,1,"Final Diagnosis. Breast, left, modified radical mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of. III) [tubules 3/3, nuclei 2/3, mitoses 2/3; Nottingham score 779], forming a mass (2.8 x 2.3 x 2.1. cm) located in the retroareolar region of the breast. Ductal carcinoma in situ is absent. Angiolymphatic invasion is absent. Calcifications are not seen. The tumor involves the. overlying skin [AJCC pT4]. All surgical resection margins, including the skin and deep margins,. are negative for tumor (minimum tumor free margin, 1.1 cm, anterior superior margin). A single. (of 23) left axillary mid/low lymph node is positive for metastatic carcinoma. The positive lymph. node (1.7 cm in greatest dimension) shows extranodal extension. Lymph nodes, left high axillary, excision: Multiple (2) left high axillary lymph nodes are. negative for tumor.",BRCA,1,True,"The report states that the tumor involves the overlying skin (AJCC pT4), which is the primary factor in determining T stage. Therefore, the T stage is T4.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.",T4,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
T1a tumors are 0.5 cm or less in size.
T2 tumors are more than 2 cm but not more than 5 cm in size.
Tumors with a greatest dimension of 2.1 to 5.0 cm are classified as T2
pT1c indicates a T1 stage tumor with a size between 1.1 and 2.0 cm
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.",32.0,2745.0,99.0,True
811,TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B,1,"Clinical Diagnosis & History: Patient with left breast cancer IFDC on core left MRM and right prophylactic. TM and SLNB. Specimens Submitted: 1: SP: Left breast & axillary contents levels 1, with tags attached. 2: SP: Right breast. 3: SP: Level 3 axillary contents. 4: SP: Sentinel node #1, level one right axilla. 5: SP: Sentinel node #2. lovel one right axilla. DIAGNOSIS: 1). BREAST, LEFT AND AZILLARY CONTENTS, LEVELS I AND II; EXCISION: - INVASIVE DUCTAL CARCINOMA, WITH MEDULLARY FEATURES, HISTOLOGIC GRADE. II/ILI (MODERATE TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION. IN SIZE AND SHAPE) MEASURING 2.3 CM IN LARGEST DIMENSION MICROSCOPICALLY. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID TYPE WITH HIGH. NUCLEAR GRADE AND EXTENSIVE NECROSIS. -THE DCIS CONSTITUTES <- 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT ADMIXED. WITH THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER OUTER QUADRANT. THE DCIS. IS LOCATED IN THE LOWER OUTER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA IS. IDENTIFIED. - NO CALCIFICATTONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. CARCINOMA. - NO VASCULAR INVASION IS NOTED. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE IS UNREMARKABLE. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF. POSITIVE LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES. EXAMINED) : LEVEL I: 2/13; LEVEL II: 0/4. - THERE IS EXTRANODAL EXTENSION OF CARCINOMA. RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. 2). BREAST, RIGHT; EXCISION: - BENIGN BREAST PARENCHYMA WITH SECRETORY CHANGE. 3). LYMPH NODES, LEFT AXILLA, LEVEL III; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 4). LYMPH NODES, SENTINEL #1, LEVEL I, RIGHT AXILLA; EXCISION: - TWO BENIGN LYMPH NODES (0/2) DEEPER LEVEL RECUTS AND SPECIAL. STAINS HAVE BEEN ORDERED. THE RESULTS WILL BE REPORTED IN AN ADDENDUM. 5). LYMPH NODE, SENTINEL #2, LEVEL I, RIGHT AXILLA; EXCISION: - BENIGN BREAST TISSUE. NO LYMPH NODE IDENTIFIED. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. HER2-C. ER-C. PR-C. NEG CONT. IMM RECUT. NEG-HER2. AE1:AE3. CAM 5.2. AE1:AE3. CAM 5.2. NEG CONT. IMM RECUT. NEG CONT. IMM RECUT. Gross Description: 1). The specimen is received fresh, labeled, ""Left breast & axillary. contents levels 1,2 with tags attached"". It is a product of left modified. mastectomy, consisting of an ellipse of tan skin, breast tissue and axillary. tail designated as levels one and two. The skin measures 15.0 x 4.0 cm. The breast tissue measures 23.0 x 23.0 x 6.5 cm. The axillary tail site. measures 14.0 x 6.5 x 2.0 cm. The nipple is everted. No visible scars are. present on the skin surface. A scanty amount of skeletal muscle tissue is. present at the deep margin which is inked. The breast tissue was sectioned. to reveal an ill-defined pink-gray focally hemorrhagic rubbery tumor. completely surrounded by thickened fibrous tissue situated in the lower. outer quadrant, 3.5 em from the deep surgical margin. The fibrous tissue. surrounding the tumor abuts the deep surgical margin. The rest of the tissue. is. predominantly fibrous. Serial sectioning of the axillary tail reveals. ?age 3 of 5. multiple lymph nodes, ranging from 0.3 up to 1.5 cm in greatest dimension. Representative sections were submitted, portion of the tumor was given to. TPS. Summary of Sections: N nipple. T tumor. DM deep margin closest to the tumor. UOQ upper outer quadrant. LOQ lower outer quadrant. LIQ lower inner quadrant. LN1 lymph nodes level one. LN2 lymph nodes level two. 2). The specimen is received fresh, labeled, ""Right breast, (stitch marks. axillary tail)"" It is a product of right modified mastectomy consisting of. an. ellipse of tan skin with breast tissue. The skin measures 15.5 x 5.0 cm. The breast tissue measures 16.0 x 16.0 x 6.0 cm. The nipple is everted. Grossly no visible scars are present on the skin surface. There is a scanty. amount of skcletal muscle tissue present at the deep margin which is inked. The breast tiscue was sectioned to reveal fibrofatty tissue. The fibrous. tissue counts to approximately 55% of the entire breast tissue. Grossly. evert lesions were identified. No lymph nodes were present at the axillary. tail site. Representative sections were submitted. Summary of Sections: N nipple. OUQ upper outer quadrant. LOW lower outer quadrant. UIQ upper inner quadrant. LIQ lower inner quadrant. DM deep margin. AXT axillary tail site. 3). The specimen is received in formalin, labeled, ""Level 3 axillary. contents' It consists of three piece of fibroadipose tissue measuring in. aggregate 1.5 x 1.0 x 0.6 cm. Entirely submitted. Summary of Sections: U undesignated. 4). The specimen is received in formalin, labeled, ""Sentinel node #1,. level onc, right axilla"". It consists of a single piece of adipose tissue. meacuring 2.5 x 2.0 x 0.5 cm. Entirely submitted. Summary of Sections: U undesignated. 5). The specimen is received in formalin, labeled, Sentinel node #2,. level one right axilla"". It consists of a single piece of fibroadipose. tissue with embedded lymph node, measuring 0.8 cm in its greatest dimension. Entirely submitted. Summary of Sections: LN lymph node. Summary of Sections: Part 1: SP: Left breast & axillary contents levels 1,2 with tags attached. Block. Secr. Site. PCs. 5. ALN. 13. 2. BLN. 7. 1. DM. 3. 2. LIQ. 2. 2. LOQ. 2. 2. N. 2. 4. 4. 2. UIQ. 2. 2. UOQ. 2. Part 2: SP: Right breast. Block. Sect. Site. PCs. 1. AXT. 2. 1. DM. 3. 4. LIQ. 4. 4. LOQ. 4. 2. N. 2. 4. UIQ. 4. 4. UOQ. 4. Part 3: SP: Level 3 axillary contents. Block. Sect. Site. PCs. 1. U. 3. Part 4: SP: Sentinel node #1, level one right axilla. Block. Sect. Site. PCs. 2. 2. Part 5: SP: Sentinel node #2, level one right axilla. Block. Sect. Site. PCs. 1. LN. 1. Procedures/Addenda: Addendum. Date Complete. Addendum Diagnosis. ADDENDUM. SITE: LEFT BREAST. - ER-ICA: NEGATIVE. - PR-ICA: NEGATIVE. - HER2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 0) . CONTROLS ARE SATISFACTORY. Addendum. Date Complete: Addendum Diagnosis. ADDENDUM. SITE: SENTINEL LYMPH NODE, RIGHT AXILLA. PART #4. ADDITIONAL H&E STAINED SECTIONS AND IMMUNOHISTOCHEMICAL STAINS FOR. CYTOKERATINS (AE1:AE3 AND CAM 5.2) SHOW NO EVIDENCE OF METASTATIC TUMOR.",BRCA,1,True,"The report indicates that the largest dimension of the tumor is 2.3 cm, which falls within the range for a T2 tumor (> 2 cm but not more than 5 cm). The presence of ductal carcinoma in situ (DCIS) does not affect the T stage, and there is no direct extension to the chest wall or skin. Therefore, the T stage is T2.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.",22.0,1953.0,82.0,True
1228,TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2,1,"SPECIMENS: A. SENTINEL LMYPH NODE LEFT AXILLA #1. B. SLNODE LEFT AXILLA 2. C. SLNODE 3. D. WIDE EXCISION LEFT BREAST. E. ADDITIONAL DEEP MARGIN. F. ADDITIONAL MEDIAL MARGIN. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, LEFT AXILLARY, RESECTION: -MICROMETASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1). B. LYMPH NODE, SENTINEL #2, LEFT AXILLARY, RESECTION: -ONE LYMPH NODE, NEGATIVE FOR METASTASIS (0/1). C. LYMPH NODE, SENTINEL #3, LEFT AXILLARY, RESECTION: -ONE LYMPH NODE, NEGATIVE FOR METASTASIS (0/1). D. BREAST/LEFT, RESECTION: INVASIVE DUCTAL CARCINOMA, SBR GRADE III/III. -TUMOR SIZE: 3.3x2.6x2.5 CM. -MARGINS FREE OF TUMOR. -SEE TEMPLATE. FIBROCYSTIC CHANGES WITH APOCRINE METAPLASIA, SCLEROSING AND BLUNT DUCT. ADENOSIS. E. BREAST, ADDITIONAL DEEP MARGIN, RESECTION: -BREAST TISSUE, NEGATIVE FOR TUMOR. F. BREAST, ADDITIONAL MEDIAL MARGINS, RESECTION: -BENIGN BREAST TISSUE WITH SCLEROSING ADENOSIS AND FOCAL ATYPICAL DUCTAL. HYPERPLASIA. Invasive Breast Cancer Template. INVASIVE TUMOR: Histologic type: Ductal. Tumor Size : 3.3x2.6x2.5 cm. Size of Invasive Focus: 3.3x2.6x2.5 cm. Grade, Histologic: 3. Grade, Nuclear: 3. Mitoses : 3. Scarff Bloom Richardson grade: III. Necrosis: present. Invasion Vasc/Lymphatic: present. DCIS component. DCIS Quantity: <25%. DCIS Type: solid. DCIS Location: Inside main mass. Nuclear grade: high. Necrosis: absent. Margins: Negative. Lymph nodes: Positive (1/3). Micrometastases: Yes. Extranodal extension: no. Stage, Pathology : pT2N1a (see below). Non-neoplastic areas: Fibrocystic changes with sclerosing and blunt duct adenosis. Hormone receptor status & HERCEPTEST: Previously done,. SPECIMEN(S): A. SENTINEL LMYPH NODE LEFT AXILLA #1 B. SLNODE LEFT AXILLA 2 C. SLNODE 3 D. WIDE. EXCISION LEFT BREAST E. ADDITIONAL DEEP MARGIN F. ADDITIONAL MEDIAL MARGIN. CLINICAL HISTORY: year old with left breast ca. FROZEN SECTION DIAGNOSIS: A. SENTINEL LYMPH NODE LEFT AXILLA #1. Touch Prep: Negative by Dr., called to Dr at. B. SENTINEL LYMPH NODE LEFT AXILLA #2. Touch Prep: Negative by Dr., called to Dr al. C. SENTINEL LYMPH NODE #3. Touch Prep: Negative by Dr., called to Dr. a. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE LEFT AXILLA #1. Received fresh is a 1.8x0.9x0.8cm. lymph node. The lymph node is bisected to reveal tan pink. homogenous cut surface. Touch preparation is made. The specimen is submitted in toto in one. cassette. B. SENTINEL LYMPH NODE LEFT AXILLA #2. Received fresh are two pieces of tan pink soft tissue measuring 0.4x0.4x0.3cm. each. One of them is. recognized as lymph node which is bisected. Touch preparations are made. The specimen is submitted. in toto in one cassette. C. SENTINEL LYMPH NODE #3. Received fresh is one lymph node measuring 1.3x0.8x0.3cm. It is bisected. Touch preparations are. made. The specimen is submitted in toto in one cassette. D. WIDE EXCISION LEFT BREAST. Received fresh is an oriented portion of firm breast tissue measuring 7.5x7x4.5cm. The specimen is. inked and sectioned to reveal a 3.3x2.6x2.5cm. white firm tumor mass, located 0.5cm. from the. posterior margin, 1.5cm. from superior margin, 0.4cm. from the medial margin, 0.7cm. from the inferior. margin. One section from the tumor is submitted for tissue procurement. A separate white nodule. measuring 0.3cm. in diameter is located 1.2cm. from the main tumor mass. This nodule is .1cm. from. the medial margin. Representative sections are submitted as follows: D1-D4: tumor mass with adjacent margin, representative. D5: separate nodule in toto. D6-D9: representative sections from normal looking breast tissue. E. ADDITIONAL DEEP MARGIN. Received in formalin is an unoriented portion of breast tissue measuring 2.2x2.5x1.5cm. The specimen. is inked and serially sectioned to reveal tan yellow lobulated cut surface. No gross lesion is identified. Representatives are submitted in two cassettes. F. ADDITIONAL MEDIAL MARGIN. Received in formalin is one fragment of tan yellow to pink soft to firm tissue measuring 2.7x2x1.5cm. The specimen is inked and serially sectioned to reveal tan fibrotic cut surface. No gross lesion is. identified. The specimen is submitted in toto in two cassettes. Microscopic/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final: Pathologist,.",BRCA,1,True,"The T stage is determined by the size of the tumor. In this report, the tumor size is given as 3.3x2.6x2.5 cm, which is larger than 2 cm but not more than 5 cm, corresponding to a T2 stage. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage. Direct extension to the skin or chest wall is not mentioned in the report, so it does not upstage the T stage to T4.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
Tumor stage is determined by the T, N, and M categories, with T representing the size and extent of the primary tumor, N representing the involvement of nearby lymph nodes, and M representing the presence of distant metastasis.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.",22.0,1953.0,100.0,True
1293,TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848,1,"OC ID. Gross Description: Breast with the tumor measuring 2.7 x 2.5 cm. Fatty lymph nodes are soft and hyperemic. Microscopic Description: Infiltrating duct carcinoma; G2. Ten examined lymph nodes demonstrate focal fibrosis and lipomatosis. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: T2 tumor size more than 2cm not more than 5 cm, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Central breast. Tumor size: 2.5 x 0x 2.7 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Axillary 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Left, upper inner quadrant (central).",BRCA,0,True,"The report states that the tumor measures 2.5 x 0 x 2.7 cm, which falls in the T2 category of being more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) does not affect the T stage, and tumor grade is not used to determine T stage. Angiolymphatic invasion, extracapsular extension, and the number of lymph nodes examined are also not factors in determining T stage.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.",21.0,1725.0,88.0,True
1085,TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070,3,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF LMP. DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: CONSULT: Right breast mass: core biopsy positive for carcinoma. ER/PR's were done. An ellipse of skin with. breast tissue, 8.5 by 6.5 by 5.0 cm, shows a tumor mass, 2.2 by 1.7 by 3.0 cm, located 2.0 cm from post. margin and 1.0 cm from anterior margin. ADDENDA: Addendum. DATE or LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTTRAOPERATVR CONSULTATION: CONSULT: Right breast mass : core biopsy positive for carcinoma. ER/PR's were done. An ellipse of skin. with. breast tissue, 8.5 by 6.5 by 5.0 cm, shows a tumor mass, 2.2 by 1.7 by 3.0 cm, located 2.0 cm from post. margin and 1.0 cm from anterior margin. MACROSCOPIC DESCRIPTION: S U P P L E M is N T A L R P. specimen is received fresh labeled with the patient's name and ""right breast mass"". It consists of an. oval, yellow, soft, lobulated breast tissue, 8.5 by 6.5 by 5.0 cm with surgical sutures and an ellipse of. white-tan skin attached, 5.5 by 1.6 cm in greatest dimension, and is grossly unremarkable. The specimen is. previously inked and sectioned which reveals a 3.0 by 2.2 by 1.7 cm tumor mass, located 2.0 cm from. posterior resection margin and 1.0 cm from anterior resection margin. The tumor mass if firm and focally. hemorrhagic. Representative sections are submitted labeled ""A1-A2"" tumor and anterior resection margin;. ""A3-. A4"" tumor and superior resection margin; ""A5-A6"" lateral resection margin; ""A9-A10"" posterior resection. margin; ""All-A12"" medial resection margin; ""A13-A14"" additional sections of the tumor; ""A15"" skin with. underlying tissue. My signature below is attestation that I have reviewed all slides and agree with the findings as noted. below. FINAL DIAGNOSIS: RIGHT SEGMENTAL MASTECTONT: - MIXED INFILTRATING DUCT AND MUCINOUS CARCINOMA, 3.0 BY 2.2 BY 1.7 CM., GOOD NUCLEAR GRADE (SEE NOTE). - SURGICAL MRGINS ARE NGATIVE FOR TUMOR. DUCTAL CARCINOMA IN-SITU, NON-COMEDO TYPE, PRESENT AT PERIPHERY AND WITHIN THE TUMOR. - SKIN, UNREMARKABLE. NOTE: Neuroendocrine markers will be performed and results will be reported if positive Special stains. including NSE and Grimelius, are positive and support the presence of neuroendocrine features often seen in. this type of breast carcinoma.",BRCA,1,True,"The report states that the tumor size is 3.0 by 2.2 by 1.7 cm. According to the rules provided, T1 tumors are 2 cm or less in size. Therefore, this tumor is a T1 tumor.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin.",T1,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin.",22.0,1944.0,94.0,True
731,TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0,1,"Sex: Female. Ref Physman. ADDENDUM REPORT. BREAST PROGNOSTIC PANEL: Block(A4). TEST. REFERENCE RANGES. Estrogen Receptor: POSITIVE (93%). 1% is Positive. < 1% is Negative. Staining Intensity: Strong. Progesterone Receptor: POSITIVE (60%). 1% is Positive. < 1% is Negative. Staining Intensity: Strong. Ki-67 (MIB1) Proliferation Marker. HIGH (32%). > 20% is High. 10-20% is Borderline. <10% is Low. Her2 by IHC: EQUIVOCAL (2+ staining). 0-1+ Negative. 2+ Equivocal. 3+ Positive. Weak, circumferential membrane staining in > 10% of cancer cells or <30% with strong complete membrane. staining. A reflex to HER-2/neu by FISH (fluorescent in situ hybridization) will be performed and an additional report will follow. These results were interpreted at. Slides from this sample. were evaluated and deemed adequate for ER/PR/Ki-67/. asay conditions were met, including cold ischemia time and fixation. parameters. All controls show appropriate reactivity. [Specific testing information and references have been added to the microscopic description). The original diagnosis remains unchanged. DIAGNOSIS: A. Right breast mastectomy: Invasive mammary carcinoma. Favor pleomorphic lobular carcinoma. Size: 2.2 cm. Architectural score: 3 of 3. Nuclear score: 2 of 3. Mitotic score: 2 of 3. Total score: 7 of 9. Grade 2. Prognostic panel will follow as an addendum. No evidence of in situ carcinoma. No evidence of angiolymphatic invasion. All surgical margins of excision are free of carcinoma. Closest margin is deep and is 1.5 cm. B. Right axiliary sentinel lymph node: One lymph node, Metastatic carcinoma. Size of involvement within the node: 0.3 cm. No evidence of extracapsular extension. Confirmed by staining for pancytokeratin. TMN: T2pN1. CLINICAL HISTORY: Preoperative Diagnosis: Right modified radical mastectomy with sentinel node mapping with frozen section. Invasive mammary carcinoma. ER positive. PR positive. Her-2 negative. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right breast. B. Right axilla sentinel node. GROSS DESCRIPTION: A. The first container A is received labeled with the patient's name. ight breast.' The specimen consists of portion of fibroadipose breast. tissue. and. overlying. skin. measuring 20.0 x 16.5 x 6.0 cm and weighs 643 grams. The skin surface measures 20.0 x 9.2 cm, is light tan, wrinkled. There. are. lesions. seen. grossly. The nipple is eccentrically placed and appears grossly unremarkable. There is no orientation given to the specimen. The. margins have been inked yellow with the exception of the deep margin, which has been inked black. Sectioning reveais a firm gray-tan ill-defined mass. that measures 2.2 x 2.0 x 1.8 cm that is 1.5 cm from the deep margin and is 2.7 from the closest lateral margin. The surrounding breast tissue reveals. yellow-tan fatty fibroadipose tissue. There are no other lesions identified. At the periphery of the breast, there are no lymph nodes identified. Received. with the specimen are three cassettes, one yellow, one green and one blue labeled. Representative sections are submitted in cassettes. labeled. follows: nipple block 1; deep margin overlying the mass in block 2; sections from the mass in blocks 3 through 7; random. sections taken from all four quadrants in blocks 8 through 11. B. The second container B is received in formalin labeled. right axilla sentinel node.' The specimen consists of a portion of fibroadipose. tissue that measures 3.5 x 2.0 x 1.5 cm. Sectioning reveais a single rymph node that measures 1.8 x 0.7 x 0.9 cm. The lymph node is sectioned and is. entirely submitted in two cassettes labeled. MICROSCOPIC EXAMINATION: THERAPEUTIC MARKER ASSAY CONDITIONS. Breast Cancer Analysis using Immuno-histochemistry,. and Pathologist. review. is an automated digital slide creation, management, viewing. and computer-assisted analysis system which aids the pathologist in the detection, classification,. ER/PgR,. and counting of cells of interest thereby standardizing slide scoring through quantitative. HER2/neu Scoring. assessment of marker intensity, size and shape. This laboratory uses a modified version of a FDA. approved test. An antibody other than the FDA approved antibody for the. system. algorithm is used. The performance characteristics of these assays have been determined by. Performance characteristics refer to the analytical performance of the. test. Cold Ischemic. Specimen should be placed in neutral buffered formalin within 1 hour of removal from the patient. Time, Fixative,. and fixed for a minimum of 6 but not in excess of 48 hours. Specimen are processed by routine. Processing. tissue processing methods. Staining Method Used. Staining platform, antibodies and associated reagent below are all manufactured by. and. are FDA approved. ER - Anti-Estrogen receptor (clone SP1) primary antibody is a rabbit monocional antibody (IgG) that. is used for the qualitative detection of estrogen receptor antigens. PgR - Anti-Progesterone Receptor (clone 1E2) primary antibody is a rabbit monocional antibody. Primary. (IgG) that is used for the quantitative detection of the A, B and C isoforms of human progesterone. Antibodies. receptor antigens. Ki-67 - Anti-Ki-67 primary antibody is directed against the C-terminal portion of the Ki-67 antigen,. which is expressed in the nuclei of proliferating cells (normal and neoplastic). The antibody identifies. proliferating activity in sections of formalin-fixed, paraffin-embedded tissue on an automated slide. stainer platform. (IgG) HER-2/neu that is used - PATHWAY for semi-quantitative Anti-HER-2/neu detection (485) of primary antibody is a rabbit monocional antibody. automated ER, PR, HER-2/neu are platform. prepared from sections of formalin-fixed, HER2 antigens. paraffin-embedded tissue on an. slide stainer. Controls. Antigen. A tris based buffer internal elements from normal breast tissue included low protein with expression,. protein All Controls expression, show appropriate reactivity (high protein expression, negative. Retrieval Type. Detection. the covalent with a slightly basic pH, tissue. which, at elevated temperatures is sample. capable of hydrolyzing. bonds formed by formalin in. System Type. Indirect biotin streptavidin detection system.",BRCA,1,True,"The tumor size is reported as 2.2 cm, which falls within the T2 category of being more than 2 cm but not more than 5 cm in size. The T stage is primarily determined by the size of the tumor, and in this case, the size is greater than 2 cm, so the T stage would be T2.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin.",22.0,1944.0,56.0,False
918,TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A,3,"Surgical Pathology: Pinat. CLINICAL HISTORY: Inflammatory breast cancer. GROSS EXAMINATION: A. ""Biopsy of left_breast"", fresh. The specimen consists of a 2 x 0.6 cm. ellipse of tan skin with underlying disc of subcutaneous tissue measuring 3 x. 1.5 x 0.5 cm. Within the subcutaneous tissue is a firm, tan, ill-defined. lesion measuring approximately 2.2 cm in greatest dimension. A portion of the. specimen is submitted for ER/PR studies and to the tissue bank. The remainder. of the specimen is sectioned and submitted in Block A1-A3. Dr. DIAGNOSIS: A. ""BIOPSY OF LEFT BREAST"": BREAST WITH INFILTRATING DUCTAL CARCINOMA (2.2 CM), N.S.A.B.E NUCLEAR GRADE. MODERATELY-DIFFERENTIATED, HISTOLOGIC GRADE 3. COMEDO TYPE INTRADUCTAL CARCINOMA IS PRESENT REPRESENTING 5% OF THE TOTAL. TUMOR VOLUME. LYMPHATIC/VASCULAR INVASION IS PRESENT, BUT NO TUMOR IS SEEN IN DERMAL. LYMPHATICS. SURGICAL MARGINS ARE POSITIVE FOR CARCINOMA. Data. eBrowser Result for. 1 of 1.",BRCA,1,True,"The report states that the largest dimension of the tumor is approximately 2.2 cm, which falls within the range for a T2 tumor (> 2 cm but not more than 5 cm). The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,95.0,True
685,TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0,1,"Diagnosis: Invasive lobular breast carcinoma (maximum diameter 2.5 cm, malignancy grade II), with. excision extending into the healthy tissue. Tumor classification (also taking into account xxxxxxxx): pT2 (maximum diameter 2.5 cm),. pNO sn (0/1), MX, R0, G2 (L0, V0).",BRCA,0,True,"The report indicates that the maximum diameter of the tumor is 2.5 cm. According to the rules provided, T2 tumors are more than 2 cm but not more than 5 cm in size. Therefore, the T stage for this report is T2.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,100.0,True
1066,TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA,0,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: PATH HAS SPECIMEN nnDATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MAST. CLINICAL HISTORY: PATH_HAS SPECIMEN. MATERIAL SUBMITTED:/ RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATTVE CONSULTATION: CONSULT: Right breast: 8.0 by 7.0 by 2.5 cm, with 1.7 by 1.5 by 1.5 cm tumor. All margins grossly negative. ADDENDA: Addendum. FINAL DIAGNOSIS: ER/PR. DMMUNOPEROXIDASE IDENTIFICATION or ESTROGEN AND PROGESTERONI RECEPTORS IS CARRIED OUT ON SLIDE. ""Al"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (95%) AND PROCESTERONE RECEPTOR. (95%) THEREFORE, BOTH ARE INTERPRETED AS POSITIVI. HER-2/NEU. c-erbB2 (HER-2/NEU) IMMUNOSTAININC IS CARRIED OUT ON MAGEE SURGICAL. BLOCK ""D2"" (BREAST CANCER). USING A 1:300 DILUTION or DARO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE DNTRACELLULAR DOMAIN or c-. erb82) WITEOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING IS- IDENTIFIED. THEREFORE, c-erb82. (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 01. FINAL DIAGNOSIS: FINAL DIAGNOSIS: RIGHT SEGMENTAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMO), INTERNEDIATE HISTOLOGIC AND NUCLEAR GRADE. - NOTTINGHAM SCORE 5. - SIZE OF TUMOR 1.7 CM. - RETROGRADE EXTENSION INTO LOBULES IS SEEN. - LYMPHOCYTIC INFILTRATION SEE. - MICROCALCIFICATIONS. - PROLIFERATIVE FIBROCYSTIC CHANGES AND INTRADUCTAL PAPILLOMA. - SCLEROSING ADENOSIS. - MARGINS ARE FREE.",BRCA,0,True,"The report states that the size of the tumor is 1.7 cm, which falls under the T1 category of tumors that are 2 cm or less in size. Specifically, since it's less than or equal to 1 cm, it's a T1b tumor.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T1,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,100.0,True
1010,TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1,2,"P.23/33. SNOSIS: MODIFIED RADICAL MASTECTOMY -. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM SCORE 3; NUCLEAR GRADE 3, TUBULES 3, MITOSIS 3, TOTAL. SCORE 9/9. B. TUMOR SIZE 5.5 CM WITH EXTENSIVE INTRATUMORAL LYMPHOCYTIC INFILTRATION. C. TUMOR LOCATED IN THE UPPER/OUTER AND LOWER/OUTER QUADRANT. D. DUCTAL CARCINOMA IN-SITU, NUCLEAR GRADE 3, SOLID AND CRIBRIFORM WITH COMEDO NECROSIS. PRESENT ADMIXED WITH TUMOR AND ACCOUNTS FOR 25% OF TUMOR MASS. E. ANGIOLYMPHATIC INVASION IDENTIFIED. F. POSTERIOR MARGIN OF UPPER/OUTER AND LOWER/OUTER QUADRANT FREE OF TUMOR. CLOSEST. MARGIN IS POSTERIOR MARGIN WHICH IS 0.6 CM AWAY FROM THE TUMOR. G. BIOPSY SITE CHANGES. H. ESTROGEN RECEPTOR IS NEGATIVE, PROGESTERONE RECEPTOR IS NEGATIVE, HER-2/NEU IS NEGATIVE. (1+) PER CORE BIOPSY. 1. ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA (see comment). J. TEN OF TWENTY-ONE LYMPH NODES WITH METASTATIC CARCINOMA (10/21)WITH EXTRACAPSULAR. SPREAD IN ONE. K. FIBROCYSTIC CHANGES, WITH DUCTAL EPITHELIAL HYPERPLASIA AND APOCRINE METAPLASIA. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 5.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 5.5 cin. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASIN: CALCIFICATION: TUMOR TYPE, IN SITU: Cribriform. Solid. Comedo. DCIS admixed and outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 6 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 6 mm. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 10. LYMPH NODES EXAMINED: 21. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 28 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NOOE (IF APPLICABLE): SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH, FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pNX. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: ncgative. PROGESTERONE RECEPTORS: negative. HER2/NEU:",BRCA,3,True,"The report indicates that the size of the tumor is 5.5 cm, which falls under the T3 category of 'tumors more than 5 cm in size'. The presence of ductal carcinoma in situ (DCIS), angiolymphatic invasion, and positive surgical margins do not affect the T stage determination.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T3,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,100.0,True
1159,TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566,0,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. ender: F. Material: Total organ resection - left breast and axillary tissues. Unit in charge: (. Material received on: : Expected time of examination: up to 8 working days. Clinical diagnosis: Macroscopic breast'sized 24 x 19.5 x 5 cm removed with axillary tissues sized 10 x 7 x 2.5 cm and a skin flap of 24 x 12 and cm. 0 Tumour from sized the. description: Left 1.9 x 1.3 x 1.4 found in the subaurolar part, located 5.2 cm from the upper boundary, 2.8 cm from the base cm. skin. Metastatic lymph nodes 2 cm in length. Microscopic description: Carcinoma Foci of carcinoma ductale in situ DCIS detected within the tumour (cribrate and solid type with high nuclear atypia with comedo. ductale invasivum - NHG2 (3+2+1/6 mitoses/10 HPF - visual area 0.55 mm). necrosis, 5% of the tumour). Mamilla sine laesionibus. Glandular tissue showing lesions of the type mastopathia fibrosa. AXILLARY LYMPH NODES. Metastases carcinomatosae in lymphonodis (No IX/XV). Infiltratio capsulae lymphonodis et telae perinodalis. Histopathological ductale invasivum et ductale in situ mammae sinistrae. Invasive ductal and in situ ductal carcinoma of the IX/XV). left breasty. diagnosis: Carcinoma Metastases carcinomatosae in lymphonodis axillae (No IX/XV). Cancer metastases of the axillary lymph nodes (No. (NHG2, pTic, pN2a). page 2 / 2. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTestTM by DAKO. Negative reaction in invasive cancerous cells ( Score = 1+ ).",BRCA,2,True,"The report states that the tumor measures 1.9 x 1.3 x 1.4 cm, which is larger than 2 cm but not more than 5 cm, meeting the criteria for a T2 stage. The presence of ductal carcinoma in situ (DCIS) and lymph node metastases do not affect the T stage.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,100.0,True
1229,TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84,1,"SPECIMENS: A. SENTINEL NODE #1 LEFT AXILLA. B. SENTINEL NODE #2 & #3 LEFT AXILLA. C. SENTINEL NODES #4 & #5. D. SENTINEL NODE #6 LEFT AXILLA. E. SENTINEL NODE #7 & #8 LEFT AXILLA. F. SENTINEL NODE #9 LEFT AXILLA. G. LEFT BREAST. H. LEFT AXILLARY CONTENTS. DIAGNOSIS: A. SENTINEL NODE #1 LEFT AXILLA: -METASTATIC CARCINOMA TO ONE OUT OF ONE LYMPH NODE, CONSISTENT WITH. METASTASIS FROM PRIMARY BREAST CARCINOMA (1/1). B. SENTINEL NODE #2 AND #3 LEFT AXILLA: - TWO LYMPH NODES - NEGATIVE FOR TUMOR (0/2). C. SENTINEL NODE #4 AND #5: - TWO LYMPH NODES - POSITIVE FOR METASTATIC CARCINOMA (2/2). D. SENTINE NODE #6 LEFT AXILLA: - METASTATIC CARCINOMA TO TWO OUT OF THREE LYMPH NODES. WITH LYMPHOVASCULAR INVASION (2/3). E. SENTINEL NODE #7 AND #8 LEFT AXILLA: - METASTATIC CARCINOMA TO ONE OUT OF ONE LYMPH NODE. WITH PERINODAL FAT EXTENSION CONSISTENT WITH METASTASIS. FROM PRIMARY BREAST CARCINOMA. F. SENTINEL NODE #9 LEFT AXILLA: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). G. LEFT BREAST, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE III WITH ASSOCIATED. FOCI OF DUCTAL CARCINOMA IN SITU, SOLID, COMEDO PATTERN,. HIGH NUCLEAR GRADE. - SIZE OF TUMOR- 3.2 X 2.2 X 2.0 CM. - DEEP MARGINS OF RESECTION - NEGATIVE FOR TUMOR. - SKIN AND NIPPLE - NEGATIVE FOR TUMOR. - FOCAL COLUMNAR CELL CHANGE WITH FOCAL. MICROCALCIFICATIONS. - FOCAL RESORBING FAT NECROSIS AND HEMORRHAGE ,CONSISTENT WITH POST. BIOPSY SITE CHANGES. H. LEFT AXILLARY CONTENTS: - EIGHTEEN LYMPH NODES - NEGATIVE FOR TUMOR (0/18). BREAST CANCER TEMPLATE. Specimen type: Mastectomy. Needle localization: Laterality: Left. INVASIVE TUMOR: Present. Multifocal: Histologic type: Ductal. Tumor Size (cm): 3.2 x 2.2 x 2.0 cm. Size of Invasive Focus: 3.2 x 2.2 x 2.0 cm. Tumor site: Lower outer quadrant. Grade, Histologic: 3. Grade, Nuclear: 3. Grade, Mitotic: III. Modified Scarff Bloom Richardson grade: Necrosis: Present. Invasion Vasc/Lymphatic: Present. DCIS COMPONENT: DCIS Quantity: Estimate 20%. DCIS Type: Comedo; Solid. DCIS Location: Associated with invasive tumor. DCIS Size: Nuclear grade: High. Necrosis: Present. Location of Ca++: DCIS; Benign Epithelium. DCIS correlates with Ca++ in sections: Margins: Negative. Lobular Neoplasia: None. Lymph nodes: Positive (6/28); Sentinel lymph node. and axillary dissection. Isolated tumor cell clusters: Micrometastases: Extranodal extension: Non-neoplastic areas: columnar cell change. Hormone receptor status (by IHC): Biomarker report (from previous bx -. - ER, negative; PR, negative. HERCEPTEST (by IHC): Her2/neu - positive 3+ (100%). Pathologic Stage : pT2 N2. SPECIMEN(S): A. SENTINEL NODE #1 LEFT AXILLA. B. SENTINEL NODE #2 & #3 LEFT AXILLA. C. SENTINEL NODES #4 & #5. D. SENTINEL NODE #6 LEFT AXILLA. E. SENTINEL NODE #7 & #8 LEFT AXILLA. F. SENTINEL NODE #9 LEFT AXILLA. G. LEFT BREAST. H. LEFT AXILLARY CONTENTS. CLINICAL HISTORY: None given. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA: Lymph node, sentinel #1, excision: Positive for carcinoma. (Microscopic). By Dr called in at. C. Breast, left, mastectomy: Margins are grossly negative for tumor. By Dr called in at. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated A. sentinel lymph. node #1 left axilla is a beige-tan lymph node measuring 0.8x0.5x0.4cm. The specimen is bisected,. touch preps are performed. The entire specimen is submitted in a cassette labeled A1. B. SENTINEL LYMPH NODES #2 & #3, LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated B. sentinel lymph. nodes #2 & #3 is a portion of firm red-tan fibroadipose tissue measuring 5.5x2.0x1.0cm Two beige-tan. lymph nodes are identified. The specimen is serially sectioned, touch preps are performed. The. specimen is submitted in toto in blocks B1-B3. C. SENTINAL LYMPH NODES #4 & #5, LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated C. sentinel nodes #4. & #5 are two beige-tan firm lymph nodes. The larger measuring 1.5x1.0x0.9cm. The smaller. measuring 0.4x0.3x0.3cm. The entire specimen is submitted for microscopic evaluation. Cassettes are. submitted as follows: C1: the smaller lymph node. C2: the larger lymph node serially sectioned. D. SENTINEL LYMPH NODE #6, LEFT AXILLA. Received in formalin in a container labeled with the patient name designated D. sentinel node #6 is a. firm beige-tan lymph node measuring 1.0x0.9x0.7cm. specimen is bisected and submitted entirely in. cassette D1. E. SENTINEL LYMPH NODE #7 & #8, LEFT AXILLA. Received in formalin in a container labeled with the patient name designated E. sentinel node is a group. of beige-tan, firm, matted lymph nodes, measuring in aggregate 2.2x1.9x0.7cm. The specimen is. bisected and submitted entirely in cassette E1-E2. F. SENTINEL LYMPH NODE #9, LEFT AXILLA. Received in formalin in a container labeled with the patient name designated F. sentinel node #9 left. axilla is a firm beige-tan lymph node with attached adipose tissue. The lymph node measures. 0.4x0.4x0.3cm. The entire specimen is submitted in cassette F1. G. LEFI BREAST. Received in fresh state with patient's name and identification number and labeled ""left breast"". The. specimen consists of a left mastectomy specimen weighing 797 grams and with total dimensions of. 26.0 x 19.0 x 5.5 cm. There is an attached stitch indicating the left axillary tail area of the breast. Overlying skin measures 18.0 x 12.0 cm. The nipple is erect and grossly not remarkable,and shows no. areas of ulceration. There is a firm palpable mass noted along the supero-central aspect of the. specimen, which on serial cut section shows an ill-defined, firm, nodular mass with ill-defined borders. measuring 3.2 x 2.2 and 2.0 cm with focal areas of hemorrhage. The remainder of the specimen. consists mostly of fatty breast tissue parenchyma with alternating strands of fibrous stroma. The deep. margin is inked black. Grossly, the tumor is is seen 0.9 cm from the nearest superior margin. There is. no other identifiable tumor focus and scant axillary fat shows predominantly adipose tissue with possible. tiny 0.1 cm lymph node. Multiple sections are submitted and labeled as follows: G1-G2: bisected anterior margin adjacent to mass. G3: skin and mass. G4-G5: tissue inferior to mass, bisected. G6: deep margin. G7-G12: sections of mass. G13-G14: fibrous tissue from superior inner quadrant. G15-G18: fibrous and firm tissue from superior outer quadrant. G19-G20: fibrous tissue from inferior outer quadrant. G21-G22: fibrous tissue from lower inner quadrant. G23-G24: nipple and subjacent tissue perpendicularly sectioned. G25: 1 possible axillary lymph node. H. LEFT AXILLARY CONTENTS. Received in formalin and labeled ""left axillary contents"" is an aggregate of pink-yellow soft tissue. measuring 9.0x5.5x1.8cm 16 possible lymph nodes are found, ranging in size from 0.1 to 1.7cm. Nodes are submitted in toto as follows: H1: 6 possible lymph nodes. H2-H6: 2 bisected lymph nodes each. ADDENDUM: Correction of typographical error on template regarding tumor site. Should read as follows: Tumor site - upper outer quadrant. Microscopic/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologist. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Review: Pathologist,. Addendum Final: Pathologist,.",BRCA,2,True,"The T stage is determined by the size of the tumor. In this report, the size of the tumor is 3.2 x 2.2 x 2.0 cm, which is larger than 2 cm but not more than 5 cm, corresponding to a T2 stage. The presence of ductal carcinoma in situ (DCIS), lymphovascular invasion, perinodal fat extension, and isolated tumor cell clusters do not affect the T stage determination.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,100.0,True
1145,TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07,2,"page 1 / 1. copy No. Examination: Histopathological examination. Gender: F. Material: 1. Multiple organ resection - left breast with axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the breast. Macroscopic description: Left breast-sized 22.4 x 14.2 x 5.3 cm removed along with axillary tissues sized 8 x 9 x 3.5 cm and a 24.3 x 8.2 cm skin flap. Weight 860 g. Tumour sized 5 x 3.5 x 5.5 cm found on the boundary of outer quadrants, 2.4 cm from the upper boundary, 0.4 cm from the base. and 1.6 cm from the skin. Microscopic description: Carcinoma ductale invasivum (partim mucinosum) - NHG2 (2+2+3/24 mitoses/10 HPF - visual area: 0.55mm). Carcinoma intraductale mamillae. Glandular tissue with lesions of the type mastopathia fibrosa. Invasive lesions 0.5 cm away from the base. AXILLARY LYMPH NODES: Metastases carcinomatosae in lymphonodis (No II/XLIII). Histopathological diagnosis: Carcinoma invasivum partim mucinosum mammae sinistrae. Invasive ductal and partially mucinous carcinoma of the left breast.'. Metastases carcinomatosae in lymphonodis axillae (No II/XLIII). Cancer metastases in axillary lymph nodes. (NHG2, pT3, pN1a). Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Positive reaction in invasive carcinoma cells ( Score = 3+ ).",BRCA,1,True,"The tumor size is 5 x 3.5 x 5.5 cm, which is more than 5 cm, meeting the criteria for T3 as per the rule: 'T3 tumors are more than 5 cm in size.'","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T3,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,100.0,True
1004,TCGA-BH-A0DQ.D644B589-A6ED-4DCC-97D4-751E22AE3A7D,1,"P.13/33. INAL DIAGNOSIS: PART 1: BREAST, RIGHT. SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, NOS TYPE, MODERATELY DIFFERENTIATED,. B. THE TUMOR MEASURES 2.3 CM (GROSS MEASUREMENT), NOTTINGHAM SCORE 6/9 (TUBULES 2. NUCLEAR GRADE 2, MITOSES 2), OVERALL GRADE 2/3. c. DUCTAL CARCINOMA IN-SITU (DCIS), CRIBRIFORM TYPE WITH ASSOCIATED COMEDO NECROSIS,. NUCLEAR GRADE 2. COMPRISING 5% OF TOTAL TUMOR VOLUME AND IS PRESENT IN ASSOCIATION. WITH INVASIVE CARCINOMA. D. NO DEFINITIVE LYMPHOVASCULAR INVASION IS SEEN. E. MARGINS: THE INVASIVE CARCINOMA EXTENDS TO THE SUPERIOR MARGIN, REMAINDER OF MARGINS. ARE FREE. F. ATYPICAL DUCTAL HYPERPLASIA, FLAT EPITHELIAL ATYPIA. FIBROCYSTIC CHANGES WITH. ASSOCIATED CALCIFICATIONS, DUCTAL EPITHELIAL HYPERPLASIA, FIBROADENOMATOID NODULE AND. PREVIOUS BIOPSY SITE CHANGES. G. ER-POSITIVE, PR-POSITIVE, HER 2/NEU-NEGATIVE (IHC SCORE 0), CROSS REFER. PART 2: #1 SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. A. ONE LYMPH NODE POSITIVE FOR MICRO METASTATIC CARCINOMA (1/1). B. THE METASTATIC FOCUS MEASURES 1MM (ON GLASS SLIDE), NO EXTRA CAPSULAR EXTENSION IS. IDENTIFIED. PART 3: #2 SENTINEL LYMPH NODE. RIGHT AXILLA, BIOPSY -. ONE BENIGN LYMPH NODE, NO TUMOR SEEN (0/1). PART 4: #1 NON-SENTINEL LYMPH NODE, RIGHT AXILLA, BIOPSY -. Site: breast, NOS C50.9 3/0/11 lew. CASE a NUT VIN. ONE BENIGN LYMPH NODE, NO TUMOR SEEN (0/1). LATERALITY: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. PROCEDURE: Right. Segmental. SIZE OF TUMOR: Not specified. MULTICENTRICITY/MULTIFOCALITY OF Maximum INVASIVE dimension FOCI: invasive component: 2.3 cm. TUMOR TYPE (Invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 2. Tubule formation: 2. Mitotic activity score: 2. Total Nottingham score: 6. JUDD:0644B589-A6ED-4DCC-97D4-751E22AE3A70. ANGIOLYMPHATIC INVASION: Nottingham grade (1. 2, 3): 2. DERMAL LYMPHATIC INVASION: CALCIFICATION: Not applicable. TUMOR TYPE, IN SITU: Cribriform. Comedo. DCIS admixed with invasive carcinoma. SURGICAL MARGINS INVOLVED BY INVASIVE Percent of COMPONENT: tumor occupied by in situ component: 5 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Yes, focal. LYMPH NODES POSITIVE: LYMPH NODES EXAMINED: 1. ME I MOU(S) OF LYMPH NODE EXAMINATION: 3. SENTINEL NODE METASTASIS: H/F stain. SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) 1 inm. METASTASES TO IPSILATERAL INTERNAL No MAMMARY LYMPH NODE (IF APPLICABLE): T ADH No. N STAGE, PATHOLOGIC: pT2. M STAGE, PATHOLOGIC: pN1mi. ESTROGEN RECEPTORS: pMX. PROGESTERONE RECEPTORS: positive. HER2/NEU: positive. zero or 1+.",BRCA,1,True,"The report states that the size of the tumor is 2.3 cm, which falls under the T2 category of tumors that are more than 2 cm but not more than 5 cm in size. The presence of ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia do not affect the T stage, and the absence of lymphovascular invasion also does not impact the T stage determination.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",T2,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination.",22.0,2134.0,100.0,True
879,TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7,2,"Final Diagnosis. Breast, right, simple mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III) [tubules 3/3, nuclei 1/3,. mitoses. 1/3;. Nottingham score 5/9], forming a mass (5.7 x 4.8 x 2.1 cm) located in the mid outer quadrant of the breast [AJCC pT3]. Lobular. carcinoma in situ is identified. Angiolymphatic invasion is present. The non-neoplastic breast parenchyma is unremarkable. Biopsy site changes are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All surgical. resection margins, including the deep margin, are negative for tumor (minimum tumor free margin, 0.3 cm, deep margin). Lymph node, right axillary sentinel, excision: A single (1 of 1) right axillary sentinel lymph node is positive for metastatic. carcinoma. Extranodal extension is not present. Blue dye is identified. Lymph nodes, right axillary, dissection: Multiple (14 of 16) axillary lymph nodes are positive for metastatic carcinoma [AJCC. pN3]. Breast, left, simple mastectomy: Proliferative fibrocystic disease without atypia characterized by ductal hyperplasia, usual type,. sclerosing adenosis, parenchymal fibrosis, and cyst formation. Her-2/NEU has been ordered on paraffin-embedded tissue.",BRCA,3,True,"The T stage is determined by the size of the tumor. In this report, the tumor size is 5.7 x 4.8 x 2.1 cm, which is larger than 5 cm, classifying it as a T3 tumor. The presence of lobular carcinoma in situ, angiolymphatic invasion, and negative surgical margins do not affect the T stage determination.","T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination. The presence of multiple tumors does not change the T stage determination if the largest tumor size is used.",T3,"T stage is determined by the size of the tumor, unless there is direct extension to the chest wall or skin.
T1 tumors are 2 cm or less in size, with T1a being less than or equal to 0.5 cm, T1b being greater than 0.5 cm but less than or equal to 1 cm, and T1c being greater than 1 cm but less than or equal to 2 cm.
T2 tumors are more than 2 cm but not more than 5 cm in size.
T3 tumors are more than 5 cm in size.
T4 tumors are of any size with direct extension to the chest wall or skin.
No lymph node involvement indicates an N0 stage.
The absence of distant metastasis indicates an M0 stage.
Tumor grade is not used to determine T stage, but it is still important diagnostic information.
The presence of ductal carcinoma in situ (DCIS) does not affect the T stage.
The presence of metastases in lymph nodes is determined by the N category, not the T category.
Angiolymphatic invasion is not a factor in determining T stage.
The presence of positive surgical margins does not affect the T stage.
Tumor size is the primary factor in determining T stage.
Tumor grade is not used to determine the overall cancer stage, but it is still important diagnostic information.
Tumor grade is determined by nuclear grade, tubule formation, and mitotic activity.
Tumor stage is not determined by the number of lymph nodes examined or the method of lymph node examination.
The presence of extracapsular extension in lymph nodes is determined by the N category, not the T category.
Tumor stage is based on the largest tumor size, even if there are multiple tumors.
Direct extension to the skin or chest wall upstages the T stage to T4.
Lymph node status is determined by the N category.
Distant metastasis is determined by the M category.
Tumor stage is based on the size of the tumor, with T1 being 2 cm or less, T2 being more than 2 cm but not more than 5 cm, T3 being more than 5 cm, and T4 being any size with direct extension to the chest wall or skin. The presence of inflammatory breast cancer, lymphatic/vascular invasion, moderately-differentiated histologic grade 3, and positive surgical margins do not affect the T stage determination. The presence of multiple tumors does not change the T stage determination if the largest tumor size is used.",22.0,2243.0,98.0,True
